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ABSTRACT 
This work describes the development of Brønsted acid catalyzed asymmetric acetalization of 
aldehydes and its application to kinetic resolution of chiral diols.  
In the first part, the first asymmetric version of the direct O,O-acetalization of 
aldehydes with 1,2- and 1,3-diols is presented. The reaction is catalyzed by chiral confined 
Brønsted acids, which are based on an imidodiphosphoric acid moiety and can provide 
structurally versatile confined chiral microenvironments. A new confined catalyst significantly 
outperformed previously established phosphoric acids and their derivatives, giving highly 
enantioenriched acetal products. The catalyst is readily prepared from the natural product 
thymol, possessing isopropyl and methyl substituents in the 2- and 5-position, respectively, on 
the aryl group providing a more rigid catalyst structure. A highly enantioselective reaction can 
be performed delivering acetals with excellent enantioselectivity (er up to 99.8:0.2) and 
excellent yields. The method tolerates both aliphatic and aromatic aldehydes delivering the 
corresponding acetal products with high enantioselectivities. 
 The second part of this thesis describes a highly enantioselective kinetic resolution of 
chiral racemic diols through acetal formation employing the thymol derived imidodiphosphoric 
acid catalyst and an even bulkier catalyst which possesses a cyclohexyl substituent instead of 
the isopropyl substituent in the 2-position on the aryl group. The reaction is highly efficient for 
the resolution of diols with tertiary alcohol stereocenters, giving selectivity factors of up to 
389. Remarkably, in cases where the selectivity factors are only moderate, highly 
enantioenriched diols can still be obtained via a stereodivergent resolution to diastereomeric 
acetals. This approach can be used for resolution of 1,2-diols possessing similar aliphatic 
substituents at the tertiary alcohol stereocenter. 
Initial studies regarding the development of related asymmetric S,O- and S,S-
acetalizations are also presented in this thesis. 
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KURZZUSAMMENFASSUNG 
Diese Arbeit beschreibt die Entwicklung einer Brønstedsäure-katalysierten asymmetrischen 
Acetalisierung von Aldehyden und deren Anwendung in der kinetischen Racematspaltung von 
chiralen Diolen.  
Im ersten Teil dieser Arbeit wird die erste asymmetrische direkte O,O-Acetalisierung 
von Aldehyden mit 1,2- und 1,3-Diolen vorgestellt. Die Reaktion wird durch chirale sterisch 
anspruchsvolle Brønstedsäuren katalysiert, die eine Imidodiphosphorsäure-Einheit enthalten 
und eine Vielzahl chiraler Mikroumgebungen ermöglichen. 
Ein neuer sterisch anspruchsvoller Katalysator lieferte deutlich bessere Ergebnisse als 
bisher etablierte Phosphorsäuren und deren Derivate und ermöglichte die Synthese hoch 
enantiomerenreiner Acetale als Produkte. Der Katalysator ist leicht zugänglich und kann 
ausgehend vom Naturstoff Thymol synthetisiert werden, welcher einen Isopropyl- und Methyl-
Substituenten in der 2- und 5-Position besitzt und so eine starre Katalysatorstruktur aufweist. 
Dies ermöglicht die Synthese von Acetalen mit exzellenter Enantioselektivität (er bis zu 
99.8:0.2) und hoher Ausbeute. Die Methode toleriert sowohl aliphatische als auch aromatische 
Aldehyde und liefert die entsprechenden Acetale in hohen Enantioselektivitäten. 
Der zweite Teil dieser Arbeit beschreibt eine hochselektive kinetische Racematspaltung 
von racemischen Diolen durch Acetalbildung. Hierfür wurde eine sterisch anspruchsvollere 
Imidodiphosphorsäure mit Cyclohexyl- und Methyl-Substituenten in der 2-und 5-Position der 
Aryl-Gruppe verwendet. Die Reaktion ist sehr effizient für die Auftrennung von Diolen mit 
tertiären Alkohol-Stereozentren und liefert Selektivitätsfaktoren von bis zu 389. In Fällen, in 
denen der Selektivitätsfaktor geringer ist, können trotzdem enantiomerenreine Diole durch 
eine stereodivergente Racematspaltung zu diastereomeren Acetalen erhalten werden. Diese 
Methode kann zur Racematspaltung von 1,2-Diolen mit ähnlichen Substituenten am tertiären 
Stereozentrum angewandt werden. 
Erste Untersuchungen zur Entwicklung von asymmetrischen S,O- und S,S-
Acetalisierungen werden ebenfalls in dieser Arbeit vorgestellt. 
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VI 
Et ethyl 
ESI electrospray ionization 
GC (GC-MS) gas chromatography (gas chromatography coupled with mass detection) 
H8-BINOL 5,5’,6,6’,7,7’,8,8’-octahydro-1,1’-bi-2-naphtol 
HOMO highest occupied molecular orbital 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectrometry 
HX* designating chiral Brønsted acids, e.g. chiral phosphoric acid diesters 
L ligand (abbreviation used in schemes) 
LUMO  lowest unoccupied molecular orbital 
m meta 
m multiplet 
M metal (abbreviation used in schemes) 
M molar (concentration) 
Me methyl 
MS mass spectrometry, molecular sieves 
MTBE methyl tert-butyl ether 
MW molecular weight 
m/z atomic mass units per charge 
N normal (concentration) 
nbd norbornadiene 
NMR nuclear magnetic resonance spectroscopy 
NOE(SY) nuclear Overhauser effect (spectroscopy) 
NuH/Nu nucleophile 
o ortho 
p para 
PG protecting group 
Ph phenyl 
PMP para-methoxyphenyl 
Pr propyl 
PTSA para-toluenesulfonic acid 
Py pyridine 
LIST OF ABBREVIATIONS 
 
VII 
quint quintet 
rac. racemic 
r.t. room temperature 
sept septet 
sext sextet 
SPINOL 1,1’-spirobiindane-7,7’-diol 
t tert, tertiary 
t triplet 
TADDOL α,α,α’,α’-tetraaryl-1,3-dioxolan-4,5-dimethanol 
TBS tert-butyl-dimethylsilyl  
TES -SiEt3 
Tf -SO2CF3 
TFA trifluoroacetic acid 
TFAA trifluoroacetic anhydride 
THF tetrahydrofuran 
THP tetrahydropyran 
TLC thin layer chromatography 
TMS trimethylsilyl 
TRIP 3,3'-bis(2,4,6-triisopropylphenyl)-1,1'-binaphthyl-2,2'-diyl hydrogen 
phosphate 
VAPOL 2,2′-Diphenyl-(4-biphenanthrol) 
 
ACKNOWLEDGEMENTS 
 
VIII 
ACKNOWLEDGEMENTS 
I am extremely grateful to Prof. Dr. Benjamin List for giving me the opportunity to work in the 
wonderful research environment of the Max-Planck Institut für Kohlenforschung. I am 
indebted to him for his academic support, for the encouragement to tackle challenging 
problems, and for being always motivating and inspiring. I feel honored to be one of his 
graduate students and to have been exposed to a great scientific atmosphere in the List group.   
 I am grateful to Prof. Dr. Albrecht Berkessel for accepting to review this thesis and to 
Prof. Dr. Axel Klein and Dr. Martin Klußman for serving on my defense committee. I also thank 
Mattia Monaco, Gabriele Pupo, Dr. Thomas James, Dr. Manuel van Gemmeren and Dr. Ilija 
Čorić for kindly proofreading this thesis and for their valuable suggestions.  
I would like to thank professors Eun Joo Kang and Kwang-Hyun Ahn for being highly 
inspiring during my master studies. I also thank Prof. Dr. Mikiko Sodeoka for enabling me to 
have valuable research time at RIKEN in Japan.   
I am extremely grateful to Dr. Ilija Čorić who developed the imidodiphosphoric acids 
and worked with me on the acetalization and the kinetic resolution projects. I would also like 
to thank Dr. Chiara Palumbo for collaborating with me on the kinetic resolution project and 
Natascha Wippich for providing me with valuable catalysts. I am grateful to Dr. Philip Kraft 
from the Fragrance Research department of Givaudan Schweiz AG for the odor evaluation of 
my acetal compound. 
I would like to thank Alexandra Kaltsidis and Dr. Monika Lindner for their support in 
various forms, and all of the technician staff, especially Marianne Hannappel, Simone Marcus, 
Hendrik van Thienen, Natascha Wippich, Stefanie Dehn and Arno Döring for the management 
and the assistance in the laboratory and for making it a safe and enjoyable place to work. 
Expertise and support of GC, HPLC, MS, and crystallography departments at the Max-Planck 
Institut für Kohlenforschung is gratefully acknowledged. I am grateful to my colleagues from 
the List, Klußman and Maulide groups for sharing chemicals and for their friendship. I will 
cherish the memory of my stay in Mülheim an der Ruhr and great times I had with my 
labmates. 
 
1. INTRODUCTION           
 
1 
1. INTRODUCTION 
1.1. Catalytic asymmetric synthesis of acetals 
The acetalization of aldehydes with alcohols is one of the most common transformations in 
organic synthesis. Moreover, enantiopure acetals represent a class of important motives in 
many natural products and bioactive compounds.[1-6] Approaches to the synthesis of chiral 
acetals have been investigated over the past decades, nevertheless, these methods are usually 
based on the use of enantioenriched starting materials or reagents.  
The formation of acetals is commonly performed by treating carbonyl compounds with 
an alcohol or a diol in the presence of relatively strong Brønsted acids. The reaction proceeds 
through the formation of oxocarbenium ion intermediates. Strong Brønsted acids are used not 
only for the formation of acetals, but also for cleavage of acetals. The sensitivity of the acetal 
product under acidic conditions makes performing an asymmetric acetalization with 
enantiopure acids challenging. Thus, even if high enantioselectivity is initially induced in an 
asymmetric acetalization reaction, the product may also be activated by the catalysts, 
reversibly forming the oxocarbenium ion intermediate and thus leading to racemization of the 
product (Scheme 1.1). 
 
Scheme 1.1. Reversibility and racemization issues in acetalization reactions. 
To avoid these issues, the acetalization reaction can be run under milder reaction conditions, 
and/or to give cyclic acetals that are usually more stable than acyclic acetals under acidic 
conditions. The racemic version of Brønsted acid catalyzed acetalization of aldehydes with diols 
to give cyclic O,O-acetals has been performed numerous times, however, its asymmetric 
version was entirely unknown prior to the work described in this thesis (Scheme 1.2). We have 
found that a new member of our recently developed class of chiral confined Brønsted acids 
finally enables this elusive transformation with high enantioselectivity. 
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Scheme 1.2. Brønsted acid catalyzed acetalization of aldehydes with diols. 
 
1.2. Kinetic resolution of diols via acetal formation 
Next to ester and silyl groups, acetals are one of the most common protecting groups for 
alcohols. They possess complimentary stability properties to ester and silyl groups during 
further synthetic steps, and also alternative deprotection conditions. The acetal moiety is 
resistant to hydrolysis under mildly acidic conditions and is stable in a range of basic and 
nucleophilic conditions. Acetals are stable in the presence of the fluoride anion, which is 
commonly used to remove silyl groups. Due to usually simple access to racemic alcohols, 
kinetic resolutions present a popular strategy for the preparation of enantioenriched 
compounds (Scheme 1.3). Most practical methods involve reactions that enantioselectively 
introduce a common alcohol protecting group, which can be of use in further synthetic steps. 
Numerous enzymatic and nonenzymatic methods for asymmetric acylation, and more recently 
silylation have been developed providing esters and silyl ethers respectively. However, the 
processes for the kinetic resolution of alcohols via acetal formation were reported only 
recently.[7-8] Kinetic resolutions of diols through the formation of an acetal have not been 
described prior to our work. We have applied our newly developed asymmetric acetalization 
reaction to the kinetic resolution of diols, giving highly enantioenriched diols and acetal 
products. 
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Scheme 1.3. Kinetic resolution of alcohols by placing common protecting groups. 
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1.3. Brønsted acid catalysis with challenging substrates 
Asymmetric Brønsted acid catalysis, in particular with chiral phosphoric acid type catalysts, has 
acquired wide popularity and importance in the field of organocatalysis.[9-10] However, 
substrates are usually required to possess relatively high basicity, sterically demanding 
protecting groups, large aromatic/planar surfaces, and/or bulky substituents to have sufficient 
steric interaction with the catalyst for high asymmetric induction (Figure 1.1).[11] Either strong 
covalent or hydrogen bond interactions between the catalyst and substrates result in high 
asymmetric induction, as successfully demonstrated with, for example, iminium ions. Opposed 
to reactions involving large substrates or possessing a strong interaction between the catalyst 
and substrates, reactions involving small substrates which cannot have sufficient steric 
interaction with the catalyst or possessing weak interactions between the catalyst and 
substrates result in low asymmetric induction. Therefore, for example, successful asymmetric 
addition reactions of nucleophiles to oxocarbenium ions have very rarely been reported.[12-14] 
 
 
Figure 1.1. Asymmetric induction of phosphoric acid type catalysts. 
Recently, the List group designed and reported confined Brønsted acid catalysts that possess 
an extremely sterically demanding chiral microenvironment.[15] We demonstrate the utility of 
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this catalyst class in asymmetric acetalization reactions that involve small and functionally 
unbiased substrates and proceed through oxocarbenium ions intermediates.   
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2. BACKGROUND 
2.1. Asymmetric catalysis 
A structure which is not superimposable with its mirror image is chiral.[3] Chirality results from 
the absence of certain symmetry elements. A chiral element is usually found in molecules 
which contain a tetrahedral carbon atom (stereogenic or chiral center) possessing four 
different substituents. The chirality of molecules can alternatively originate from the presence 
of an axial chirality, a planar chirality or others (Figure 2.1).[16] The two mirror images of a chiral 
compound are therefore not identical and are called enantiomers.  
 
Figure 2.1. Examples of chiral molecules. 
Most molecules in nature are chiral, and living organisms tend to produce only a single 
enantiomer.[17] Enantiomers of a chiral compound are identical in terms of usual physical 
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properties such as boiling point and density. However, enantiomers can behave dramatically 
different in chiral environments that are sensitive to changes in spatial orientation of a single 
functional group. For example, enantiomers of Carvone smell differently, each having its own 
characteristic odor. The tragic case of Thalidomide demonstrated that using chiral drugs as 
racemic mixtures can cause disastrous outcomes, since one enantiomer has sedative 
properties while the other one is teratogenic and induces fetal malformations (Figure 2.2).[3]     
O O
(R)-Carvone
from spearmint oil
(S)-Carvone
from caraway seed oil
N
O
O
NH
O
O N
O
O
NH
O
O
(R)-Thalidomide
sedative properties
(S)-Thalidomide
induces fetal malformations  
Figure 2.2.  Enantiomers with different biological properties. 
These are just two examples where biological systems react differently to one enantiomeric 
form of a certain molecule. Therefore, developing synthesis of chiral molecules in 
enantiomerically pure form by controlling the stereochemistry of chemical reactions is highly 
important.   
 There are basically two options to access single enantiomers, either the racemic 
mixture of a molecule is resolved into separate enantiomers, or the enantioenriched 
compound is produced by asymmetric synthesis. The latter is a more attractive approach, 
because it minimizes the waste of the undesired enantiomer, which is a general drawback of 
resolution strategies. Regarding asymmetric synthesis, the use of starting materials from the 
chiral pool or of chiral auxiliaries are basic approaches which are well established in industrial 
processes. An external chiral auxiliary, which can be recoverable and recyclable, can induce the 
asymmetry in the target molecule. Natural products often are the source of chirality in these 
auxiliaries.[17] 
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 A catalyst is a substance which can participate in chemical reactions, accelerating the 
rate of the reaction, without being consumed. Catalysts can be employed to reaction processes 
to promote a different reaction pathway that involves a lower energy transition state, 
compared to uncatalyzed reactions that proceed through higher energy transition states.  
In asymmetric catalysis which is a fundamental part of asymmetric synthesis, the 
catalyst not only accelerates the reaction but also produces the compounds favoring the 
formation of a specific enantiomer or diastereomer. A small quantity of a chiral, enantiopure 
catalyst can transform a large amount of chiral/achiral starting material into enantiomerically 
pure products.  
Developments of asymmetric catalysis are divided in three main fields: biocatalysis, 
metal catalysis, and organocatalysis.[18] Biocatalysis is based on the use of enzymes and is the 
oldest known synthetic method for asymmetric catalysis. In the field of asymmetric metal 
catalysis, the pioneering contributions were recognized with the 2001 chemistry Nobel Prize to 
William Knowles and Ryoji Noyori for catalytic asymmetric reduction reactions, and to K. Barry 
Sharpless for enantioselective oxidations.  
Next to bio- and metal catalysis, the interest in organocatalysis has increased 
significantly in the last few years.[18-19] Although metal catalysts and biocatalysts have been 
used for a large variety of reactions, organocatalysts seem to be attractive alternatives to a 
number of known metal-catalyzed reactions. Also, organocatalysis enables reactions that are 
not possible with metals or enzymes. Numerous reactions in the field of organocatalysis have 
been developed even overcoming drawbacks from the reactions with metal- and biocatalysis. 
2. BACKGROUND 
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2.2. Asymmetric organocatalysis 
Organocatalysts have recently emerged as a third class of powerful asymmetric catalysts. 
Organocatalysts are purely organic and metal free small molecules which mainly consist of 
carbon, nitrogen, sulfur, phosphorous, and hydrogen. They can readily be designed and 
synthesized and are generally stable toward oxygen and moisture. Thus organocatalyzed 
reactions usually do not require inert atmosphere and high purity solvents which are often 
used in metal catalysis.[20]  
 In early studies of asymmetric reactions employing small organic molecules, Bredig and 
Fiske reported a hydrogen cyanide addition to benzaldehyde catalyzed by cinchona alkaloid in 
1912.[21-22] In 1960 Pracejus developed a cinchona alkaloid promoted asymmetric addition of 
methanol to ketenes.[23] In the early 1970’s a proline catalyzed intramolecular aldol reaction 
has been disclosed  by Hajos and Parrish[24-25] and by Eder, Sauer, and Wiechert.[26-27]  
Although organocatalytic reactions have a long history, the full potential of 
organocatalysis was exposed with initial reports by List and MacMillan. Their independent 
reports showed that aldehydes or ketones can be activated by the use of nonmetallic small 
molecules as catalysts for asymmetric reactions. List described that amino acid L-proline 
catalyzed the direct intermolecular asymmetric aldol reactions by activating acetone as an 
enamine (Scheme 2.1).[28] Enamines are better nucleophiles than the corresponding enols 
having a higher HOMO (highest occupied molecular orbital) energy. The carboxylic acid moiety 
of proline can simultaneously activate the aldehyde electrophile further promoting the 
reactions and fixing the relative special orientation of the substrates required for high 
enantioselectivities.     
O
+
H
O OHO(30 mol%)
DMSO
N
H
CO2H
97%, er 98:2
N
O
R H
enamine
activation
Brønsted acid
activation
O
O
H
 
Scheme 2.1. Proline catalyzed aldol reaction. 
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MacMillan reported that a chiral imidazolidinone catalyst can activate enals to form iminium 
ions promoting a Diels-Alder reaction with dienes (Scheme 2.2).[29] Iminium ions are better 
electrophiles than the corresponding enals (or aldehydes) having a lower LUMO (lowest 
unoccupied molecular orbital) energy. The stereochemistry of the products is explained with 
benzyl group on the catalyst shielding one of the faces of the dienophile leaving the other face 
exposed to cycloaddition.    
 
Scheme 2.2. Imidazolidinone catalyzed Diels-Alder reaction. 
These achievements with well-defined modes of activation have triggered and accelerated the 
development of numerous new activation modes with small organic catalysts. 
 
Classification of modern organocatalysis 
According to the report by Seayad and List in 2004, most organocatalysts can be classified as 
Lewis bases, Lewis acids, Brønsted bases and Brønsted acids.[30] They introduced a 
classification system for organocatalysts based on Brønsted acid/base and Lewis acid/base 
theories (Scheme 2.3). Based on their interaction with substrates, organocatalysts can be 
classified as proton donors (Brønsted acid), proton acceptors (Brønsted base), electron 
acceptor (Lewis acid), and electron donors (Lewis base).  
In Brønsted acid catalysis, the catalyst initiates the catalytic cycle by protonation of substrates. 
The resulting complex proceeds to undergo a reaction, then product and the catalyst are 
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liberated to enable repetition of the catalytic cycle. The Brønsted base catalytic cycle is 
initiated by deprotonation of the substrates. Lewis acid catalysis and Lewis base catalysis are 
conceptually related catalytic modes which involve catalysts that accept or donate electrons, 
respectively, to activate the substrate.        
 
Scheme 2.3. Schematic organocatalytic cycles (A = acid, B = base, S = substrate, P = product). 
Notwithstanding the efforts for classification of organocatalysts, organocatalysts usually 
facilitate these modes concurrently in the reactions. For example, proline’s amino group acts 
as a Lewis base donating its pair of electrons to form a corresponding enamine with aldehydes 
or ketones and simultaneously its carboxylic acid moiety acts as Brønsted acid by activating the 
electrophile utilizing hydrogen bonding and protonation (Figure 2.3).[28] 
 
Figure 2.3. Dual activation mode of proline. 
2. BACKGROUND 
 
12 
2.3. Asymmetric Brønsted acid catalysis 
The use of metal based Lewis acid catalysts has been recognized as efficient approach to 
activate electrophiles, particularly carbonyl groups. Lewis acid catalysts lower the electron 
density of the substrate by accepting a pair of electrons of the substrate and consequently 
inducing nucleophilic attack to the electrophile (Figure 2.4). Chiral Lewis acid catalysts which 
are composed of metal based Lewis acid and a chiral ligand have been employed in numerous 
asymmetric reactions.  
O
HR
MLn*
X
O
HR
H X*H*X
O
HR
X*
H
Lewis acid activation:
Brønsted acid activation:
by hydrogen bonding
by protonation  
Figure 2.4. Activation modes of aldehydes by acids. 
On the other hand, asymmetric Brønsted acid catalysis has been growing significantly in the 
field of organocatalysis enabling the activation of a wide range of functional groups.[31] 
Brønsted acid catalysts are often stable to oxygen and moisture and are easier to handle than 
Lewis acids. The use of metal catalysts can result in traces of toxic metal impurities in the final 
products, which is especially relevant in the pharmaceutical industry. This can be avoided by 
using Brønsted acid catalysts which are metal-free molecules. The activation mode of Brønsted 
acid catalysts involves protonation/deprotonation, and the fact that Brønsted acids can 
activate various organic substrates is well known. However, asymmetric Brønsted acid catalysis 
has been considered difficult because a proton cannot possess substituents which could be 
made chiral. However, since 2004 it has been demonstrated in numerous reactions that the 
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respective counteranion can impart enantioselectivity during the reaction, by hydrogen 
bonding with a protonated substrate.[32-33]  
Chiral Brønsted acid catalysis is generally classified into two categories, general 
Brønsted acid catalysis and specific Brønsted acid catalysis (Scheme 2.4).[34] General Brønsted 
acid catalysis operates when the catalyst activates the substrate by hydrogen bonding and the 
proton transfer occurs to the transition state of the rate determining step. A specific Brønsted 
acid catalysis is the case when the proton is completely dissociated from the catalyst therefore 
the substrate is fully protonated for further transformation.  
 
Scheme 2.4. Simplified catalytic cycles of general and specific Brønsted acid catalysis. 
A given reaction can be categorized to either of these classes depending on the 
substrate and the reaction type. However, it is not always straightforward to classify by these 
two mechanisms. Nonetheless, the nature of the catalyst can be suggested from the pKa value 
of the Brønsted acid (Figure 2.5).[31]  
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Figure 2.5. Types of chiral Brønsted acids. 
 
2.3.1. General Brønsted acid catalysis 
Hydrogen bonding catalysts which can be classified as general acid catalysts are weak Brønsted 
acids. Due to their weak acidity, the proton cannot be fully transferred to the substrate but it 
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activates the substrate by hydrogen bonding interaction. Nature has employed general 
Brønsted acid catalysis in enzyme mediated enantioselective synthesis of organic molecules 
where hydrogen bonding to a transition state occurs. However, highly enantioselective 
catalysis based on this type of activation mode was introduced only very recently. Among 
others, chiral thioureas and the chiral diol TADDOL are the most prominent examples. In 1998, 
Sigman and Jacobsen found that chiral urea and thiourea derivatives can catalyze 
enantioselective hydrocyanation reactions of imines known as Strecker reaction, suggesting 
that the imine substrate interacts with the catalyst through a dual hydrogen bond interaction 
to the urea protons.[35-36] Later, they revised the mechanism of this reaction proposing catalyst 
promoted proton transfer from hydrogen isocyanide to imine and anion binding, rather than 
the direct activation of neutral imine electrophiles by hydrogen bonding (Scheme 2.5).[37-38] 
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Scheme 2.5. Thiourea catalyzed asymmetric Strecker reaction. 
The Rawal group reported a highly enantioselective hetero Diels-Alder reaction between diene 
and benzaldehyde catalyzed by a chiral diol TADDOL (Scheme 2.6).[39] 
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Scheme 2.6. TADDOL catalyzed hetero Diels-Alder reaction. 
These examples are just the tip of the iceberg in this field, and numerous other reactions and 
catalysts have been studied that employ hydrogen bonding catalysis for the activation of 
electrophiles.[36, 40] 
 
2.3.2. Specific Brønsted acid catalysis 
Compared to general Brønsted acid catalysts, relatively stronger Brønsted acid catalysts that 
activate the substrate by fully protonating it can be classified as specific Brønsted acid catalysts. 
The field of asymmetric catalysis with strong Brønsted acids exploded since the reports from 
the Akiyama and Terada groups. The Akiyama group reported a highly enantioselective 
Mannich reaction using a chiral BINOL-derived phosphoric acid as a catalyst (Scheme 2.7).[33]  
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Scheme 2.7. Chiral phosphoric acid catalyzed Mannich reaction by Akiyama et al. 
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The Terada group simultaneously reported an asymmetric Mannich reaction catalyzed by a 
similar chiral BINOL-derived phosphoric acid (Scheme 2.8).[32] Later, however, the Ishihara 
group found that the actual catalyst in this reaction was not the phosphoric acid, but rather its 
calcium salt which was formed during purification on silica gel.[41] 
 
Scheme 2.8. Chiral phosphate catalyzed Mannich reaction by Terada et al. 
After these reports, chiral phosphoric acid catalysis attracted much attention being successfully 
applied to numerous asymmetric reactions.[9-10, 34, 38, 42-43] Chiral phosphoric acids generally 
possess bulky substituents which play a crucial role in enantiofacial discrimination of 
substrates. Furthermore, they enable bifunctional activation modes in which a Brønsted acidic 
site and a basic site simultaneously activate the electrophile and the nucleophile, respectively 
(Figure 2.6).[9]   
 
Figure 2.6. Bifunctionality in chiral phosphoric acids. 
 
2. BACKGROUND 
 
17 
Phosphoric acids and derivatives 
One of the most successful chiral phosphoric acids is the TRIP catalyst which was initially 
reported by the List group (Figure 2.7).[44-46]  TRIP possesses bulky substituents (2,4,6-iPr3C6H2) 
near the active site and was initially applied to the highly enantioselective asymmetric transfer 
hydrogenation of imines.[44-45] Moreover, the TRIP anion can be employed as the counteranion 
in asymmetric counteranion-directed catalysis (ACDC) which was introduced by Mayer and 
List.[47-48] Later this principle has been applied in metal catalysis as well.[49-50] Along with the 
success of BINOL based phosphoric acids, some other chiral scaffolds have been designed and 
investigated aiming at modified geometrical parameters of the active site. The Akiyama group 
introduced a new chiral phosphoric acid catalyst which is derived from TADDOL for Mannich 
type reactions,[51] and the Antilla group developed the VAPOL phosphoric acid for imine 
amidation reactions (Figure 2.7).[52] The Gong group reported the high enantioselective 
Biginelli reaction catalyzed by H8-BINOL-based phosphoric acids which are superior to BINOL 
based analogs in certain cases,[53] and a bis-BINOL-derived phosphoric acid was designed by the 
Du group for the transfer hydrogenation of quinolines (Figure 2.7).[54] In 2010, Lin, Wang and 
coworkers introduced the naphthyl-substituted SPINOL backbone phosphoric acids which are 
based on spirobiindane scaffold and were employed to catalyze the asymmetric Friedel-Crafts 
reaction of indoles with imines (Figure 2.7).[55] The List group reported independently and, 
simultaneously, a kinetic resolution of alcohols via asymmetric transacetalization using the 
2,4,6-iPr3C6H2-substituted SPINOL-derived phosphoric acid (STRIP) as an efficient catalyst 
(Figure 2.7).[56] The Akiyama group developed biphenol-derived phosphoric acids for 
asymmetric C-H bond functionalization via a hydride shift/cyclization reaction (Figure 2.7).[57] 
Two independent reports by Gong and coworkers, and Momiyama and Terada et al. presented 
the development of bisphosphoric acids which were applied to a three component 1,3-dipolar 
cycloaddition reaction, and Diels-Alder reaction of α,β-unsaturated aldehydes with 
amidodienes, respectively (Figure 2.8).[58-59] 
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Figure 2.7. Chiral phosphoric acids and derivatives. 
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Figure 2.8. Bisphosphoric acids. 
Other than phosphoric acids, a binaphthyl derived dicarboxylic acids were used by the 
Maruoka group to achieve an enantioselective Mannich reaction of N-Boc-imines with diazo 
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compounds,[60] and a phosphordiamidic acid was designed by the Terada group for the direct 
Mannich reaction of N-acyl-imines with 1,3-dicarbonyl compounds (Figure 2.9).[61] 
 
Figure 2.9. Other strong chiral Brønsted acids.   
 
Phosphoramides and derivatives 
Although those seminal reports demonstrated that chiral phosphoric acids are highly potent 
catalysts for development of novel asymmetric processes, their usage has been limited to the 
transformations which involve more basic nitrogen-based electrophiles, because of their 
relatively low acidity.[9]  
Towards the development of stronger Brønsted acids that are more reactive and acidic 
than phosphoric acids, various derivatives have been studied by the Yamamoto group. The 
chiral N-triflyl phosphoramide was suggested as a sufficiently strong chiral Brønsted acid 
catalyst to catalyze the asymmetric Diels-Alder reaction of α,β-unsaturated ketones with 
siloxydienes (Figure 2.10).[62] Later they reported N-triflyl thio- and seleno-derivatives for the 
protonation reactions of silyl enol ethers (Figure 2.10).[63] 
 
Figure 2.10. N-triflyl phosphoramides and derivatives. 
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In 2010, the List group reported the direct asymmetric N,O-acetalization of aldehydes 
catalyzed by N-phosphinyl phosphoramides. This is a novel class of stronger Brønsted acids 
possessing the phosphinyl electron-withdrawing group instead of the triflyl group in 
Yamamoto’s catalyst (Figure 2.11).[64] 
 
Figure 2.11. N-phosphinyl phosphoramides. 
 
2.3.3. Confined Brønsted acids 
In the field of asymmetric Brønsted acid catalysis, chiral phosphoric acids were successfully 
employed in a wide range of asymmetric transformations.[9-10, 65] However, substrates have 
often been electronically or sterically biased to achieve high asymmetric induction. BINOL 
backbone chiral phosphoric acids and derivatives have been rationalized as successful catalysts 
in numerous enantioselective reactions due to a strong hydrogen bond between the 
protonated imine substrate and the chiral anion, N+–H···–X* (Figure 2.12).[11] The strong 
hydrogen bond furnishes a structurally organized chiral ion pair, promoting enantioselective 
addition of nucleophiles to imines. A strong covalent or hydrogen bonding interaction between 
the catalyst and the substrates can lead to a well-organized transition state which can result in 
high enantioselectivity. 
 
Figure 2.12. Strong binding of iminium ion with a chiral counteranion. 
On the other hand, substrates or intermediates which possess only very weakly acidic C–H 
bonds, such as oxocarbenium ions, are very rarely found to give high enantioselectivity in 
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asymmetric reactions (Figure 2.13).[12-14] The presence of several weak anion binding sites does 
not enable strong and geometrically restricted interaction with the chiral anion resulting in low 
enantioselectivity.[1, 11]  
 
Figure 2.13. Multiple binding sites of oxocarbenium ion with a chiral counteranion. 
Phosphoric acid type catalysts have imparted selectivity to large substrates which possess 
sterically demanding protecting groups, large aromatic/planar surfaces, or bulky substituents 
being placed in a sterically demanding environment of the catalyst. This sufficient steric 
interaction with the catalyst’s active site is able to accommodate one of the two enantiomeric 
transition states leading to good reactivity and selectivity (Figure 2.14). However, phosphoric 
acid type catalysts are rarely efficient in enabling asymmetric reactions of small aliphatic 
substrates, because of the lack of sterically well defined interactions with the active site of the 
catalyst (Figure 2.14).[11, 15]    
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Figure 2.14. Schematic steric interaction of the phosphoric acid type catalysts. 
To solve the inability of current synthetic Brønsted acid catalysts, in 2012, Čorić and List 
designed and synthesized novel confined Brønsted acid catalysts based on a C2-symmetric 
imidodiphosphoric acids which are able to provide an extremely sterically demanding chiral 
microenvironment (Figure 2.15).[1, 11, 15] 
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Figure 2.15. C2-symmetric imidodiphosphoric acid with small substrate. 
The C2-symmetric imidodiphosphoric acids possess compact chiral environments and induce 
enantioselectivity in reactions involving small molecules/intermediates and featuring less 
organized transition states that for example do not possess strong hydrogen bonding 
interactions between the catalyst and the nucleophile or electrophile. The imidodiphosphoric 
acid which possesses 2,4,6-Et3C6H2 substituents efficiently catalyzed the asymmetric 
conversion of small and further unfunctionalized hydroxyl enolether substrates providing 
various spiroacetals with high enantioselectivity (Scheme 2.9).[15] 
 
Scheme 2.9. Catalytic asymmetric spiroacetalization. 
These confined chiral Brønsted acids were also demonstrated as superior catalysts for the 
asymmetric oxidation of sulfides to sulfoxides with hydrogen peroxide, which is presumably 
bound by the catalyst inside its chiral cavity (Scheme 2.10).[66]  
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Scheme 2.10. Enantioselective organocatalytic sulfoxidation. 
Following these reports, the direct asymmetric acetalization of aldehydes with diols catalyzed 
by chiral imidodiphosphoric acid, which is the topic of this thesis, was developed (chapter 
4.1).[67]  
Recently, the List group reported an asymmetric Prins cyclization of salicylaldehydes 
with homoallylic alcohols catalyzed by cyclohexyl, methyl-substituted imidodiphosphoric acid, 
which was developed during our acetalization studies[68] (Scheme 2.11).[69] 
 
Scheme 2.11. Asymmetric Prins cyclization of salicylaldehydes. 
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The Zhu group showed that the imidodiphosphoric acid which we had earlier introduced for 
the asymmetric acetalization,[11, 67] can promote the enantioselective desymmetrization of 
bicyclic bislactones with alcohols and the products can be utilized as chiral building blocks in 
natural product synthesis (Scheme 2.12).[70] 
 
Scheme 2.12. Enantioselective desymmetrization of bicyclic bislactones. 
The Nielsen group reported that the use of the same imidodiphosphoric acid as a co-catalyst 
promotes an enantioselective oxa-Pictet-Spengler reaction (Scheme 2.13).[71] Allylic ethers 
undergo sequential isomerization to enol ethers catalyzed by ruthenium, and then the 
imidodiphosphoric acid catalyzes the formation of an oxocarbenium ion followed by 
enantioselective endo cyclization.  
 
Scheme 2.13. Dual ruthenium hydride/Brønsted acid catalyzed tandem sequence.  
Other imidodiphosphoric acids were reported and applied to various transformations. The 
Zheng and Zhang group reported asymmetric three-component Mannich reactions catalyzed 
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by the less bulky 1-naphthly substituted imidodiphosphoric acid to give syn-β-amino ketones 
with high enantioselectivity (Scheme 2.14).[72] 
 
Scheme 2.14. Asymmetric three-component Mannich reactions. 
2-Naphthyl imidodiphosphoric acid catalyzed enantioselective Biginelli reactions of aromatic 
aldheydes, thiourea, and ethyl acetoacetate to give dihydropyrimidinethiones were reported 
by the same group (Scheme 2.15).[73] 
 
Scheme 2.15. Enantioselective Biginelli reaction. 
Imidodiphosphoric acids are readily accessible requiring only a single additional synthetic step 
compared to the corresponding phosphoric acids. Thus, catalysts can be derived from various 
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BINOL frameworks with different 3,3’-substituents on two BINOL backbones. The Jiang and 
Zhang group reported enantioselective Friedel-Crafts reactions of pyrrole with trimethylsilyl 
protected 3-arylindolylmethanols catalyzed by imidodiphosphoric acid bearing phenyl and 
naphthyl-substituents respectively on the two BINOL frameworks (Scheme 2.16).[74] 
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Scheme 2.16. Enantioselective Friedel-Crafts-type alkylations. 
A H8-BINOL derived imidodiphosphoric acid was prepared by the same group to catalyze 
enantioselective aza-Friedel-Crafts reactions of pyrroles and enamides/imines (Scheme 
2.17).[75] 
 
Scheme 2.17. Enantioselective aza-Friedel-Crafts reaction. 
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This H8-BINOL derived imidodiphosphoric acid enables asymmetric Pictet-Spengler-type 
reactions of indolyl anilines with ketones (Scheme 2.18). The utility of this method was 
demonstrated with the synthesis of a HIV-1 inhibitor.[76]   
 
Scheme 2.18. Asymmetric Pictet-Spengler-type reaction. 
Very recently, H8-BINOL derived imidodiphosphoric acid catalyzed enantioselective cyclization 
reactions of β,γ-unsaturated α-ketoesters, arylamines and acetylacetone to give penta-
substituted 1,4-dihydropyridines with high enantioselectivity were reported (Scheme 2.19).[77]    
 
Scheme 2.19. Catalytic asymmetric synthesis of penta-substituted 1,4-dihydropyridines. 
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2.4. Chiral acetals  
Acetals are one of the most common stereogenic centers in nature. Stereogenic acetals are 
widely found in natural products, in small insect pheromones such as olean and also in 
complex spiroketal polyketides (Figure 2.16).[4-6]  
 
Figure 2.16. Stereogenic acetals in nature. 
Acetals form glycosidic bonds that form carbohydrates which are the most abundant class of 
natural organic compounds, including cellulose and starch (Figure 2.17).[3] The configuration of 
the anomeric acetal stereocenter in starch differs from the one in cellulose. This highlights the 
importance of controlling the relative and absolute configuration of acetal stereocenters.[11]  
 
Figure 2.17. Cellulose and starch. 
Spiroacetals are one subgroup of acetals and are structurally particularly distinctive 
compounds in which two oxygen-carbon single bonds of two rings are connected at a single 
carbon atom (Figure 2.16).[15] Their absolute configuration can result in nonanomeric or 
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anomeric configuration, which is often thermodynamically favored as a consequence of the 
anomeric effect. The term anomeric effect is used to describe the observation that 
electronegative (O, N, or S usually) substituents of tetrahydropyrans in the 2-position stabilize 
axial orientation of the substituent (Scheme 2.20).[78] The relative amount of axial isomer is 
then increased compared to equatorial isomer, and can sometimes become preferred (Scheme 
2.20b). This effect is often attributed to the presence of n–σ* stabilizing interaction that 
involves the donation of oxygen lone pair into C–heteroatom antibonding orbital of the 2-
substituent (Scheme 2.20c).[79] The anomeric carbon of glucose, which is the most abundant 
natural sugar, prefers equatorial configuration but only with 2:1 ratio, as a result of anomeric 
stabilization of the axial diastereomer (Scheme 2.20d). A more electronegative substituent at 
anomeric carbon prefers more to be axial rather than equatorial. The anomeric effect is 
observed also in spiroacetals resulting often in the axial preference (Scheme 2.20e).[4] 
Spiroacetals feature as a core motif in a variety of natural products and thus controlling the 
configuration of spiroacetals is very important.[11] Although many synthetic methods have been 
developed, access to spiroacetals with chiral catalyst control in a highly enantioselective 
manner was reported only recently.[15, 80] 
The importance of chiral acetals is also demonstrated by their presence in sugars, 
alkaloids and several chiral pharmaceuticals.[11, 81-82]  Furthermore, they can be used as 
diastereocontrolling elements in organic synthesis.[2, 83-85] However, methods for 
enantioselective synthesis of stereogenic acetals are underdeveloped and mainly rely on chiral 
starting materials or reagents to induce the enantioselective formation of acetal 
stereocenters.[86-91] 
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Scheme 2.20. The anomeric effect. 
 
2. BACKGROUND 
 
31 
Dioxolanes and dioxanes  
Due to their relative stability in mildly acidic conditions and the convenience of preparation, 
the synthesis of cyclic acetals has been a common transformation in organic synthesis. 
Reaction of a single molecule of a diol, which contains two hydroxyl groups, with carbonyl 
groups of ketones or aldehydes forms cyclic acetals. When 1,2-diol is used it provides a five-
membered 1,3-dioxolane ring, and 1,3-diol provides a six-memebered  1,3-dioxane ring. One 
important use of cyclic acetals is as protecting groups for carbonyl groups. They are readily 
introduced and cleaved in high yields and are among the most useful protecting groups.[92] 
Moreover, synthesis of chiral cyclic acetals with control of their relative and absolute 
configuration is important as they can be common structural subunits in natural products and 
bioactive compounds.[1] Molecules with stereogenic acetal can be employed to relief muscle 
spasms, as anti-infective agents, as cardiovascular and immune agents (Figure 2.18).[93]  
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Figure 2.18. Biological and pharmacological activity of cyclic acetals. 
Although several asymmetric syntheses for stereoselective formation of O,O-acetals have been 
published, these synthetic methods rely on the use of enantioenriched staring materials or 
reagents. There are few recent examples of catalytic asymmetric reactions that form highly 
enantioenriched acetals, but direct acetalization of aldehydes with diols to give 1,3-dioxolanes 
or 1,3-dioxanes was unknown prior to our work described in this thesis.[67]  
 
2.4.1. Organocatalytic asymmetric acetalizations via iminium intermediates. 
Meanwhile, N,X-acetalizations that involve iminium intermediates in the reaction have been 
developed. Chiral N,N-, N,O-, and N,S-acetals are common motives in pharmaceuticals and are 
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present in natural products. Consequently, their catalytic asymmetric syntheses have been 
studied over the years.  
The initial study of asymmetric N,N-acetalization that includes addition of nitrogen 
nucleophiles to imines using a chiral Brønsted acid has been reported by the Antilla group in 
2005 (Scheme 2.21).[52, 94] 
 
Scheme 2.21. Catalytic asymmetric N,N-acetalization. 
In 2008, the Antilla group also reported a catalytic asymmetric addition of alcohols to imines 
providing chiral N,O-acetals with high enantioselectivity (Scheme 2.22).[95] 
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Scheme 2.22. Catalytic asymmetric N,O-acetalization. 
Independently, a direct asymmetric N,N-acetalization of aldehydes has been developed by the 
List group, and the Rueping group subsequently reported the same reaction using various 
aromatic aldehydes (Scheme 2.23).[96-97] The reactions proceed through imine formation, 
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followed by intramolecular amidation giving cyclic N,N-acetals which are often found in diverse 
commercial pharmaceuticals.       
 
Scheme 2.23. Direct catalytic asymmetric N,N-acetalization of aldehydes. 
Subsequently, the direct synthesis of cyclic N,O-acetals from aldehydes and hydroxyl amides 
catalyzed by chiral N-phosphinyl phosphoramides was reported by the List group (Scheme 
2.24).[64]  
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Scheme 2.24. Direct catalytic asymmetric N,O-acetalization of aldehydes. 
Afterwards, the Antilla group reported the preparation of enantioenriched N,S- and N,Se-
acetals via an asymmetric addition of thiols and seleophenol to imines (Scheme 2.25).[98] 
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Scheme 2.25. Catalytic asymmetric N,S- and N,Se-acetalizations. 
All of these reported acetalization reactions are based on the enantioselective addition to an 
iminium ion intermediate catalyzed by phosphoric acid derivatives. To achieve a successful 
asymmetric reaction, a well organized transition state is required having a strong covalent or 
hydrogen bonding interaction between the catalyst and the substrates. Imines are easily 
activated by Brønsted acids because of their basicity and in the subsequent iminium salts a 
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strong hydrogen bonding to the chiral anion of the Brønsted acid enables the formation of a 
well organized transition state which results in high enantioselectivity (Figure 2.19). 
 
Figure 2.19. Hydrogen bonds between iminium ion and chiral phosphate anion. 
 
2.4.2. Approaches to the synthesis of enantioenriched O,O-acetals 
Although O,O-acetals are much more common motives in natural products and organic 
synthesis than the analogous N,N-, N,O-, or N,S-acetals, synthetic methods for their 
asymmetric synthesis are mostly based on enantiopure/enantioenriched starting materials or 
reagents. 
 
Using enantiopure/enantioenriched starting materials or reagents 
The Davies group reported stereoselective reactions of an enantiopure ortho-substituted 
benzaldehyde chromium tricarbonyl complex to obtain enantioenriched o-anisaldehyde methyl 
isopropyl acetal (Scheme 2.26).[86] The enantiopure aldehyde chromium complex can be 
prepared by chromatographic separation of diastereomeric valinol imine derivatives.[99] 
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Scheme 2.26. Using enantiopure metal complex as a starting material. 
Enantioenriched acyl alkyl acetals can be obtained via a Baeyer-Villiger oxidation using optically 
active α-alkoxyalkyl ketones as starting materials (Scheme 2.27).[87]   
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Scheme 2.27. Baeyer-Villiger oxidation of enantioenriched α-alkoxy ketones. 
Enantiopure α-alkoxy peresters undergo photolytic decarboxylation to give enantioenriched 
acyl alkyl acetals with retention of stereochemistry (Scheme 2.28).[89]  
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Scheme 2.28. Photolytic decarboxylation of enantiopure α-alkoxy peresters. 
The reduction of achiral esters using a chiral reagent formed by combining NaAlH4 and 
ephedrine, followed by in situ acetylation of the enantioenriched alkoxy aluminium 
intermediate, provides enantioenriched acyl alkyl acetals (Scheme 2.29).[88] 
 
Scheme 2.29. Enantioselective reduction of esters using chiral aluminium reagent. 
An asymmetric selenenylation of vinyl ethers employing an enantioenriched selenium reagent 
was developed by the Uchiyama group (Scheme 2.30). The selenium group can be removed to 
give the corresponding acetals with moderate to good enantioselectivity.[90-91]  
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Scheme 2.30. Asymmetric selenenylation of vinyl ethers. 
These methods that are based on enantiopure/enantioenriched starting materials or reagents 
are very substrate specific and often do not result in high enantioselectivity. 
 
Catalytic asymmetric approaches: metal catalysis 
Catalytic asymmetric synthesis is the most practical and straightforward strategy for the 
preparation of enantioenriched compounds. However, there are only few examples of the 
catalytic asymmetric synthesis of O,O-acetals. Among these methods, catalytic asymmetric 
approaches to the synthesis of O,O-acetals with the acetal center as the only stereogenic 
element have been developed employing metal catalysts.   
 A chiral molybdenum catalyst can promote asymmetric ring closing metathesis of 
achiral triene acetals to give enantioenriched cyclic acetals with good enantioselectivity 
(Scheme 2.31).[100-101]  
2. BACKGROUND 
 
38 
(5 mol%)
O
Me
O
OO
Me
Mo
N
O
O
ClCl
tBu
tBu
er 91.5:8.5
Ph
Me
H
 
Scheme 2.31. Molybdenum catalyzed ring closing metathesis reaction. 
An asymmetric isomerization of exocyclic double bond using a chiral nickel catalyst can provide 
cyclic allyl acetals having a more stable endocyclic double bond with high enantioselectivity 
(Scheme 2.32).[102-103] 
 
Scheme 2.32. Ni-catalyzed asymmetric isomerization of double bond. 
However, these desymmetrization reactions are transformations, in which the acetal carbon is 
not the reaction center. Transformations towards catalytic asymmetric O,O-acetalization that 
involve the acetal carbon as the reaction center have been reported only recently. 
The first catalytic asymmetric acetalization reaction using a metal-catalyst was reported 
by Nagano and Katsuki.[104] A chiral salen-ruthenium complex catalyzes the hydroetherification 
of enol ethers to obtain enantioenriched acetal products, although the exact mechanism is 
unkown (Scheme 2.33).      
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Scheme 2.33. First catalytic asymmetric acetalization. 
The use of a chiral metal complex under O2 induces the asymmetric coupling of cinnamyl 
alcohols and vinyl ethers to give acetal products with low to moderate enantioselectivity 
(Scheme 2.34).[105]  
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Scheme 2.34. Asymmetric coupling of allylic alcohols and vinyl ethers. 
After the catalytic asymmetric acetalization studies by our group,[11, 15, 56, 106] Handa and 
Slaughter employed a chiral gold(I) diaminocarbene complex as catalyst for enantioselective 
alkynylbenzaldehyde cyclizations obtaining highly enantioenriched acetal products (Scheme 
2.35).[107]  
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Scheme 2.35. Gold catalyzed asymmetric synthesis of acetals.  
Recently, the Rhee group reported the palladium catalyzed asymmetric intermolecular 
hydroalkoxylation of alkoxyallenes with alcohols and subsequent ring-closing-metathesis to 
give acetals with high diastereocontrol (Scheme 2.36).[108] The method can be utilized to give 
various mono- and disaccharides. 
 
Scheme 2.36. Pd-catalyzed asymmetric hydroalkoxylation of alkoxyallenes with alcohols. 
Later, a palladium catalyzed enantioselective hydroalkoxylation of alkoxyallens using phenols 
as pronucleophiles to obtain acyclic acetals was described (Scheme 2.37).[109]  
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Scheme 2.37. Enantioselective hydroalkoxylation of alkoxyallens with phenols. 
Very recently, a chiral Gd complex catalyzed enantioselective [3+2] cycloaddition of aryl 
oxiranyl diketones and aromatic aldehydes was reported (Scheme 2.38).[93] The reaction 
proceeds through C–C bond cleavage of oxiranes to form a carbonyl ylide and subsequent 
cyclization with aldehydes providing chiral 1,3-dioxolanes with high enantioselectivities and 
diastereoselectivities.     
 
Scheme 2.38. Catalytic asymmetric [3+2] cycloaddition of aldehydes with oxiranes.  
 
Catalytic asymmetric approaches: Brønsted acid catalysis 
The first example of an enantioselective Brønsted acid catalyzed acetal synthesis was reported 
by the List group, employing an asymmetric transacetalization reaction (Scheme 2.39).[106] 
Although Brønsted acids are the most common catalysts for transacetalization reactions, 
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functional similarity of the starting material and the product can lead to reversibility and 
racemization under the acidic conditions. By developing an intramolecular variant of the 
transacetalization reaction this issue could be avoided to give highly enantioenriched acetal 
products. Afterwards several Brønsted acid catalyzed asymmetric reactions to form 
enantioenriched acetal products have been developed. 
 
Scheme 2.39. Catalytic asymmetric transacetalization. 
The asymmetric transacetalization reaction can be applied to the kinetic resolution of alcohols 
to give access to enantioenriched  acetal protected homoaldols compounds (Scheme 2.40).[56]   
 
Scheme 2.40. Kinetic resolution of alcohols via catalytic asymmetric transacetalization. 
Using the transacetalization reaction reported by the List group, it was later shown that 
asymmetric desymmetrization of prochiral meso 1,3-diols through mono-transacetalization can 
be achieved (Scheme 2.41).[110]  
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Scheme 2.41. Asymmetric desymmetrization of meso 1,3-diols via transacetalization. 
The first catalytic asymmetric spiroacetalization reaction was disclosed recently by the List 
group. By employing confined imidodiphosphoric acids, small unfunctionalized spiroacetals can 
be obtained with high enantioselectivity (Scheme 2.42).[15]    
 
Scheme 2.42. Imidodiphosphoric acid catalyzed spiroacetalizations. 
Subsequent to the publication of this work, the Nagorny group reported the asymmetric 
spiroacetalization of hydroxyenol ethers catalyzed by the chiral phosphoric acid TRIP (Scheme 
2.43).[80] This report, compared to the reaction in Scheme 2.42 demonstrated that less 
sterically demanding phosphoric acid catalysts could tackle larger, decorated substrates.   
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Scheme 2.43. Chiral phosphoric acid catalyzed spiroacetalizations.  
 
Attempt towards direct O,O-acetalization of aldehydes 
An attempt at a direct catalytic asymmetric O,O-acetalization of an aldehyde with a diol using a 
chiral metal catalyst was reported in 1999 by P. Barbaro et al. (Scheme 2.44).[111] However, the 
acetalization reaction proceeded without significant enantioselectivity, even when different 
reaction conditions were employed, such as using different metal catalysts, solvents, and 
substrates. 
 
Scheme 2.44. Catalytic acetalization using chiral metal complex. 
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2.5. Asymmetric synthesis of diols 
Diols are common motives in natural products and bioactive compounds, and are also valuable 
synthetic building blocks (Figure 2.20).[112-114] Consequently, access to enantiomerically pure 
diols has attracted much attention, and it is still an important synthetic task.  
 
Figure 2.20. Diols in nature and bioactive compounds. 
 
2.5.1. Synthetic approaches to enantioenriched diols  
Diols with secondary alcohol stereocenter 
Numerous synthetic methods to access to enantiomerically pure diols have been studied. One 
of the most well-known approaches to the enantioselective synthesis of 1,2-diols is the 
Sharpless asymmetric dihydroxylation reaction (Scheme 2.45).[115-120] Enantioenriched 1,2-diols 
can be obtained from olefins using an osmium catalyst with chiral ligands (DHQD)2-PHAL or 
(DHQ)2-PHAL.  
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Scheme 2.45. Sharpless dihydroxylation reaction. 
Next to the Sharpless dihydroxylation of olefins, numerous other methods have been 
developed such as opening of epoxides,[121-126] asymmetric hydrogenation of α-
hydroxyketones,[127-129] α-oxyamination/reduction of carbonyls,[130-132] diboration/oxidation of 
alkenes.[133-134] The Jacobsen group reported a hydrolytic kinetic resolution reaction of terminal 
epoxides catalyzed by a cobalt-salen complex to give 1,2-diol products in high enantiomeric 
excess and recovering enantioenriched epoxides (Scheme 2.46).[124]  
 
Scheme 2.46. Opening of epoxides. 
Enantioenriched 1,2-diols can be obtained from α-hydroxyketones via asymmetric 
hydrogenation (Scheme 2.47).[129] 
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Scheme 2.47. Hydrogenation of α-hydroxyketones. 
A proline catalyzed enantioselective α-oxyamination reaction of aldehydes with 
nitrosobenzene provides enantioenriched α-oxyamination products. Reduction of the product 
with NaBH4, followed by hydrogenolysis of N-O bond gives the corresponding terminal 1,2-diol 
in high enantiomeric excess (Scheme 2.48).[130] 
 
Scheme 2.48. α-Oxyamination of aldehydes/reduction. 
The Morken group developed enantioselective diboration of alkenes in the presence of Rh or 
Pt catalysts obtaining the corresponding dihydroxylation products after oxidation (Scheme 
2.49).[133, 135]   
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Scheme 2.49. Enantioselective diboration/oxidation of alkenes. 
Although many more methods than the aforementioned approaches have been reported,[136-
140] most of the methods are only amenable to 1,2-diols with secondary alcohol stereocenters 
although some can provide aryl,alkyl-substituted 1,2-diols with tertiary alcohol stereocenters 
with high enantioselectivity.    
 
Diols with teriary alcohol stereocenter 
Highly enantioselective approaches capable of delivering diols with tertiary alcohol 
stereocenters are much less common.[120, 136, 138] Two selected approaches are given here. 
The desymmetrization of prochiral 2-substituted glycerols via monobenzoylation was 
achieved with high enantioselectivity giving highly enantioenriched tertiary alcohols (Scheme 
2.50).[136]   
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Scheme 2.50. Desymmetrization of triols. 
A recently reported Pd-catalyzed decarboxylative cycloaddition of vinylethylene carbonates 
with formaldehyde provides enantioenriched 1,3-dioxolanes which can be converted into the 
corresponding tertiary vinylglycols (Scheme 2.51).[138]  
 
Scheme 2.51. Decarboxylative cycloaddition/deprotection. 
 
2.5.2. Kinetic resolution of alcohols 
Due to the usually simple access to racemic alcohols, kinetic resolutions represent a popular 
strategy for the preparation of enantioenriched compounds.[141-142] Most practical methods 
involve reactions that enantioselectively introduce a common alcohol protecting group, which 
can be of use in further synthetic steps (Scheme 2.52).  
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Scheme 2.52. Kinetic resolution of alcohols by placing common alcohol protecting groups. 
Numerous enzymatic and nonenzymatic methods for asymmetric acylation,[143-149] and more 
recently silylation[150-152] have been developed.  
For example, a kinetic resolution of trans-cycloalkane-1,2-diols through an 
enantioselective acylation reaction catalyzed by a lipophilic chiral tetrapeptide was recently 
reported (Scheme 2.53).[149]   
 
Scheme 2.53. Kinetic resolution of diols via acylation. 
Most reported methods for the kinetic resolution of diols via asymmetric acylation and 
silylation enabled the enantioselective generation of enantioenriched diols with a secondary 
alcohol stereocenter, but they have rarely been applied to diols with tertiary alcohol 
stereocenters. Although several methods for the kinetic resolution via silylation have been 
developed and arisen as a popular strategy to access enantioenriched diols, there are only 
scarce examples that provide enantioenriched diols with a tertiary alcohol stereocenter. 
Hoveyda, Snapper et al. developed a kinetic resolution of syn-1,2-diols and vicinal diols that 
bear a tertiary alcohol through catalytic asymmetric silylation catalyzed by a simple chiral 
organocatalyst (Scheme 2.54). [152] 
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Scheme 2.54. Kinetic resolution of diols via asymmetric silylation. 
Next to ester and silyl groups, acetals are one of the most common protecting groups for 
alcohols. They possess complimentary stability properties to ester and silyl groups during 
further synthetic steps, and also alternative deprotection conditions. However, asymmetric 
acetalization reactions have been developed only very recently,[1, 15, 56, 67, 80, 104, 107-108, 110, 153-154] 
thus, processes for the kinetic resolution of alcohols via acetal formation are still 
underdeveloped. 
The fist example of a kinetic resolution of alcohols via acetal formation was reported by 
the List group (Scheme 2.55).[56] The highly enantioselective kinetic resolution of acetal 
protected homoaldols via asymmetric transacetalization was achieved. The use of the 
spirocyclic phosphoric acid STRIP as the catalyst was the key to the resolution of a wide range 
of secondary and tertiary homoaldols. 
 
Scheme 2.55. Kinetic resolution of homoaldols via transacetalization.  
Simultaneously with the work described in this thesis,[68] the Terada group reported[155] the 
kinetic resolution of racemic amino alcohols through intermolecular acetalizations using H8-
TRIP as catalyst (Scheme 2.56).  
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Scheme 2.56. Kinetic resolution of amino alcohols via acetalization.
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3. OBJECTIVES OF THIS PH.D. WORK 
3.1. Catalytic asymmetric acetalization of aldehydes with diols 
The objective of this Ph.D. work was the development of direct asymmetric acetalization 
reactions of aldehydes, which would probably involve enantioselective control of the addition 
of nucleophiles to oxocarbenium ions. The goal was to identify suitable reaction partners and 
selective Brønsted acid catalysts.  
Although the Brønsted acid catalyzed acetalization of aldehydes with alcohols is one of 
the most common transformations in organic synthesis, an asymmetric variant remained 
elusive as controlling the enantioselective addition of nucleophiles to oxocarbenium ions is 
very challenging. An issue for Brønsted acid catalyzed enantioselective formation of O,O-
acetals is the probable racemization of the acetal product in the presence of acids by reversible 
formation of the oxocarbenium ion. We hypothesized that this issue could potentially be 
avoided by employing diols which could form more stable cyclic acetal products that would be 
less prone to racemization (Scheme 3.1).      
 
Scheme 3.1. Acetalization with diols.  
Another issue, compared to asymmetric N,X-acetalizations (X = O, N, S) which involve iminium 
intermediates, is that the oxocarbenium ion possesses weaker hydrogen bonds with a chiral 
anion of the catalyst. Also, the presence of multiple weak hydrogen bonds results in more 
possibilities for substrate orientation and transition state geometries. Consequently the 
nucleophilic attack proceeds with low asymmetric induction.[1, 11]  
Recently, our group developed confined Brønsted acids and employed them as catalysts 
for asymmetric spiroacetalizations.[15] Confined imidodiphosphoric acids could enable the 
control of oxocarbenium ion by providing an extremely sterically demanding chiral 
microenvironment. We envisioned that confined imidodiphosphoric acids would provide a 
suitable catalytic platform for the direct O,O-acetalization of aldehydes (Scheme 3.2). 
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Scheme 3.2. Towards catalytic asymmetric O,O-acetalization. 
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3.2. Kinetic resolution of diols via acetal formation 
After the realization an asymmetric acetalization reaction the next objective would be to 
explore potential applications. 
Next to the Sharpless dihydroxylation of olefins, numerous other methods have been 
developed for synthesizing enantioenriched diols. However, most of the reported methods are 
incapable of delivering diols possessing a tertiary alcohol stereocenter with high 
enantioselectivity. Kinetic resolution can be an attractive alternative strategy for synthesis of 
enantioenriched diols because of the accessibility of racemic diols. Although numerous studies 
of kinetic resolution of diols have been reported, these methods are rarely applied to diols 
bearing tertiary alcohol stereocenters. Meanwhile, acetals are particularly useful protecting 
groups possessing complementary stability properties to ester and silyl groups during further 
synthetic steps and also alternative deprotection conditions. Nevertheless, kinetic resolutions 
of alcohols proceeding by acetal formation are underdeveloped as asymmetric acetalization 
reactions were developed only recently.  
We envisioned that confined imidodiphosphoric acid could discriminate the alcohol 
stereocenter of chiral racemic diols during an acetalization reaction thus enabling the kinetic 
resolution of diols (Scheme 3.3). 
 
Scheme 3.3. Kinetic resolution of diols via asymmetric acetalization. 
Additionally, as the acetalization reaction creates an additional stereocenter, a complementary 
stereodivergent resolution of diols into two separable diastereoisomers might be feasible 
(Scheme 3.4). 
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Scheme 3.4. Stereodivergent resolution of diols via asymmetric acetalization. 
The objectives of this Ph.D work were the development of a direct asymmetric O,O-
acetalization and a related highly enantioselective kinetic resolution of diols via asymmetric 
acetalization by using a chiral confined imidodiphosphoric acid catalyst.  
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4. RESULTS AND DISCUSSION 
4.1. Catalytic asymmetric acetalization 
4.1.1. Reaction design and optimization 
(with I. Čorić)[67] 
 
Acetals are among the most common stereocenters in nature, and classic protecting groups for 
aldehydes and ketones. Therefore, the Brønsted acid catalyzed acetalization of aldehydes with 
alcohols is one of the essential transformations in organic synthesis (Scheme 4.1). Although the 
non-enantioselective version of this reaction has probably been performed by every synthetic 
chemist, a catalytic asymmetric variant has been entirely unknown. Presumably, asymmetric 
reaction is challenging due to problems associated with asymmetric additions to oxocarbenium 
ions utilizing chiral Brønsted acid catalysts (Scheme 4.1). Despite the fact that our laboratory 
has developed numerous chiral Brønsted acid catalysts, and has studied the direct asymmetric 
acetalization of aldehydes with alcohols for many years, only very little success towards this 
goal was achieved.  
We hoped that the new class of confined imidodiphosphoric acids might be able to 
control oxocarbenium ion intermediates and provide a suitable chiral sterically demanding 
environment. We focused on the acetalization with diols which presumably could give more 
stable cyclic products. Therefore the acetal product would not reversibly form oxocarbenium 
ion, a process, which leads to the racemization of initially enantioenriched acetal product.     
 
Scheme 4.1. Brønsted acid catalyzed acetalization of aldehydes with alcohols. 
We initiated our investigation toward an asymmetric acetalization with diol 2a and aldehyde 
3a to give acetal 4a using one of the most successful phosphoric acid catalysts, 1a ((S)-TRIP) 
with 2,4,6-iPr3C6H2 substituents in the 3,3’-positions (Table 4.1). However, with 10 mol% of (S)-
TRIP in toluene at room temperature only poor enantioselectivity (er 66.5:33.5) was achieved 
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for cyclic acetal 4a with a conversion of 66% after 7 days. The recently developed spirocyclic 
analogue STRIP 1b, which surpassed TRIP in several transformations, gave a slightly improved 
e.r. of 79:21, but significantly lower reactivity with a conversion of 19% after 7 days. Neither 
enantioselectivity nor reactivity improved by using catalysts 1c and 1d, which gave excellent 
results for the related N,N and N,O-acetalizations of aldehydes. This striking failure highlights 
the difficulties arising when dealing with oxocarbenium ion intermediates, such as A in Scheme 
4.1, in Brønsted acid catalysis, even when using some of the most successful phosphoric acid 
catalysts. 
Table 4.1. Initial catalyst screening for asymmetric acetalization.a  
 
Catalyst[44-45, 
156] 
 
 
 (S)-1a (TRIP) (R)-1b (STRIP) 
erb 66.5:33.5 79:21 
conv.c 66% 19% 
 
 
Catalyst[64, 
157] 
 
 
 (S)-1c (S)-1d 
erb 52.5: 47.5 51.5:48.5 
conv.c 50% 31% 
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a) Reactions were performed on 0.05 mmol scale with molecular sieves (30 mg/0.05 mmol) in toluene (0.1 ml) and 
terminated with a few drops of triethylamine after the indicated times. b) Samples for HPLC analysis were isolated 
by thin layer chromatography using EtOAc/hexanes as the eluent. Enantiomeric ratios were determined by HPLC 
analysis on a chiral stationary phase. c) Incomplete conversions were determined by 1H NMR. 
Recently, a new generation of chiral confined Brønsted acids based on a C2-symmetric 
imidodiphosphate anion has been developed in our group.[15] The architecture of these 
catalysts has provided superb results for the first catalytic asymmetric spiroacetalization, and 
for the asymmetric sulfoxidation with hydrogen peroxide, reactions that involve sterically little 
demanding and/or loosely organized transitions states.[15, 66] We expected that confined 
catalysts could enable a putative oxocarbenium ion intermediate to be geometrically 
restrained. Consequently, this would reduce the diversity of transition states, resulting in 
increased enantioselectivity.[11] However, the use of our previously reported confined acids 5a 
and b did not lead to the improvement of either the enantioselectivity or the reactivity for the 
acetalization reaction (Table 4.2, entries 1 and 2).  
We reasoned that imidodiphosphoric acids 5a and b might be either too sterically 
demanding or of inappropriate geometrical shape to create the chiral environment for 
supporting the transition state of the acetalization reaction efficiently. However, the 
imidodiphosphoric acids enable the construction of a wide variety of chiral environments. The 
steric demand of the active site remains very high even with less sterically demanding 
substituents due to the presence of four aryl-substituents (Ar). In comparison, with phosphoric 
acids that possess only two substituents, which are often required to be very bulky, limiting the 
choice of the substituent and consequently the geometrical variability of the chiral 
environment. 
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Table 4.2. Acetalization with confined Brønsted acids.a  
 
entry catalyst time conv. (%)b erc 
1 5a 7 days 66 79:21 
2 5b 7 days < 5 – 
3 5c 2 h > 99 71:29 
4 5d 2 h > 99 41.5:58.5 
5 5e 7 days 91 81:19 
6 5f 3 h > 99 84.5:15.5 
7 5g 20 h > 99 90:10 
8 5g (5 mol%) 22 h > 99 90.5:9.5 
9 5h (5 mol%) 4 days > 99 93.5:6.5 
10 5i (5 mol%) 48 h > 99 95:5 
11d 5i (5 mol%) 48 h > 99 95.5:4.5 
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a) Reactions were performed on 0.05 mmol scale with molecular sieves (30 mg/0.05 mmol) in toluene (0.1 ml) and 
terminated with a few drops of triethylamine after the indicated times. b) Incomplete conversions were 
determined by 1H NMR. c) Samples for HPLC analysis were isolated by thin layer chromatography using 
EtOAc/hexanes as the eluent. Enantiomeric ratios were determined by HPLC analysis on a chiral stationary phase. 
d) With 2 equiv of 3a, 10 mg of molecular sieves, 0.1 M concentration.  
We examined several imidodiphosphoric acid catalysts 5c-i with a variety of substituents Ar. 
Catalysts 5c and 5d with electron-withdrawing 3,5-(CF3)2C6H3 and C6F5 substituents were 
especially active, giving full conversion in two hours, although with low enantioselectivity 
(Table 4.2, entries 3 and 4). Catalysts 5e-g with various substitution patterns all gave improved 
enantioselectivity and reactivity compared to catalysts 1a-d, and 5a, b (Table 4.2, entries 5-7). 
The striking differences in the reactivity and selectivity between catalysts 5a, b and 5e, 
compared to catalysts 5f, g indicate the structural versatility of the active sites available with 
confined acids. For example, while catalyst 5f with p-biphenyl substituents gave full conversion 
in 3 h, catalyst 5b was almost inactive. Presumably, access of the substrates to the active site 
of catalyst 5b is completely blocked by the four 9-anthracenyl substituents. Gratifyingly, 
confined imidodiphosphoric acid 5g with the unsymmetrical 1-naphthyl substituent provided a 
promising enantiomeric ratio of 90:10 and allowed for lower catalyst loading (Table 4.2, entries 
7 and 8). Focusing on nonsymmetric Ar substituents, we next examined the o-isopropylphenyl-
substituted catalyst 5h, and further improvement of the enantioselectivity was observed (Table 
4.2, entry 9). It was hypothesized that having an extra substituent in the 4- or 5-position on the 
2-isopropylphenyl group to increase the steric interaction between different substituents 
might provide a more rigid catalyst structure. To our delight, a highly enantioselective reaction 
was achieved with catalyst 5i, which was derived from the natural product thymol, delivering 
acetal 4a with an enantiomeric ratio of 95.5:4.5 and enabling the use of a lower amount of 
aldehyde 3a (Table 4.2, entries 10 and 11). Additional screening of solvents (CH2Cl2, diethyl 
ether, hexane), and molecular sieves (3 Å, 4 Å, without MS) with catalyst 5i resulted in inferior 
results in terms of reactivity and selectivity. 
 
 
 
4. RESULTS AND DISCUSSION 
 
62 
4.1.2. Substrate scope 
With optimized conditions in hand, we set out to explore the generality of the reaction. The 
starting materials, diols 2 and aldehydes 3 were available in one or three steps from 
commercially available chemicals (Scheme 4.2).  
 
Scheme 4.2. Preparation of substrates. 
Placing chloro- or nitro-substituents on the aromatic ring of the diol does not significantly 
affect the enantioselectivity, albeit with the nitro-substituted diol the reactivity was 
significantly lower (Table 4.3, entries 2 and 3). The synthesis of disubstituted (chloro and 
bromo) acetal 4d showed the lower reactivity, and only moderate enantioselectivity was 
achieved (Table 4.3, entry 4). Placing methyl substituents on the arene ring of the diol led to 
lower yield with good enantioselectivity (Table 4.3, entry 5). Interestingly, a significant 
decrease in the enantioselectivity was observed using a tertiary alcohol with phenyl 
substituents on the benzylic position of the diol (Table 4.3, entry 6). Different aldehydes still 
afforded good but slightly lower enantioselectivities (Table 4.3, entries 7-10).  
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Table 4.3. The acetalization reaction with aromatic diols.a  
 
entry temp./time product  yield (%) er 
1 r.t./2 days 
 
4a 86 96:4 
2 r.t./4 days 
 
4b 82 95:5 
3 50 °C/10 days 
 
4c 93 94.5:5.5 
4 50 °C/5 days 
 
4d 60 92:8 
5 50 °C/8 days 
 
4e 61 94:6 
6 50 °C/2 days 
 
4f 44 79:21 
7 r.t./4 days 
 
4g 83 94.5:5.5 
8 r.t./4 days 
 
4h 75 93.5:6.5 
9b 0 °C/15 h 
 
4i 88 87:13 
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10 r.t./4 days 
 
4j 86 91.5:8.5 
a) Reactions were performed on 0.2 mmol scale (0.1 M solution), 5 Å MS (40 mg). Enantiomeric ratios were 
determined by HPLC analysis on a chiral stationary phase. b) With 5 equiv. of 3i.  
We next investigated the applicability of this catalytic system to other classes of diols. It was 
found that with a simple aliphatic 1,3-diol (3-methylbutane-1,3-diol, 2k), the enantioselectivity 
was even higher and enantiomeric ratios between 95.5:4.5 and 97.5:2.5 could be obtained 
with various aldehydes (Table 4.4, entries 1-3). These results encouraged us to tackle the 
acetalization with a 1,2-diol to access five-membered acetals. 2-methylpropane-1,2-diol (2n) 
was readily prepared by opening of the epoxide in acidic conditions and used without further 
purification (Scheme 4.2, b). The reaction of isovaleraldehyde (3a) with 1,2-diol 2n gave a 
superb acetalization reaction with an enantiomeric ratio of 99.8:0.2 at 0 °C (Table 4.4, entry 4). 
Linear and α-branched aldehydes could be employed with equal success in the reaction (Table 
4.4, entries 5 and 6) although lower reactivity was observed with the α-branched aldehyde. 
Table 4.4. The acetalization reaction with aliphatic diols.a  
 
entry temp./time product  yield (%) er 
1 50 °C/6 days 
 
4k 83 96.5:3.5 
2 r.t./2 days 
 
4l 93 95.5:4.5 
3 r.t./2 days 
 
4m 86 97.5:2.5 
4 0 °C/22 h 
 
4n 72 99.8:0.2 
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5 r.t./3 days 
 
4o 72 99:1 
6 r.t./10 days 
 
4p 82 99.5:0.5 
a) Reactions were performed on 0.2 mmol scale (0.1 M solution), 5 Å MS (40 mg). Enantiomeric ratios were 
determined by HPLC or GC analysis on a chiral stationary phase.  
Although our asymmetric acetalization reaction could be performed with aliphatic aldehydes 
very efficiently, aromatic aldehydes present an additional challenge as the corresponding 
acetals are more sensitive towards acid catalyzed racemization under the reaction conditions. 
Gratifyingly, exploration of the substrate scope revealed that a variety of aromatic aldehydes 
also undergo a very efficient acetalization in the presence of 5 mol% of catalyst 5i (Table 4.5). 
Table 4.5. The acetalization reaction of aromatic aldehydes.a 
 
entry temp./time product  yield (%) er 
1 r.t./2 days 
 
4q 89 95.5:4.5 
2 r.t./62 h 
 
4r 79 98:2 
3 r.t./42 h 
 
4s 74 96:4 
4a r.t./5 days 
 
4t 65 98.5:1.5 
4b 50 °C/4 days 
 
4t 85 95:5 
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5 r.t./27 h 
 
4u 86 88:12 
6 50 °C/6 days 
 
4v 83 99.5:0.5 
7 50 °C/7 days 
 
4w 79 97.5:2.5 
8 r.t./52 h 
 
4x 77 96.5:3.5 
a) Reactions were performed on 0.2 mmol scale (0.1 M solution), 5 Å MS (40 mg). Enantiomeric ratios were 
determined by HPLC analysis on a chiral stationary phase.  
The asymmetric acetalization of benzaldehyde with 1,2-diol 2n gave 5-membered acetal 4q in 
89% yield with e.r. of 95.5:4.5 (Table 4.5, entry 1). Acetals 4q-s with electron-withdrawing 
substituents in either p- or m- positions on the phenyl ring could be obtained with excellent 
enantioselectivities (Table 4.5, entries 2-4), while acetal 4u with a methyl substituent in meta 
position on the phenyl ring was obtained with lower selectivity (Table 4.5, entry 5). Excellent 
enantiomeric ratios of 99.5:0.5 and 97.5:2.5 were observed with disubstituted benzaldehydes 
3v-w, even at the slightly elevated reaction temperatures (Table 4.5, entries 6 and 7). Similarly, 
the asymmetric acetalization of 6-bromo-2-naphthaldehyde proceeded with high enantiomeric 
ratio of 96.5:3.5 (Table 4.5, entry 8). 
The absolute configurations of acetals 4j and 4x were determined to be (S) by single-
crystal X-ray analysis (Figure 4.1), and configurations of other products were assigned by 
analogy. 
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Figure 4.1. X-ray structures of acetals 4j and 4x. 
 
4.1.3. Discussion 
The first catalytic asymmetric acetalization reaction of aldehydes was successfully established. 
Imidodiphosphoric acids proved to be an excellent platform for the construction of Brønsted 
acids with structurally versatile confined chiral microenvironments. A novel Brønsted acid, 5i, 
readily available from natural product thymol (Scheme 4.3), drastically outperforms known 
catalysts and delivers acetals with excellent enantioselectivity.  
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Scheme 4.3. Thymol derived imidodiphosphoric acid. 
Regarding the mechanism of the reaction, we believe that the reaction proceeds through 
primary alcohol derived oxocarbenium ions B1, B2, and B3, and that tertiary alcohol and 
phenol derived oxocarbenium ions are less probable (Scheme 4.4). Initially, the hemiacetal 
intermediate A is formed from the reversible addition of the primary alcohol moiety of the diol 
to the aldehyde. Protonation of its hydroxyl moiety by the catalyst leads to the expulsion of a 
water molecule and formation of the crucial oxocarbenium ion intermediate B. The chiral 
imidodiphosphate counteranion provides a chiral environment for the oxocarbenium cation, 
and functions as a base that directs the nucleophilic attack of the second alcohol moiety to the 
si-face of the oxocarbenium ion furnishing the (S)-configured cyclic acetal.  
 
Scheme 4.4. Plausible mechanism. 
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Mechanistic studies  
(with I. Čorić)[67] 
To get insight on the nature of the oxocarbenium ion intermediates we decided to make 
alternative precursors to the two potential oxocarbenium ions that could be formed from the 
two OH moieties of a diol. Methyl acetals can be prepared that could lead to either of the two 
potential oxocarbenium ions, similarly as from the two potential hemiacetal intermediates in 
the direct acetalization reaction (Scheme 4.5). Subsequent cyclization under the reaction 
conditions should proceed with similar enantioselectivity from the hemiacetal and from the 
corresponding methyl acetal because both proceed through the same oxocarbenium ion 
intermediate. Thus, the methyl acetal that would proceed through the “correct” oxocarbenium 
ion would give the same enantioselectivity as observed in the direct acetalization reaction. In 
contrast, the methyl acetal that would proceed through the “wrong” oxocarbenium ion would 
likely give a significantly different enantioselectivity and could then be excluded as 
intermediate in our direct acetalization reaction. 
R2O
R3O
H
H
R2O
R3O
OMe
R1
X*
R1
R2O
R3O
R2O
R3O
H
R1
H
H
R1
H
R2O
R3O
X*
– HX* – HX*
+ HX*
– MeOH
R1
OMe
R2O
R3O
H
OH
R1 H
R2O
R3O R1
OH
+ HX*
– MeOH
product
+ HX*
– H2O
+ HX*
– H2O
 
Scheme 4.5. Two alternative precursors of potential oxocarbenium ions. 
We thus prepared racemic methyl acetal derivatives of the proposed hemiacetal intermediates 
A (OMe instead of OH) in Scheme 4.4, as alternative precursors for oxocarbenium ions B1 and 
B3 in Scheme 4.4. Due to structural differences between diols 2a and 2n we performed 
mechanistic studies separately for diols 2a and 2n. The mechanism of the reaction with 1,3-diol 
2k as the substrate is proposed to proceed in analogy to that of the reactions of diols 2a and 
2n.  
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The reaction of diol 2a with acetaldehyde can be envisioned proceeding through two 
distinct oxocarbenium species B1 and D1 formed from hemiacetal intermediates A1 and C1, 
respectively (Scheme 4.6). 
 
Scheme 4.6. Mechanistic possibilities and experimental support for intermediates A1 and B1. 
To examine these two pathways we synthesized acetals Me-A1 and Me-C1 which were 
expected to give two different oxocarbenium ions, imitating two hemiacetal intermediates A1 
and C1, respectively (Scheme 4.7).[158]  
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Scheme 4.7. Preparation of racemic methyl acetal derivatives Me-A1 and Me-C1.  
The reaction of acetal Me-A1 proceeded with similar enantioselectivity as the direct 
acetalization of acetaldehyde, a result consistent with a common intermediate B1 (Scheme 4.6). 
However, under the same reaction conditions, acetal Me-C1 was first rapidly (<10 min) 
converted to acetal Me-A1, followed by the reaction that proceeded to give the acetal 4i. 
These results indicate that oxocarbenium ion D1 which could be formed from hemiacetal C1 is 
improbable intermediate in the direct acetalization reaction, and corroborate to a pathway 
proceeding through A1 and B1.  
 A similar set of experiments was designed for the acetalization with 1,2-diol 2n (Scheme 
4.8). The reaction with hydroxyacetal Me-A3 provided 4o with e.r. of 97.5:2.5, similarly to the 
direct acetalization, a result consistent with a common intermediate B3. Hydroxyacetal Me-C3 
which is a precursor for oxocarbenium ion D3 gave only low enantioselectivity, excluding 
tertiary alcohol derived oxocarbenium ion D3 as the intermediate in our direct acetalization 
reaction. 
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Scheme 4.8. Mechanistic possibilities and experimental support for intermediates A3 and B3. 
The racemic acetals Me-A3 and Me-C3 which imitate two hemiacetal intermediates A3 and C3 
were prepared according to similar procedure as in Scheme 4.7 (Scheme 4.9).[158]  
 
Scheme 4.9. Preparation of racemic methyl acetal derivatives Me-A3 and Me-C3. 
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4.2. Resolutions of diols via catalytic asymmetric acetalization  
4.2.1. Reaction design and optimization 
Due to simple access to racemic 1,2-diols, kinetic resolutions present a popular strategy for the 
preparation of enantioenriched compounds. For example, the addition of Grignard reagents to 
hydroxy ketones gives racemic 1,2- and 1,3-diols with tertiary alcohol centers (Scheme 4.10). 
Most practical methods for the kinetic resolution of diols involve asymmetric acylation and 
silylation reactions, and most reported methods provide enantioenriched diols with secondary 
alcohol stereocenters, but they have rarely been applied to diols with tertiary alcohol 
stereocenter.  
 
Scheme 4.10. Readily accessible racemic diols. 
Based on our direct acetalization of aldehydes with diols, we hypothesized that chiral catalysts 
might additionally discriminate the alcohol stereocenter of chiral alcohols during the 
acetalization reaction, thus promoting a kinetic resolution (Scheme 4.11).  
 
Scheme 4.11. Proposed kinetic resolution of diols via acetalization. 
We initiated our studies on the kinetic resolution of diols by using 1,2-diol rac-6a with 
secondary alcohol stereocenter, which are usually preferred substrates for other kinetic 
resolutions and thymol-derived substituted imidodiphosphoric acid catalyst 5i, which was 
identified as the best catalyst for our previous asymmetric acetalization studies. However, 
almost no selectivity was obtained for the resolution of diol 6a under identical reaction 
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conditions (Table 4.6, entry 1). The product 7a was obtained with very high enantioselectivity 
for both diastereomers. Although the catalyst controls the stereochemistry of the acetal 
stereocenter very well, little differentiation based on the stereochemistry of the alcohol 
stereocenter was observed giving recovered diol 6a with an er of 61:39. Using various 
differently substituted catalysts, and using substrate 6b with a phenyl substituent did not 
result in promising selectivity factors.  
Table 4.6. Initial reaction development with secondary diols.a  
catalyst (5 mol%)
toluene, r.t., MS 5 Å
rac-6 7
+HO
OH
HO
OH
+
recovered 6
O
O
O
O
Ar
Ar
P
O O
O
Ar
Ar
P
HO
N
Et
Et Et Ph
5
5a 5f 5g
Ar =
5h
iPr
5i
iPr
Me
Me
Me Me
5j
H
R
H
R
H
R
3a (2.0 equiv)
H
O
5k
Cy
Me
 
entry cat. conv.b 6 er 6c,d 7 
er 7c,e 
er 7-epi-7c,e 
dr 7c Sf 
1 5i 70% 
6a 
61:39 
7a 
>99.5:0.5 
94.5:5.5 
1.1:1 1.4 
2 5a 22% 6a 53.5:46.5 7a 
>99.5:0.5 
93:7 
1.5:1 1.8 
3g 5k 81% 6a 69:31 7a 
99.5:0.5 
95:5 
1.1:1 1.6 
4 5a 12% 
6b 
55.5:44.5 
7b 
96.5:3.5 
>99.5:0.5 
13:1 10 
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5 5f 82% 6b 71.5:28.5 7b 63:37 
95:5 
6:1 2 
6 5g 91% 6b 72.5:27.5 7b 71:29 
98.5:1.5 
3:1 2 
7 5h 47% 6b 62:38 7b 78.5:21.5 
96.5:3.5 
4:1 2 
8h 5i 39% 6b 67:33 7b 85.5:14.5 
>99.5:0.5 
9:1 5 
9 5j 22% 6b 54:46 7b 82:18 
99:1 
4:1 2 
a) Unless otherwise specified reactions were performed on 0.05 mmol scale with molecular sieves (10 mg/0.05 
mmol) in toluene (0.5 ml) and terminated with a few drops of triethylamine. b) Theoretical conversion calculated 
from ee values of the product and the recovered starting material (see chapter 7.3.3). c) Samples for HPLC or GC 
analysis were isolated by thin layer chromatography using EtOAc/hexanes as the eluent. d) Determined by HPLC 
analysis on a chiral stationary phase. e) Determined by GC analysis on a chiral stationary phase. f) Calculated from 
theoretical conversion and enantiomeric excess of enantioenriched diol (see chapter 7.3.3). g) Reaction was 
performed on 0.50 mmol scale with 2 mol% of catalyst and 4.0 equiv of 3a at 20 °C. Isolated yield: 10% (6a), 80% 
(7a). Samples for HPLC or GC analysis were isolated by silica chromatography.  h) 4 equiv of 3a, 20 °C.  
We next approached the kinetic resolution of diols with tertiary alcohol stereocenters. 
Although tertiary alcohols are usually worse substrates than secondary alcohols for kinetic 
resolutions, previous results with kinetic resolution of homoaldols via transacetalization 
proved that those could be very good substrates for acetalization reactions.[11, 56, 156] Indeed, 
increasing the bulkiness of the substrate under the standard reaction conditions using 2,4,6-
Et3C6H2 substituted catalyst 5a led to significant improvement of the selectivity factor (Table 
4.7, entry 1). Further screening of various imidodiphosphoric acids proved that thymol-derived 
catalyst 5i is a superior catalyst for the kinetic resolution of tertiary diols (Table 4.7, entry 3). 
To our delight, using only 1 mol% of catalyst 5i at 20 °C further improved the selectivity factor 
to 118 (Table 4.7, entry 6). It is noteworthy that with most of the well established methods for 
the kinetic resolution of diols, it is rare to achieve efficient resolution of diols with tertiary 
alcohol stereocenters.[152]  
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Table 4.7. Optimization of the reaction with tertiary diol.a  
 
entry catalyst conv.b er 6cc,d er 7cc,e dr 7cc,f Sg 
1 5a 34% 74.5:25.5 98.5:1.5 49:1 47 
2 5g 73% 98:2 81:19 5:1 7 
3 5i 54% >99.5:0.5 97:3 19:1 63 
4 5j 54% 95:5 95.5:4.5 12:1 24 
5h 5i 51% 98:2 98:2 23:1 93 
6h,i 5i 50% 97.5:2.5 98.5:1.5 58:1 118 
a) Reactions were performed on 0.05 mmol scale with molecular sieves (10 mg/0.05 mmol) in toluene (0.5 ml) and 
terminated with a few drops of triethylamine. b) Theoretical conversion calculated from ee values of the product 
and the recovered starting material (see chapter 7.3.3). c) Samples for HPLC or GC analysis were isolated by thin 
layer chromatography using EtOAc/hexanes as the eluent. d) Determined by HPLC analysis on a chiral stationary 
phase. e) Determined by GC analysis on a chiral stationary phase. f) For most minor diastereomers er >99.5:0.5. g) 
Calculated from theoretical conversion and enantiomeric excess of enantioenriched diol (see chapter 7.3.3). h) 20 
°C. i) 4 equiv of 3a, 1 mol% of catalyst.  
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We next investigated the applicability of our catalytic system to 1,3-diols. An additional 
screening of conditions was required because of their slightly lower reactivity and selectivity 
(Table 4.8). We prepared and used a new catalyst 5k which is bulkier than 5i, hoping to 
improve selectivity factors (Table 4.8, entry 2). Indeed catalyst 5k provided improved results 
for the kinetic resolution of 1,3-diol 8a giving selectivity factor of 19. Although the use of 
different aldehydes at 20 °C did not provide a significant improvement (Table 4.8, entries 3-6), 
using more reactive acetaldehyde enabled the reaction to be run at a lower temperature with 
2 mol% catalyst loading resulting in a good selectivity factor of 28 (Table 4.8, entry 7).    
Table 4.8. Optimization of the reaction with 1,3-diol (with I. Čorić).a  
 
entry catalyst aldehyde time conv.b er 8ac,d er 9c,e dr 9e,f Sg 
1 5i 
3a 
17 h 30% 67:33 97.5:2.5 11:1 12 
2 5k 
3a 
16 h 55% 95:5 93:7 12:1 19 
3 5k 
O
H 3b 
1 h 39% 77:23 95.5:4.5 27:1 20 
4 5k 
O
H 3c 
2.7 h 37% 75:25 97.5:2.5 22:1 23 
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5 5k 
O
H
3d 
16 h 33% 68:32 97.5:2.5 8:1 10 
6 5k 
3f 
16 h 23% 61:39 92:8 19:1 9 
7h 5k 
O
H 3b 
40 h 56% 98:2 92:8 22:1 28 
a) Reactions were performed on 0.05 mmol scale with molecular sieves (10 mg/0.05 mmol) in toluene (0.5 ml) and 
terminated with a few drops of triethylamine. b) Theoretical conversion calculated from ee values of the product 
and the recovered starting material (see chapter 7.3.3). c) Samples for HPLC or GC analysis were isolated by thin 
layer chromatography using EtOAc/hexanes as the eluent. d) Determined by HPLC analysis on a chiral stationary 
phase. e) Determined by GC analysis on a chiral stationary phase. f) For most minor diastereomers er >99.5:0.5. g) 
Calculated from theoretical conversion and enantiomeric excess of enantioenriched diol (see chapter 7.3.3). h) 2 
mol% of catalyst at 0 °C.  
The starting racemic 1,2- and 1,3-diols required as starting materials are readily prepared via 
the addition of Grignard reagents to hydroxyl ketones or simple ketones (Scheme 4.12 and 
Scheme 4.13). 
 
Scheme 4.12. Preparation of racemic 1,2-diols. 
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Scheme 4.13. Preparation of racemic 1,3-diols. 
 
4.2.2. Substrate scope 
Having optimized reaction conditions for 1,2- and 1,3-diols in hand, we started to evaluate the 
generality of the reaction. Examination of different aldehydes indicated that efficient kinetic 
resolution of diol rac-6c can be obtained in the presence of 1-2 mol% of 5i to give a variety of 
1,3-dioxolanes 7 with excellent enantioselectivities and diastereoselectivities (Table 4.9). 
Employing simple acetaldehyde or n-pentanal resulted in high selectivity factors of 39 and 64, 
respectively (Table 4.9, entry 1 and 2). Increased steric bulk at the α-position using 
isobutyraldehyde resulted in a higher selectivity factor of 79, although a higher catalyst loading 
was required (Table 4.9, entry 3). The reaction did not proceed at all when more sterically 
demanding pivaldehyde was employed (Table 4.9, entry 4). We wondered if increasing the 
bulkiness at the β-position of isovaleraldehyde could be beneficial since the highest selectivity 
factor was obtained when isovaleraldehyde was used which is bulkier than linear aldehydes 
and at the same time less bulky than α-trisubstituted aldehydes. Indeed, an excellent 
selectivity factor of 122 was observed with 3,3-dimethylbutyraldehyde (Table 4.9, entry 5). 
However, considering its lower reactivity compared to isovaleraldehyde (Table 4.7, entry 6), we 
used isovaleraldehyde for evaluating the diol scope of the acetalization.  
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Table 4.9. Kinetic resolution of tertiary 1,2-diols with different aldehydes.a 
 
entry 
catalyst 
loading 
aldehyde time conv.b 
yield 
6cc 
er 6cd 
yield 
7c 
er 7e,f dr 7e Sg 
1 1 mol% 
O
H 3b 
23 h 55% 40% 99:1 48% 94:6 20:1 39 
2 1 mol% 
O
H 3c 
12 h 49% 47% 94.5:5.5 47% 97:3 57:1 64 
3 2 mol% 
O
H
3d 
36 h 52% 42% 99:1 49% 98:2 26:1 79 
4 2 mol% 
3e 
10 d - - - <2%h - - - 
5 2 mol% 
3f 
96 h 52% 39% 99.5:0.5 47% 98:2 52:1 122 
a) Reactions were performed on 0.50 mmol scale with molecular sieves (100 mg) in toluene (5 ml) and terminated 
with a few drops of triethylamine. b) Theoretical conversion calculated from ee values of the product and the 
recovered starting material (see chapter 7.3.3). c) Isolated yield on a 0.5 mmol scale. d) Determined by HPLC 
analysis on a chiral stationary phase. e) Determined by GC analysis on a chiral stationary phase. f) For most minor 
diastereomers er >99.5:0.5. g) Calculated from theoretical conversion and enantiomeric excess of enantioenriched 
diol (see chapter 7.3.3). h) Determined by 1H NMR analysis.  
A variety of substituents on the aromatic ring of diols was examined for the kinetic resolution 
(Table 4.10, entries 1-6). By placing chloro-, methoxy-, or methyl-substituents at the para-
position of the aromatic ring of the diol, we could achieve very high selectivity factors from 64 
to 99 with 2-3 mol% of the catalyst (Table 4.10, entries 1-3). Employing diols with meta- or 
ortho-substituents resulted in increased enantioselectivity compared to those bearing para-
substitution; with excellent selectivity factors of 110 and 135 obtained in these cases (Table 
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4.10, entries 4 and 5). A superb kinetic resolution was achieved with a selectivity factor of 389 
when methyl,naphthyl-substituted diol rac-6l was employed providing enantioenriched diol 6l 
with an er of 98.5:1.5, while 1,3-dioxolane 7l was obtained with er over 99.5:0.5, and a dr of 
93:1. Encouraged by these results, we next investigated the reaction with different diols, 
replacing the methyl group to other substituents. The reaction of ethyl-substituted diol rac-6m 
using 2 mol% of 5i proceeded with a selectivity factor of 115 (Table 4.10, entry 7). Interestingly, 
even a diol with two similarly bulky substituents, phenyl and isopropyl, exhibited an impressive 
selectivity factor of 372, with only 1 mol% catalyst (Table 4.10, entry 8). The reaction 
proceeded to 50% conversion, whereby (R)-6n underwent acetalization with a dr of 191:1 and 
an er of 99.5:0.5 for acetal product 7n, while (S)-6n was recovered with an er of 99:1. 
Table 4.10. Kinetic resolution of aryl,alkyl-substituted 1,2-diols.a  
 
entry 
catalyst 
loading 
time  conv.b compound yieldc erd,e dr 7d Sf 
1 3 mol% 10 h 49% 
6g 
47% 94.5:5.5  
87 
7g 
45% 98.5:1.5 52:1 
2 2 mol% 17.5 h 50% 
6h 
49% 96.5:3.5  99 
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7h 
48% 98.5:1.5 53:1 
3 2 mol% 13 h 52% 
6i 
44% 97.5:2.5  
64 
7i 
46% 96:4 52:1 
4 1 mol% 19 h 46% 
6j 
54% 90.5:9.5  
110 
7j 
45% 98.5:1.5 124:1 
5 1 mol% 17 h 49% 
6k 
51% 96.5:3.5  
135 
7k 
47% 98.5:1.5 92:1 
6 1 mol% 22 h 50% 
HO
OH 6l 
45% 98.5:1.5  389 
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7l 
44% >99.5:0.5 93:1 
7 2 mol% 20 h 52% 
6m 
46% 99.5:0.5  
115 
7m 
44% 98:2 36:1 
8 1 mol% 11 h 50% 
6n 
44% 99:1  
372 
7n 
49% 99.5:0.5 191:1 
a) Reactions were performed on 0.50 mmol scale with molecular sieves (100 mg) in toluene (5 ml) and terminated 
with a few drops of triethylamine. b) Theoretical conversion calculated from ee values of the product and the 
recovered starting material (see chapter 7.3.3). c) Isolated yield on a 0.50 mmol scale. d) Determined by HPLC or 
GC analysis on a chiral stationary phase. e) For most minor diastereomers er >99.5:0.5. f) Calculated from 
theoretical conversion and enantiomeric excess of enantioenriched diol (see chapter 7.3.3).  
We next investigated the applicability of our catalytic system to 1,3-diols. Due to their slightly 
declined reactivity and selectivity, an additional screening of conditions was required (see, 
Table 4.8). Using a bulkier catalyst 5n and acetaldehyde at 0 °C resulted in good selectivity 
factor of 29 for resolution of 1,3-diol rac-8a (Table 4.11, entry 1). A methyl,naphthyl-
substituted 1,3-diol gave still good but slightly lower selectivity factor of 16 (Table 4.11, entry 
2). In both cases enantioenriched diols could be isolated in good yields and high enantiomeric 
ratios of 99:1 and 94.5:5.5, respectively.  
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Table 4.11. Kinetic resolution of 1,3-diols.a  
 
entry time  conv.b compound yieldc erd,e dr 7d Sf 
1 38 h 58% 
8a 
40% 99:1  
29 
9b 54% 91:9 17:1 
2 40 h 56% 
8g 
38% 94.5:5.5  
16 
9g 
55% 89:11 20:1 
a) Reactions were performed on 0.50 mmol scale with molecular sieves (100 mg) in toluene (5 ml) and terminated 
with a few drops of triethylamine. b) Theoretical conversion calculated from ee values of the product and the 
recovered starting material (see chapter 7.3.3). c) Isolated yield on a 0.50 mmol scale. d) Determined by HPLC or 
GC analysis on a chiral stationary phase. e) For most minor diastereomers er >99.5:0.5. f) Calculated from 
theoretical conversion and enantiomeric excess of enantioenriched diol (see chapter 7.3.3).  
 
Dialkyl-substituted 1,2-diols 
The exceptional results with aryl,alkyl-substituted 1,2-diols encouraged us to explore the 
kinetic resolution of dialkyl-substituted 1,2-diols. Although aryl,alkyl-substituted diols proved 
as excellent substrates for our kinetic resolution, dialkyl substituted diols were expected to 
result in diminished selectivities due to more similar substituents on the stereogenic center.  
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Table 4.12. Kinetic resolution of alkyl,alkyl-substituted 1,2-diols.a  
 
entry 
catalyst 
loading 
time  conv.b compound yieldc erd,e dr 7d Sf 
1 2 mol% 15 h 55% 
6o 
45% 95.5:4.5  
23 
7o 
49% 95.5:4.5 11:1 
2 2 mol% 15 h 61% 
HO
OH 6p 
33% 93:7  
9 
7p 
54% 98.5:1.5 4:1 
3 2 mol% 17 h 62% 
6a 
32% 91:9  
7 
7a 
62% 99.5:0.5 3:1 
a) Reactions were performed on 0.50 mmol scale with molecular sieves (100 mg) in toluene (5 ml) and terminated 
with a few drops of triethylamine. b) Theoretical conversion calculated from ee values of the product and the 
recovered starting material (see chapter 7.3.3). c) Isolated yield on a 0.50 mmol scale. d) Determined by HPLC or 
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GC analysis on a chiral stationary phase. e) For most minor diastereomers er >99.5:0.5. f) Calculated from 
theoretical conversion and enantiomeric excess of enantioenriched diol (see chapter 7.3.3).  
Gratifyingly, the reaction of methyl,cyclohexyl-substituted diol proceeded with a high 
selectivity factor of 23 with 2 mol% of the catalyst (Table 4.12, entry 1). With methyl,hexyl-
substituted diol, the reaction proceeded with a lower selectivity factor 9 (Table 4.12, entry 2), 
but recovered diol (S)-6p could still be obtained in 33% yield with a good er of 93:7, and the 
acetal product 7p was isolated with excellent er of 98.5:1.5, although the diastereoselectivity 
was low. A slightly lower selectivity factor of 7 was observed with the reaction of 
methyl,benzyl-substituted diol (Table 4.12, entry 3). These examples demonstrate how 
excellent stereocontrol of the acetal stereocenter formation can be accomplished by the 
catalyst regardless of the diol substrate. Even if the reactions of dialkyl-substituted diols do not 
give particularly high selectivity factors, still good enantioselectivities and acceptable yields of 
dialkyl-substituted diols could be obtained at higher conversion of the reaction. It is 
noteworthy that highly enantioenriched 1,2-diols with very similar aliphatic substituents at the 
tertiary alcohol stereocenter could be obtained by our kinetic resolution process, which are 
hard to obtain by other methods. 
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4.2.3. Stereodivergent access to enantioenriched diols 
Our initial attempts towards the kinetic resolution of diols with a secondary alcohol 
stereocenter delivered disappointing results showing almost no selectivities (Table 4.6). 
However, both diastereomers of the acetal product were obtained in an excellent er of 
99.5:0.5 and er of 95:5 respectively and in a combined yield of 80% (Table 4.6, entry 3). This 
example illustrates an important aspect of our acetalization reaction. As an additional acetal 
stereocenter is created in the acetalization reaction, a complementary divergent reaction on a 
racemic mixture is possible if the catalyst can control its formation very well. Thus, even in the 
cases where the actual enantiomer differentiation of the starting diol substrate is poor, the less 
reactive enantiomer is converted into the minor diastereomer. Indeed our catalyst enabled an 
exceptionally high degree of control in creating the acetal stereogenic center as shown in entry 
3, Table 4.6, and also in entries 2-3, Table 4.12.  
We first examined the stereodivergent resolution with racemic diol 6p which gave the 
selectivity factor 9 (Table 4.12, entry 2). A higher catalyst loading was needed to increase the 
reactivity at lower temperature. The diol enantiomers are converted into two different acetal 
diastereomers after complete conversion of the starting material (Scheme 4.14). Subsequently, 
the acetal products can be separated by chromatography on silica gel providing acetal 
protected diols 7p and epi-7p with an excellent er of 95.5:4.5 in 44% isolated yield and an er of 
99:1 in 40% isolated yield, respectively. After subsequent deprotection using 30 mol% of (±)-
CSA in methanol, the enantioenriched diols (R)-6p and (S)-6p could be obtained from the 
corresponding acetals.  
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Scheme 4.14. Stereodivergent access to enantioenriched diols 6p. 
Encouraged by this successful stereodivergent reaction, we also examined whether diols with 
secondary alcohol stereocenters can be applied to this process. Gratifyingly, the substrate rac-
6a, which gave almost no selectivity (s factor 1.6, Table 4.6, entry 3) in our kinetic resolution, 
afforded two acetal diastereomers epi-7a and 7a with an excellent er of 99.5:0.5 in 46% and an 
er of 96.5:3.5 and 47% isolated yield respectively, when catalyst 5k was employed at 15 °C 
(Scheme 4.15). Highly enantioenriched diols (S)-6a and (R)-6a can be obtained after removal of 
the acetal protecting group.  
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Scheme 4.15. Stereodivergent access to enantioenriched diols 6a. 
It is noteworthy that, from a single asymmetric reaction using one configuration of catalyst, 
both (R)- and (S)-enantiomers of diols rac-6p and rac-6s could be obtained with very high 
enantiomeric ratios.   
 
4.2.4. Discussion 
We have developed a highly enantioselective kinetic resolution of diols possessing quaternary 
stereocenters via an asymmetric acetalization reaction. Exceptional selectivity factors of up to 
389 can be obtained. In most cases both acetal product and recovered diol can be obtained 
with er over 95:5. Furthermore, due to exceptional enantiocontrol of our catalyst in creating 
the acetal stereogenic center, a complementary stereodivergent resolution of diols into two 
separable diastereoisomers was possible. This process can be applied in cases where the 
kinetic enantiomer differentiation is not satisfactory. It is noteworthy that our kinetic 
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resolution represents a method that can provide enantioenriched diols possessing tertiary 
alcohol stereocenters. Also, our process is a very atom economic method forming water as the 
only byproduct.   
Based on our previous asymmetric acetalization results, we believe that the reaction 
proceeds through the oxocarbenium ion which is derived from the primary hydroxyl 
functionality and subsequent attack of the tertiary alcohol. This cyclization step is probably the 
enantio-discriminating step, as hemiacetal formation is presumably reversible (Scheme 4.16). 
The alcohol group of the tertiary stereocenter of the diol presumably possesses hydrogen 
bonding with the chiral imidodiphosphate anion, placing the alcohol stereocenter in its close 
vicinity, to achieve an efficient kinetic resolution in the cyclization step. Potentially, the 
transition state can be stabilized further by additional oxocarbenium C–H···anion hydrogen 
bonding.[159]  
 
Scheme 4.16. Suggested mechanism. 
All of our kinetic acetal products are cis-isomers which are also thermodynamically favored 
over the corresponding trans-isomers.[160] The aldehyde alkyl chain and the larger alcohol 
substituent both take pseudoequatorial positions in the five-membered transition state, 
resulting in their cis relationship in the products (Figure 4.2). The six-membered transition 
state for 1,3-diols follows in the same manner by bulky substituents taking equatorial positions.  
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Figure 4.2. Pre-transition state assembly explaining the preferred cis-diastereomer selectivity. 
Absolute configurations of quaternary carbon stereocenters in acetal products were assigned 
opposite configurations to those observed in the recovered diols. The configuration of acetal 
stereocenters were assigned by analogy to the results from our asymmetric acetalization 
studies.[67] The cis-configuration of the product 9b was verified by NOESY correlation (Figure 
4.3).  
 
Figure 4.3. Determination of the relative stereochemistry of 9b by NOESY correlation. 
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5. SUMMARY 
5.1. Catalytic asymmetric acetalization 
Stereogenic acetals are frequently found motifs in a variety of natural products and bioactive 
compounds. Acetal formation from aldehydes and alcohols catalyzed by Brønsted acids is one 
of the most common transformations in organic synthesis. However, the asymmetric version of 
this reaction was unknown prior to our work. The success of Brønsted acid catalyzed 
asymmetric N,X-acetalizations (X = O, N, S) is based on the well-established ability of chiral 
phosphoric acids to control the enantioselective addition of nucleophiles to imine substrates 
and intermediates. However, O,O-acetalizations which require enantioselective additions to 
oxocarbenium ion intermediates remained underdeveloped. One of the challenges is that O,O-
acetals could reversibly form oxocarbenium ions resulting in racemization of the acetal 
products in the presence of acid. 
 We have developed the first catalytic asymmetric acetalization of aldehydes with 
diols.[67] Imidodiphosphoric acid with isopropyl, methyl substituents in the 2- and 5-position on 
the aryl group, readily available from natural product thymol, drastically outperformed known 
catalysts and delivered O,O-acetals with excellent enantioselectivity (Scheme 5.1). The reaction 
provides highly enantioenriched acetal products, and even the reaction of a small substrate 
can proceed with exceptional enantioselectivity giving product with an er of 99.8:0.2. 
 
Scheme 5.1. Catalytic asymmetric acetalization. 
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5.2. Kinetic resolution of diols via catalytic asymmetric acetalization 
Enantiomerically pure diols are common scaffolds in natural products and are valuable 
synthetic building blocks. Although many synthetic approaches to enantioenriched diols have 
been developed, synthetic methods that deliver diols with tertiary alcohol stereocenters with 
high enantioselectivity are very limited. Since racemic diols are readily accessible, kinetic 
resolution is a popular strategy for preparation of enantioenriched diols. Methods for kinetic 
resolution of diols through asymmetric acylation and silylation are well known. Next to ester 
and silyl groups, acetals are among the most common protecting groups for alcohols, with 
complementary stability and deprotection conditions. However, processes for the kinetic 
resolution of diols via acetalization reaction are unknown prior to our work. 
 We have developed a kinetic resolution of diols based on our asymmetric acetalization 
reaction (Scheme 5.2).[68] The reaction gives free enantioenriched 1,2- and 1,3-diols with 
tertiary alcohol stereocenters and acetal-protected diols with excellent enantioselectivities. 
Selectivity factors up to 389 can be achieved. Furthermore, a complementary stereodivergent 
resolution of diols into two separable diastereoisomers is possible, giving both enantiomers of 
a diol with high enantioselectivities after removal of acetal protecting group.  
 
Scheme 5.2. Kinetic resolution of diols via acetalization.  
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This work has been disclosed in part in the following publications: 
“Resolution of Diols via Catalytic Asymmetric Acetalization”, J. H. Kim, I. Čorić, C. Palumbo, B. 
List, J. Am. Chem. Soc. 2015, 137, 1778. 
“The Catalytic Asymmetric Acetalization”, J. H. Kim, I. Čorić, S. Vallalath, B. List, Angew. Chem. 
Int. Ed. 2013, 52, 4474. 
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6. OUTLOOK 
6.1. Acetals for fragrance chemistry 
Acetal compounds can sometimes provide pleasant scent, and subsequently the synthesis of 
acetals attracts attention of perfumery companies. Enantiomers of chiral acetal compounds 
can have very distinct and characteristic odors. For example, an important blackcurrant 
odorant contains the (2S),(4R)-1,3-oxathiane moiety and the odor is mainly caused by this 
stereoisomer of the acetal compound (A, Figure 6.1).[161] Okoumal is found to have a woody 
odor, and its stereoisomers possess different strengths of the odor depending on the 
configuration at the acetal stereocenter (B, Figure 6.1).[162]   
 
Figure 6.1. Acetal compounds with interesting scents. 
During our studies on kinetic resolutions of diols via asymmetric acetalization reactions we 
have found that one of our acetal products smells interesting. In order to evaluate the 
properties of the compound as an odorant we prepared the racemic mixture rac-7d.    
PTSA (10 mol%)
MS 5 Å, toluene
60 °C, 24 h
+
H
O
HO
OH
O
O
rac-7drac-6c 3d  
Scheme 6.1. Preparation of acetal product rac-7d.  
The compound was analysed by Dr. P. Kraft from the Fragrance Research department of 
Givaudan Schweiz AG and found that it possesses “a herbal-fruity odor in the direction of clary 
sage, with reminiscence to Claritone and Labienone”. The odor threshold is 66 ng/L air, which 
is rather weak, while good odorants are around 1.0 ng/L air or at least below 10.0 ng/L air.  
 These results demonstrate that even our simple acetal products could provide 
interesting properties, and that asymmetric acetalizations in the future might be employed for 
fragrance production.  
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6.2. Brønsted acid catalyzed asymmetric S,O-acetalization 
Next to stereogenic O,O-acetals, the stereogenic S,O-acetal motif can also be found in drugs 
(Figure 6.2). Cevimeline is used in the treatment of dry mouth in patients with Sjögren's 
syndrome,[163] and Emtricitabine for the treatment of HIV. However, catalytic asymmetric 
transformations that involve the formation of S,O-acetal stereocenters to give enantioenriched 
S,O-acetal products are very rare. The direct catalytic asymmetric S,O-acetalization of 
aldehydes is unknown.     
 
Figure 6.2. Stereogenic S,O-acetals in drug. 
As our investigations on the direct asymmetric O,O-acetalization reaction were successful, we 
have started to investigate the direct asymmetric S,O-acetalization reaction catalyzed by 
confined imidodiphosphoric acids to obtain enantioenriched S,O-acetal products (Scheme 6.2).  
 
Scheme 6.2. Towards the asymmetric S,O-acetalization. 
We initiated our investigations using commercially available simple mercaptoethanol and 
confined imidodiphosphoric acid catalyst 5i, which has previously been identified as an 
excellent catalyst for asymmetric O,O-acetalizations (Scheme 6.3). However, the reaction with 
isovaleraldehyde using 5 mol% of the catalyst gave cyclic acetal product with a poor 
enantioselectivity (er of 59.5:40.5).  
 
Scheme 6.3. Initial attempt at asymmetric S,O-acetalization. 
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We next tested the reaction with 2-mercaptobenzyl alcohol, which is bulkier than 
mercaptoethanol, and a significantly improved er of 83.5:16.5 was observed (Scheme 6.4). 
 
Scheme 6.4. Use of 2-mercaptobenzyl alcohol for S,O-acetalization.  
We speculated that there might be a competition to form the oxocarbenium and 
thiocarbenium ions resulting potentially in low enantioselectivity (Figure 6.3).  
 
Figure 6.3. The formation of potential carbenium ion intermediates. 
We next synthesized 2-(mercaptomethyl)phenol which possesses the benzylic thiol instead of 
alcohol, and employed it to the asymmetric acetalization reaction (Scheme 6.5). Gratifyingly, 
this substrate enabled us to obtain the S,O-acetal product with high enantioselectivity, er 95:5.  
O
H
+
O
S
er 95:5
OH
SH
(5 mol%)
MS 5 Å, toluene
O
O
iPr
iPr
P
OH
N
O
O
iPr
iPr
P
O
 
Scheme 6.5. Catalytic asymmetric S,O-acetalization. 
Further exploration of the reaction conditions and substrate scope will hopefully lead to a 
general methodology for the asymmetric S,O-acetalization, and analogous reactions may be 
envisioned for the kinetic resolution of chiral racemic thioalcohols via S,O-acetal formation. 
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6.3. Brønsted acid catalyzed asymmetric S,S-acetalization 
Dithioacetals are common protecting group for carbonyl compounds. They can be formed from 
thiols and aldehydes or ketones with Lewis or Brønsted acid catalysts. Dithioacetals are 
frequently used to provide umpolung of carbonyl group. However, a catalytic asymmetric 
thioacetalization is unkown.  
We wondered if our catalytic system can be applied to provide enantioenriched S,S-
acetals potentially through the formation of thiocarbenium ion intermediate.  
 
Scheme 6.6. Catalytic asymmetric S,S-acetalization. 
Gratifyingly, the asymmetric S,S-acetalization can be achieved using thymol-derived 
imidodiphosphoric acid, giving cyclic thioacetal product with high er of 98:2 (Scheme 6.6). 
Exploration of the substrate scope is expected to result in the first catalytic asymmetric 
thioacetalization and this reaction could be applied to kinetic resolution of dithiols via 
dithioacetal formation. It would be interesting to determine if S,S-acetalization reactions 
proceed through the asymmetric addition of nucleophiles to thiocarbenium ions. 
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7. EXPERIMENTAL SECTION 
7.1. General experimental conditions 
Solvents and reagents 
All solvents used in the standard procedures were purified by distillation. Absolute diethyl 
ether, tetrahydrofuran, n-hexane and toluene were obtained by distillation over sodium with 
benzophenone as indicator; absolute chloroform and dichloromethane were obtained by 
distillation over calcium hydride, and ethanol, isopropanol and methanol were dried by 
distillation over magnesium. Anhydrous acetone, acetonitrile, benzene, cyclohexane, DMF, 
DMSO, pyridine, and 1,4-dioxane were purchased from Sigma-Aldrich and used as received. 
NEt3 were purified by distillation over LiAlH4. All dried solvents and purified reagents were 
distilled prior to use or stored under an inert argon atmosphere. Commercial reagents were 
obtained from various sources and used without further purification unless indicated. All 
aldehydes were distilled prior to use or stored under an inert argon atmosphere.  
 
Known Brønsted acid catalysts 
Chiral Brønsted acid catalysts in Table 4.1 were kindly supplied by the coworkers from the 
List group and were prepared according to the literature procedures referenced in Table 4.1.  
 
Imidodiphosphoric acid catalysts 
Chiral imidodiphosphoric acid catalysts in Table 4.2, Table 4.6, Table 4.7, and Table 4.8 were 
developed and initially prepared by I. Čorić.[11] 
 
Inert gas atmosphere 
All air and moisture sensitive reactions were conducted in flame-dired glass ware under and 
inert argon atmosphere using standard Schlenk techniques. Dry argon was purchased from 
Air Liquide with higher than 99.5% purity. Unless otherwise stated, all organocatalytic 
reactions were performed under an ambient atmosphere without the exclusion of moisture 
or air. 
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Thin layer chromatography (TLC) 
Reactions were monitored by thin layer chromatography on silica gel or aluminum oxide pre-
coated plastic sheets (0.2 mm, Macherey-Nagel). Visualization was accomplished by 
irradiation with UV light at 254 nm and different staining reagents; phosphomolybdic acid 
(PMA) stain: PMA (10 g) in EtOH (100 ml); anisaldehyde stain: p-anisaldehyde (3.5 ml), glacial 
acetic acid (15 ml), EtOH (350 ml), conc. H2SO4 (50 ml). 
 
Column chromatography 
Column chromatography was performed under elevated pressure on silica gel (60, particle 
size 0.040-0.063 mm, Merck) or aluminum oxide (neutral, activated, Brockmann I, Sigma-
Aldrich; Activity II with 3% H2O; Activity III with 6% H2O). 
 
High pressure liquid chromatography (HPLC)  
HPLC analyses on a chiral stationary phase were performed on a Shimadzu LC-2010C system 
equipped with a UV detector. Commercial HPLC-grade solvents were used, and 
measurements were conducted at 25 °C. The chiral stationary phase of the columns is 
specified in each experiment. The enantiomeric ratios were determined by comparing the 
samples with the appropriate racemic mixtures. 
 
Gas chromatography (GC) 
GC analyses on a chiral stationary phase were performed on HP 6890 and 5890 series 
instruments equipped with a split-mode capillary injection system and a flame ionization 
detector (FID) using hydrogen as a carrier gas. Detailed conditions are given in the individual 
experiment. The enantiomeric ratios were determined by comparing the samples with the 
appropriate racemic mixtures. 
 
Nuclear magnetic resonance spectroscopy (NMR) 
Proton, carbon, and phosphorus NMR spectra were recorded on Bruker AV-500 or Bruker 
AV-400 spectrometers in deuterated solvents at room temperature (298 K). Proton chemical 
shifts are reported in ppm (δ) relative to tetramethylsilane with the solvent resonance 
employed as the internal standard (C6D6, δ 7.16 ppm; DMSO-d6, δ 2.49 ppm; CD2Cl2, δ 5.32 
ppm; CDCl3, δ 7.24 ppm; acetone-d6, δ 2.04 ppm). 
31P chemical shifts are reported in ppm 
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relative to H3PO4 as the external standard. Data are reported as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constants 
(Hz) and integration. Slight shape deformation of the peaks in some cases due to weak 
coupling is not explicitly mentioned. 13C chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (C6D6, δ 128.06 ppm; 
DMSO-d6, δ 39.5 ppm; CD2Cl2, 53.8 ppm; CDCl3, δ 77.0 ppm; acetone-d6, δ 206.0, 29.8 ppm). 
 
Mass spectrometry (MS) 
Mass spectra were measured on a Finnigan MAT 8200 (70 eV) or MAT 8400 (70 eV) by 
electron ionization, chemical ionization or fast atom/ion bombardment techniques. 
Electrospray ionization (ESI) mass spectra were recorded on a Bruker ESQ 3000 
spectrometer. High resolution mass spectra were obtained on a Finnigan MAT 95 or Bruker 
APEX III FT-MS (7 T magnet). All masses are given in atomic units/elementary charge (m/z). 
 
Specific rotation  
Optical rotations were determined with Autopol IV automatic polarimeter (Rudolph 
Research Analytical) using a 50 mm cell with temperature control. The measurements were 
performed   at 25 °C at a wavelength λ = 589 nm (sodium D-line) unless indicated. 
Concentrations (c) are given in g/100 ml. 
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7.2. Catalytic asymmetric acetalization 
7.2.1. Starting materials 
Representative procedure for compounds 2b-e 
 
To a solution of 5-chloro-2-hydroxybenzaldehyde (0.5 g, 3.19 mmol) in methanol (5 ml) at 0 
°C was added NaBH4 (0.24 g, 6.39 mmol) and the mixture was allowed to stir at 0 °C for 30 
min. The reaction mixture was quenched with H2O and extracted with EtOAc. The combined 
organic extracts were dried (MgSO4), filtered, and concentrated.  
 
4-chloro-2-(hydroxymethyl)phenol (2b) 
Purification: 30% EtOAc/hexane.  
Yield: White solid, 0.41 g, 81%. 
1H NMR (500 MHz, C6D6) δ 7.34 (s, 1H), 6.95 (dd, J = 8.6, 2.4 Hz, 1H), 6.63 
(m, 2H), 3.95 (d, J = 5.0 Hz, 2H). 
13C NMR (125 MHz, C6D6) δ 155.5, 129.1, 127.5, 126.3, 124.5, 118.2, 64.0. 
HRMS (EI (DE)) m/z calculated for C7H7O2Cl (M) 158.0135, found 158.0135. 
 
2-(hydroxymethyl)-4-nitrophenolphenol (2c) 
Purification: 30% EtOAc/hexane.  
Yield: Yellow solid, 0.42 g, 83%. 
1H NMR (500 MHz, DMSO-d6) δ 11.08 (brs, 1H), 8.21 (s, 1H), 8.02 (dd, J 
= 8.9, 3.0 Hz, 1H), 6.93 (d, J = 8.9 Hz, 1H), 5.39 (brs, 1H), 4.50 (s, 2H). 
13C NMR (125 MHz, DMSO-d6) δ 160.5, 139.6, 130.3, 124.1, 122.7, 114.7, 57.4.  
HRMS (EI (DE)) m/z calculated for C7H7N1O4 (M) 169.0375, found 169.0374. 
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2-bromo-4-chloro-6-(hydroxymethyl)phenol (2d) 
Purification: 30% EtOAc/hexane.  
Yield: White solid, 0.39 g, 77%. 
1H NMR (500 MHz, CDCl3) δ 7.42 (d, J = 2.5 Hz 1H), 7.15 (d, J = 2.4 Hz, 
1H), 6.77 (s, 1H), 4.77 (s, 2H). 
13C NMR (125 MHz, CDCl3) δ 149.9, 131.0, 128.2, 127.4, 125.5, 110.7, 62.5. 
HRMS (ESI+) m/z calculated for C7H6Br1Cl1Na (M+Na
+) 258.9132, found 258.9132. 
 
2-(hydroxymethyl)-4-methylphenol (2e) 
Purification: 30% EtOAc/hexane.  
Yield: White solid, 0.37 g, 72%. 
1H NMR (500 MHz, CDCl3) δ 7.05-6.95 (m, 1H), 6.84 (s, 1H), 6.78 (d, J = 
8.1 Hz, 1H), 5.08 (s, 1H), 4.81 (s, 1H), 2.26 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 153.8, 130.1, 130.0, 129.4, 128.6, 116.5, 64.8, 20.5.  
HRMS (EI (DE)) m/z calculated for C8H10O2 (M) 138.0681, found 138.0682. 
 
Procedure for compounds 2n[164]  
 
To a solution of the epoxide (3.7 ml, 41.6 mmol) in water (75 ml) was added 7 drops of 
phosphoric acid and the mixture was stirred overnight at room temperature. Solid NaHCO3 
was added until pH 7 and then the mixture was evaporated. EtOAc was added to the residue 
mixture, which was then dried (Na2SO4), filtered, and concentrated. No further purification 
was required.  
Yield: Colorless oil, 3.1 g, 83%. 
1H NMR (500 MHz, C6D6) δ 3.20 (s, 2H), 2.49 (brs, 2H), 1.05 (s, 6H). 
13C NMR (125 MHz, C6D6) δ 71.1, 70.8, 25.8. 
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Procedure for compounds 3j[165]  
 
To a solution of Meldrum’s acid (3.6 g, 25 mmol) in water (50 ml) was added 2-
naphthaldehyde (4.3 g, 27.5 mmol). The reaction mixture was stirred at 75 °C for 2 h. After 
cooling, the reaction mixture was filtered and washed with water and hexane. The resulting 
solid was recrystallized from warm ethanol.  
Yield: White solid, 2.39 g, 34%. 
1H NMR (500 MHz, CDCl3) δ 8.59 (s, 1H), 8.56 (s, 1H), 8.13 (dd, J = 8.7, 1.7 Hz, 1H), 7.95 (d, J = 
7.9 Hz 1H), 7.91-7.84 (m, 2H), 7.68-7.51 (m, 2H), 1.84 (s, 6H). 
13C NMR (125 MHz, CDCl3) δ 163.6, 160.1, 158.3, 137.2, 135.8, 132.8, 129.9, 129.6, 129.5, 
128.5, 128.2, 127.9, 127.2, 114.5, 104.7, 27.8. 
 
 
NaBH4 (0.48 g, 12.7 mmol) was added in small portions to a solution of Meldrum’s acid 
derivative (1.2 g, 4.3 mmol) and glacial acetic acid (6 ml) in CH2Cl2 (60 ml) at 0 °C. The 
reaction mixture was stirred for 1 hour at room temperature. The reaction mixture was 
diluted with CH2Cl2 and washed with brine and water. The organic phase was extracted, 
dried (MgSO4) and concentrated. 
Yield: White solid, 1.15 g, 95%.  
1H NMR (500 MHz, CDCl3) δ 7.85-7.73 (m, 4H), 7.50-7.41 (m, 3H), 3.84 (t, J = 5.0 Hz, 1H), 3.66 
(d, J = 5.0 Hz, 2H), 1.73 (s, 3H), 1.50 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 165.4, 134.9, 133.5, 132.6, 128.7, 128.4, 128.0, 128.0, 127.7, 
126.3, 126.0, 105.4, 48.4, 32.3, 28.6, 27.3. 
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To a solution of Meldrum’s acid derivative (1.1 g, 4.1 mmol) in THF (24 ml) was added Et3N 
(1.1 ml, 8.1 mmol) followed by PhSiH3 (1.5 ml, 12.0 mmol). The reaction mixture was stirred 
for 2 hours at room temperature. Water (4 ml) was added to the reaction mixture and 
stirred for 15 min, then diluted with Et2O, and washed with water and brine. The organic 
phase was extracted, dried (MgSO4), filtered and concentrated. 
Purification: 10% EtOAc/hexane.  
Yield: White solid, 0.48 g, 65%. 
1H NMR (500 MHz, C6D6) δ 9.27 (t, J = 1.2 Hz, 1H), 7.65-7.60 (m, 2H), 7.56 (d, J = 8.4 Hz, 1H), 
7.33 (s, 1H), 7.31-7.22 (m, 2H), 7.00 (dd, J = 8.4, 1.7 Hz, 1H), 2.71 (t, J = 7.6 Hz, 2H), 2.14-2.07 
(m, 2H). 
13C NMR (125 MHz, C6D6) δ 199.7, 138.4, 134.2, 132.7, 128.4, 128.3, 128.0, 127.3, 126.9, 
126.3, 125.7, 45.1, 28.3. 
HRMS (EI (DE)) m/z calculated for C13H12O (M) 184.0888, found 184.0889. 
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7.2.2. Products 
General procedure for the catalytic asymmetric acetalization 
 
The aldehyde (0.4 mmol) was added to a mixture of diol (0.2 mmol), catalyst 5i (0.01 mmol, 
5 mol%), and 5 Å molecular sieves (40 mg) in toluene (2 ml). The mixture was stirred 
vigorously at room temperature unless otherwise specified, for the indicated time and then 
treated with triethylamine (50 μl). Purification was performed by column chromatography 
on silica gel using EtOAc/hexanes or Et2O/pentane (for volatile products) as the eluents. The 
absolute configuration of acetals 4j and 4x was determined by single crystal X-ray analysis. 
The absolute configurations of the other products were assigned by analogy. 
 
Preparation of the racemates 
The samples of racemic products for HPLC/GC analysis were prepared from diol (0.05 mmol), 
aldehyde (0.1 mmol), and (PhO)2PO2H (10 mol%) as the catalyst in toluene (0.5 ml) and 
isolated by thin layer chromatography using EtOAc/hexanes as the eluent. 
 
Optimization 
The small-scale reactions in Table 4.1 and Table 4.2 of the manuscript were performed with 
0.05 mmol of the diol and after designated times quenched by adding a few drops of 
triethylamine. The samples for HPLC analysis were isolated by thin layer chromatography 
using EtOAc/hexanes as the eluent.  
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(S)-2-isobutyl-4H-benzo[d][1,3]dioxine (4a) 
Reaction time: 2 days. Purification: 5% EtOAc/hexane.  
Yield: Colorless oil, 33.1 mg, 86%. [α]25D = -112.8 (c 1.07, CH2Cl2). 
1H NMR (500 MHz, C6D6) δ 6.98-6.93 (m, 2H), 6.75-6.72 (m, 1H), 6.57-
6.55 (m, 1H), 4.89 (t, J = 5.5 Hz, 1H), 4.57-4.51 (m, 2H), 2.00-1.96 (m, 1H), 1.81-1.79 (m, 2H), 
0.88 (d, J = 3.3 Hz, 3H), 0.87 (d, J = 3.3 Hz, 3H).  
13C NMR (125 MHz, C6D6) δ 153.9, 128.2, 125.2, 121.6, 121.0, 117.1, 99.4, 66.5, 43.6, 24.1, 
23.0, 22.9.  
HRMS (EI (FE)) m/z calculated for C12H16O2 (M) 192.1150, found 192.1148.  
HPLC (OJ-H), n-heptane/i-PrOH 99:1, 0.5 ml/min, λ = 254 nm, tmajor = 10.58 min, tminor = 13.75 
min, er = 96:4. 
 
(S)-6-chloro-2-isobutyl-4H-benzo[d][1,3]dioxine (4b) 
Reaction time: 4 days. Purification: 5% EtOAc/hexane.  
Yield: Colorless oil, 37.3 mg, 82%. [α]25D = -142.8 (c 1.39, CH2Cl2). 
1H NMR (500 MHz, C6D6) δ 6.88 (dd, J = 2.5, 8.7 Hz, 1H), 6.62 (d, J = 
7.8 Hz, 1H), 6.47-6.46 (m, 1H), 4.72 (t, J = 5.4 Hz, 1H), 4.27 (s, 2H), 1.98-1.89 (m, 1H), 1.74-
1.72 (m, 2H), 0.86 (d, J = 3.8 Hz, 3H), 0.85 (d, J = 3.8 Hz, 3H).  
13C NMR (125 MHz, C6D6) δ 152.2, 125.9, 125.2, 122.9, 118.3, 99.5, 65.9, 43.4, 24.0, 23.0, 
22.9.  
HRMS (EI (FE)) m/z calculated for C12H15O2Cl (M) 226.0761, found 226.0760.  
HPLC (OJ-H), n-heptane/i-PrOH 99:1, 0.5 ml/min, λ = 220 nm, tmajor = 11.09 min, tminor = 14.20 
min, er = 95:5. 
 
(S)-2-isobutyl-6-nitro-4H-benzo[d][1,3]dioxine (4c) 
Reaction time: 10 days at 50 °C. Purification: 5% EtOAc/hexane. 
Yield: Yellow oil, 48.19 mg, 93%. [α]25D = -141.999 (c 1.72, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.74-7.71 (m, 1H), 7.38-7.37 (m, 1H), 
O
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6.44 (d, J = 9.0 Hz, 1H), 4.61 (t, J = 5.3 Hz, 1H), 4.13-4.06 (m, 2H), 1.91-1.83 (m, 1H), 1.67-1.64 
(m, 2H), 0.83 (d, J = 4.1 Hz, 3H), 0.82 (d, J = 4.1 Hz, 3H).  
13C NMR (125 MHz, C6D6) δ 158.2, 141.8, 124.1, 121.7, 121.2, 117.0, 100.1, 65.8, 43.1, 23.9, 
22.9, 22.7.  
HRMS (ESI+) m/z calculated for C12H15NO4Na (M+Na
+) 260.0893, found 260.0892.  
HPLC (AD-3), n-heptane/i-PrOH 99.5:0.5, 1.0 ml/min, λ = 220 nm, tmajor = 9.80 min, tminor = 
8.71 min, er = 94.5:5.5. 
 
(S)-8-bromo-6-chloro-2-isobutyl-4H-benzo[d][1,3]dioxine (4d) 
Reaction time: 5 days at 50 °C. Purification: 5% EtOAc/hexane.  
Yield: Yellow oil, 36.47 mg, 60%.  
1H NMR (500 MHz, C6D6) δ 7.25 (d, J = 2.4 Hz, 1H), 6.27-6.20 (m, 
1H), 4.59 (t, J = 5.5 Hz, 1H), 4.10 (d, J = 3.5 Hz, 2H), 2.04-1.85 (m, 1H), 1.81-1.60 (m, 2H), 0.86 
(dd, J = 6.7, 3.4 Hz, 6H). 
13C NMR (125 MHz, C6D6) δ 149.2, 131.2, 126.1, 124.2, 123.8, 111.5, 100.4, 65.6, 43.1, 24.1, 
23.0, 22.8. 
HRMS (EI (DE)) m/z calculated for C12H14O2BrCl (M) 303.9866, found 303.9864.  
HPLC (OJ-H), n-heptane/i-PrOH 99:1, 1.0 ml/min, λ = 220 nm, tmajor = 9.59 min, tminor = 11.53 
min, er = 92:8. 
 
(S)-2-isobutyl-6-methyl-4H-benzo[d][1,3]dioxine (4e) 
Reaction time: 8 days at 50 °C. Purification: 5% EtOAc/hexane.  
Yield: Yellow oil, 25.30 mg, 61%.  
1H NMR (500 MHz, C6D6) δ 6.93-6.87 (m, 1H), 6.78 (d, J = 8.3 Hz, 
1H), 6.34 (s, 1H), 4.93 (t, J = 5.4 Hz, 1H), 4.58 (q, J = 14.5 Hz, 2H), 2.06 (d, J = 4.1 Hz, 3H), 2.05-
1.98 (m, 1H), 1.86-1.79 (m, 2H), 0.89 (dd, J = 6.7, 3.3 Hz, 6H). 
13C NMR (125 MHz, C6D6) δ 151.7, 130.0, 128.8, 125.5, 121.2, 116.8, 99.4, 66.5, 43.7, 24.1, 
23.0, 23.0, 20.6. 
HRMS (EI (FE)) m/z calculated for C13H18O2 (M) 206.1307, found 206.1306.  
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HPLC (OJ-H), n-heptane/i-PrOH 98:2, 0.5 ml/min, λ = 205 nm, tmajor = 9.83 min, tminor = 14.09 
min, er = 94:6. 
 
(R)-2-isobutyl-4,4-diphenyl-4H-benzo[d][1,3]dioxine (4f) 
Reaction time: 2 days at 50 °C.  
Purification: 5% EtOAc/hexane.  
Yield: White solid, 30.0 mg, 44%.  
1H NMR (500 MHz, C6D6) δ 7.47-7.40 (m, 4H), 7.12-6.98 (m, 7H), 6.98-6.93 (m, 1H), 6.89 (dd, 
J = 7.8, 1.5 Hz, 1H), 6.66-6.59 (m, 1H), 5.23 (dd, J = 6.7, 4.1 Hz, 1H), 2.02-1.84 (m, 2H), 1.80-
1.66 (m, 1H), 0.80 (d, J = 6.6 Hz, 3H), 0.63 (d, J = 6.5 Hz, 3H).  
13C NMR (125 MHz, C6D6) δ 153.3, 146.8, 145.1, 130.3, 129.9, 128.8, 128.7, 127.7, 126.0, 
120.5, 117.6, 94.8, 84.8, 65.9, 43.8, 23.8, 23.4, 22.3, 15.6. 
HRMS (ESI+) m/z calculated for C24H24O2Na (M+Na
+) 367.1669, found 367.1665.  
HPLC (OD-H), n-heptane/i-PrOH 99.5:0.5, 0.5 ml/min, λ = 220 nm, tmajor = 7.08 min, tminor = 
7.75 min, er = 79:21. 
 
(S)-2-phenethyl-4H-benzo[d][1,3]dioxine (4g) 
Reaction time: 4 days. The excess of aldehyde was reduced by adding 
MeOH (0.5 ml) and NaBH4 (4 mg) to facilitate the purification.  
Purification: 5% EtOAc/hexane.  
Yield: Colorless oil, 39.8 mg, 83%. [α]25D = -94.7 (c 1.21, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.15-7.12 (m, 2H), 7.08-7.04 (m, 3H), 7.00-6.93 (m, 2H), 6.75-6.71 
(m, 1H), 6.54 (d, J = 7.7 Hz, 1H), 4.76 (t, J = 5.0 Hz, 1H), 4.53-4.47 (m, 2H), 2.81 (t, J = 8.0 Hz, 
2H), 2.17-2.13 (m, 2H).  
13C NMR (125 MHz, C6D6) δ 153.7, 141.7, 128.8, 126.3, 125.2, 121.5, 121.1, 117.0, 99.2, 66.4, 
36.4, 30.1.  
HRMS (EI (DE)) m/z calculated for C16H16O2 (M) 240.1150, found 240.1149.  
HPLC (AD-3), n-heptane/i-PrOH 99:1, 1.0 ml/min, λ = 220 nm, tmajor = 6.55min, tminor = 5.30 
min, er = 94.5:5.5. 
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(S)-2-butyl-4H-benzo[d][1,3]dioxine (4h) 
Reaction time: 4 days. Purification: 5% EtOAc/hexane.  
Yield: Colorless oil, 31.06 mg, 75%. [α]25D = -132.776 (c 1.56, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 6.98-6.94 (m, 2H), 6.75-6.72 (m, 1H), 
6.56 (d, J = 7.8 Hz, 1H), 4.78 (t, J = 5.1 Hz, 1H), 4.59-4.52 (m, 2H), 1.88-1.84 (m, 2H), 1.52-1.46 
(m, 2H), 1.27-1.20 (m, 2H), 0.84 (t, J = 7.3 Hz, 3H).  
13C NMR (125 MHz, C6D6) δ 153.9, 125.2, 121.5, 121.0, 117.1, 100.2, 66.5, 34.6, 26.1, 22.9, 
14.2.  
HRMS (EI (FE)) m/z calculated for C12H16O2 (M) 226.0761, found 226.0760.  
HPLC (OJ-H), n-heptane/i-PrOH 99:1, 0.5 ml/min, λ = 220 nm, tmajor = 11.81 min, tminor = 13.21 
min, er = 93.5:6.5. 
 
(S)-2-methyl-4H-benzo[d][1,3]dioxine (4i) 
Reaction time: 15 hours. Purification: 5% EtOAc/hexane.  
Yield: Colorless oil, 26.5 mg, 88%. [α]25D = -103.6 (c 0.94, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 6.97-6.91 (m, 2H), 6.74-6.71 (m, 1H), 6.54 (dd, J 
= 7.7, 0.5 Hz, 1H), 4.81 (q, J = 5.1 Hz, 1H), 4.54-4.47 (m, 2H), 1.40 (d, J = 5.1 Hz, 3H).  
13C NMR (125 MHz, C6D6) δ 153.8, 125.1, 121.3, 121.0, 117.0, 97.3, 66.4, 20.8.  
HRMS (EI (FE)) m/z calculated for C9H10O2 (M) 150.0681, found 150.0682.  
HPLC (OD-3), n-heptane/i-PrOH 99.5:0.5, 1.0 ml/min, λ = 220 nm, tmajor = 4.84 min, tminor = 
3.64 min, er = 87:13. 
 
(S)-6-chloro-2-(2-(naphthalen-2-yl)ethyl)-4H-benzo[d][1,3]dioxine (4j) 
Reaction time: 4 days. Purification: 5% EtOAc/hexane. 
Yield: Colorless solid, 56.12 mg, 86%. [α]25D = -97.686 (c 
1.25, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.70-7.54 (m, 3H), 7.49 (s, 
1H), 7.33-7.17 (m, 3H), 6.88 (dd, J = 2.5, 8.7 Hz, 1H), 6.64 (d, J = 8.7 Hz, 1H), 6.49-6.40 (m, 
1H), 4.62 (t, J = 5.1 Hz, 1H), 4.28 (d, J = 14.7 Hz, 1H), 4.23 (d, J = 14.7 Hz, 1H), 2.98-2.79 (m, 
2H), 2.26-3.05 (m, 2H).  
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13C NMR (125 MHz, C6D6) δ 152.1, 138.9, 134.3, 132.8, 128.5, 127.5, 127.0, 126.3, 126.0, 
125.6, 125.3, 122.8, 118.3, 99.3, 65.9, 36.1, 30.1.  
HRMS (EI(DE)) m/z calculated for C20H17O2Cl (M) 324.0917, found 324.0915.  
HPLC (OD-3), n-heptane/i-PrOH 98:2, 1.0 ml/min, λ = 220 nm, tminor = 7.00 min, tmajor = 8.25 
min, er = 91.5:8.5. 
 
(S)-2-isobutyl-4,4-dimethyl-1,3-dioxane (4k) 
Reaction time: 6 days at 50 °C. Purification: 5% Et2O/pentane.  
Yield: Colorless oil, 28.58 mg, 83%. [α]25D = -33.597 (c 0.51, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 4.83 (t, J = 5.4 Hz, 1H), 3.75-3.71 (m, 1H), 
3.58-3.53 (m, 1H), 2.05-1.97 (m, 1H), 1.77-1.68 (m, 3H), 1.17 (s, 3H), 1.05 (s, 3H), 0.94 (s, 3H), 
0.92 (s, 3H), 0.82-0.78 (m, 1H).  
13C NMR (125 MHz, C6D6) δ 94.9, 70.8, 63.0, 44.8, 36.1, 32.0, 24.3, 23.3, 23.0, 21.5.  
HRMS (CI(FE) i-Butan) m/z calculated for C10H21O2 (M+H) 173.1542, found 173.1540.  
GC (Column: 30 m BGB-176/BGB-15 (2,3-dimethyl-6-tertbutyldimethylsilyl-β-cyclodextrin), 
i.D. 0.25 mm, df. 0.25  μl; Detector: FID; Temperature: injector 220 °C, detector 320 °C, oven 
80 °C; gas: 0.4 bar H2), tmajor = 27.10 min, tminor = 26.71 min, er = 96.5:3.5. 
 
(S)-4,4-dimethyl-2-phenethyl-1,3-dioxane (4l) 
Reaction time: 2 days. The excess of aldehyde was reduced by adding 
MeOH (0.5 ml) and NaBH4 (4 mg) to facilitate the purification.  
Purification: 5% EtOAc/hexane.  
Yield: Colorless oil, 41.17 mg, 93%. [α]25D = -39.941 (c 1.35, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.15-7.11 (m, 4H), 7.07-7.03 (m, 1H), 4.68 (t, J = 5.0 Hz, 1H), 3.73-
3.69 (m, 1H), 3.51-3.46 (m, 1H), 2.83-2.80 (m, 2H), 2.11-2.06 (m, 2H), 1.73-1.65 (m, 1H), 1.17 
(s, 3H), 0.99 (s, 3H), 0.80-0.76 (m, 1H).  
13C NMR (125 MHz, C6D6) δ 142.5, 128.9, 128.7, 126.0, 94.9, 71.0, 62.9, 37.6, 36.1, 32.0, 30.7, 
21.5.  
HRMS (ESI+) m/z calculated for C14H20O2Na (M+Na
+) 243.1355, found 243.1353.  
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HPLC (AD-3), n-heptane/i-PrOH 99:1, 1.0 ml/min, λ = 220 nm, tmajor = 4.51 min, tminor = 3.92 
min, er = 95.5:4.5. 
 
(S)-2-butyl-4,4-dimethyl-1,3-dioxane (4m) 
Reaction time: 2 days. Purification: 5% Et2O/pentane.  
Yield: Colorless oil, 32.2 mg, 86%.  [α]25D = -36.557 (c 1.13, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 4.73 (t, J = 5.1 Hz, 1H), 3.76-3.72 (m, 1H), 
3.58-3.53 (m, 1H), 1.85-1.76 (m, 2H), 1.74-1.68 (m, 1H), 1.54-1.48 (m, 2H), 1.32-1.25 (m, 2H), 
1.18 (s, 3H), 1.05 (s, 3H), 0.86 (t, J = 7.3 Hz, 3H), 0.82-0.79 (m, 1H).  
13C NMR (125 MHz, C6D6) δ 95.9, 70.8, 63.0, 36.1, 35.8, 32.0, 26.8, 23.1, 21.6, 14.3.  
HRMS (CI(FE) i-Butan) m/z calculated for C10H21O2 (M+H) 173.1542. found 173.1541. 
GC (Column: 30 m BGB-176/BGB-15 (2,3-dimethyl-6-tertbutyldimethylsilyl-β-cyclodextrin), 
i.D. 0.25 mm, df. 0.25  μl; Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 
90 °C; gas: 0.5 bar H2), tmajor = 8.36 min, tminor = 8.05 min, er = 97.5:2.5. 
 
(S)-2-isobutyl-4,4-dimethyl-1,3-dioxolane (4n) 
Reaction time: 22 hours at 0 °C. Purification: 5% Et2O/pentane.  
Yield: Colorless oil, 22.92 mg, 72%. [α]25D = -13.391 (c 0.58, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 5.10 (t, J = 5.1 Hz, 1H), 3.47 (d, J = 7.7 Hz, 1H), 
3.31 (d, J = 7.7 Hz, 1H), 1.98-1.90 (m, 1H), 1.71-1.69 (m, 2H), 1.14 (s, 3H), 1.06 (s, 3H), 0.94 
(d, J = 4.1 Hz, 3H), 0.93 (d, J = 4.1 Hz, 3H).  
13C NMR (125 MHz, C6D6) δ 103.4, 77.9, 76.2, 44.2, 27.2, 25.2, 24.9, 23.3, 23.2.  
HRMS (CI(FE) i-Butan) m/z calculated for C9H19O2 (M+H) 159.1385, found 159.1384.  
GC (Column: 30 m BGB-176/BGB-15 (2,3-dimethyl-6-tertbutyldimethylsilyl-β-cyclodextrin), 
i.D. 0.25 mm, df. 0.25  μm; Detector: FID; Temperature: injector 220 °C, detector 320 °C, 
oven 60 °C; gas: 0.5 bar H2), tmajor = 15.45 min, tminor = 15.13 min, er = 99.8:0.2. 
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(S)-4,4-dimethyl-2-phenethyl-1,3-dioxolane (4o) 
Reaction time: 3 days. The excess of aldehyde was reduced by adding 
MeOH (0.5 ml) and NaBH4 (4 mg) to facilitate the purification.  
Purification: 5% EtOAc/hexane.  
Yield: Colorless oil, 29.76 mg, 72%. [α]25D = +11.186 (c 0.59, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.15-7.08 (m, 4H), 7.07-7.01 (m, 1H), 5.01 (t, J = 4.6 Hz, 1H), 3.45 
(d, J = 7.8 Hz, 1H), 3.20 (d, J = 7.70 Hz, 1H), 2.88-2.710 (m, 2H), 2.11-1.96 (m, 2H), 1.13 (s, 
3H), 1.04 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 142.2, 128.8, 128.7, 126.1, 103.4, 78.2, 76.3, 36.9, 30.6, 27.0, 
25.1.  
HRMS (CI(DE) i-Butan) m/z calculated for C13H19O2 (M+H) 207.1385, found 207.1385. 
HPLC (OD-3), n-heptane/i-PrOH 99:1, 1.0 ml/min, λ = 220 nm, tmajor = 6.44 min, tminor = 7.36 
min, er = 99:1. 
 
(S)-4,4-dimethyl-2-(pentan-3-yl)-1,3-dioxolane (4p) 
Reaction time: 10 days. Purification: 5% Et2O/pentane.  
Yield: Colorless oil, 30.66 mg, 82%. [α]25D = -11.421 (c 0.77, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 4.99 (d, J = 4.6 Hz, 1H), 3.43 (d, J = 7.7 Hz, 1H), 
3.31 (d, J = 7.7 Hz, 1H), 1.78-1.64 (m, 2H), 1.63-1.55 (m, 1H), 1.56-1.44 (m, 2H), 1.12 (s, 3H), 
1.06 (s, 3H), 0.97 (dt, J = 2.3, 7.6 Hz, 6H).  
13C NMR (125 MHz, C6D6) δ 106.1, 77.8, 76.3, 45.3, 26.9, 25.1, 21.7, 21.6, 11.9, 11.8.  
HRMS (CI(FE) i-Butan) m/z calculated for C10H21O2 (M+H) 173.1542, found 173.1540.  
GC (Column: 30 m BGB-176/BGB-15 (2,3-dimethyl-6-tertbutyldimethylsilyl-β-cyclodextrin), 
i.D. 0.25 mm, df. 0.25  μl; Detector: FID; Temperature: injector 220 °C, detector 320 °C, oven 
80 °C; gas: 0.5 bar H2) , tmajor = 14.90 min, tminor = 14.44 min, er = 99.5:0.5. 
O
O Ph
7. EXPERIMENTAL SECTION 
 
114 
(S)-4,4-dimethyl-2-phenyl-1,3-dioxolane (4q) 
Reaction time: 2 days. The excess of aldehyde was reduced by adding 
MeOH (0.5 ml) and NaBH4 (4 mg) to facilitate the purification.  
Purification: 10% Et2O/pentane.  
Yield: Colorless oil, 31.76 mg, 89%. [α]25D = +3.379 (c 0.95, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.60 (d, J = 7.5 Hz, 2H), 7.19-7.18 (m, 2H), 7.13-7.10 (m, 1H), 5.93 
(s, 1H), 3.53 (d, J = 7.7 Hz, 1H), 3.42 (d, J = 7.7 Hz, 1H), 1.16 (s, 3H), 1.12 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 139.7, 129.0, 128.4, 127.0, 103.6, 79.0, 76.5, 26.7, 25.2.  
HRMS (EI(FE)) m/z calculated for C11H14O2 (M) 178.0994, found 178.0992.  
HPLC (OD-H), n-heptane/i-PrOH 99:1, 0.5 ml/min, λ = 210 nm, tmajor = 11.51 min, tminor = 
10.62 min, er = 95.5:4.5. 
 
(S)-2-(4-chlorophenyl)-4,4-dimethyl-1,3-dioxolane (4r) 
Reaction time: 62 hours. The excess of aldehyde was reduced by 
adding MeOH (0.5 ml) and NaBH4 (4 mg) to facilitate the 
purification.  
Purification: 10% EtOAc/hexane.  
Yield: Colorless oil, 33.74 mg, 79%.  [α]25D = +9.031 (c 1.06, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.30-7.28 (m, 2H), 7.13-7.11 (m, 2H), 5.75 (s, 1H), 3.45 (d, J = 7.8 
Hz, 1H), 3.36 (d, J = 7.7 Hz, 1H), 1.10 (s, 3H), 1.09 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 138.2, 134.9, 128.7, 128.4, 102.8, 79.1, 76.4, 26.6, 25.1.  
HRMS (EI(FE)) m/z calculated for C11H13O2Cl (M) 212.0604, found 212.0604.  
HPLC (OD-H), n-heptane/i-PrOH 99.5:0.5, 0.5 ml/min, λ = 220 nm, tmajor = 9.22 min, tminor = 
11.17 min, er = 98:2. 
 
(S)-2-(4-fluorophenyl)-4,4-dimethyl-1,3-dioxolane (4s) 
Reaction time: 42 hours. The excess of aldehyde was reduced by 
adding MeOH (0.5 ml) and NaBH4 (4 mg) to facilitate the purification.  
Purification: 10% EtOAc/hexane.  
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Yield: Colorless oil, 29.03 mg, 74%. [α]25D = +3.333 (c 0.24, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.38-7.34 (m, 2H), 6.83-6.78 (m, 2H), 5.78 (s, 1H), 3.48 (d, J = 7.6 
Hz, 1H), 3.38 (d, J = 7.6 Hz, 1H), 1.12 (s, 3H), 1.10 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 163.6 (d, J = 247 Hz), 135.5 (d, J = 2.9 Hz), 128.9 (d, J = 8.2 Hz), 
115.3 (d, J = 21.5 Hz), 102.9, 79.0, 76.4, 26.7, 25.1.  
HRMS (EI(FE)) m/z calculated for C11H13O2F (M) 196.0900, found 196.0898.  
HPLC (OJ-H), n-heptane/i-PrOH 95:5, 0.5 ml/min, λ = 220 nm, tmajor = 21.99 min, tminor = 24.58 
min, er = 96:4. 
 
(S)-2-(3-chlorophenyl)-4,4-dimethyl-1,3-dioxolane (4t) 
For entry 4b in Table 4.5; Reaction time: 4 days at 50 °C. The excess of 
aldehyde was reduced by adding MeOH (0.5 ml) and NaBH4 (4 mg) to 
facilitate the purification.  
Purification: 10% EtOAc/hexane.  
Yield: Colorless oil, 36.06 mg, 85%. [α]25D = +6.315 (c 1.15, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.68-7.67 (m, 1H), 7.28 (d, J = 7.7 Hz, 1H), 7.08-7.06 (m, 1H), 6.83 
(t, J = 7.9 Hz, 1H), 5.74 (s, 1H), 3.41 (d, J = 7.7 Hz, 1H), 3.34 (d, J = 7.8 Hz, 1H), 1.064 (s, 3H), 
1.059 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 141.9, 134.6, 129.8, 129.1, 127.1, 125.0, 102.5, 79.3, 76.3, 26.5, 
25.0.  
HRMS (EI(DE)) m/z calculated for C11H13O2Cl (M) 212.0604, found 212.0606.  
HPLC (OD-H), n-heptane/i-PrOH 99.5:0.5, 0.5 ml/min, λ = 220 nm, tmajor = 9.79 min, tminor = 
8.89, er = 95:5.  
For entry 4a in Table 4.5; Reaction time: 5 days at r.t.  
Yield: 27.65 mg, 65%, [α]25D = +8.129 (c 0.99, CH2Cl2). er = 98.5:1.5.  
 
(S)-4,4-dimethyl-2-(p-tolyl)-1,3-dioxolane (4u) 
Reaction time: 27 hours. The excess of aldehyde was reduced by 
adding MeOH (0.5 ml) and NaBH4 (4 mg) to facilitate the 
purification.  
O
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Purification: 10% EtOAc/hexane.  
Yield: Colorless oil, 33.22 mg, 86%.  
1H NMR (500 MHz, C6D6) δ 7.55 (d, J = 8.0 Hz, 2H), 7.02 (d, J = 7.8 Hz, 2H), 5.96 (s, 1H), 3.57 
(d, J = 7.8 Hz, 1H), 3.44 (d, J = 7.8 Hz, 1H), 2.08 (s, 3H), 1.18 (s, 3H), 1.13 (s, 3H). 
13C NMR (125 MHz, C6D6) δ 138.6, 136.8, 129.1, 127.1, 103.7, 78.8, 76.5, 26.9, 25.2, 21.2.  
HRMS (ESI+) m/z calculated for C12H16O2Na (M+Na) 215.1042, found 215.1043.  
HPLC (AS-H), n-heptane/i-PrOH 99.5:0.5, 0.5 ml/min, λ = 220 nm, tmajor = 9.18 min, tminor = 
8.69 min, er = 88:12. 
 
(S)-2-(3,5-dibromophenyl)-4,4-dimethyl-1,3-dioxolane (4v) 
Reaction time: 6 days at 50 °C. The excess of aldehyde was reduced 
by adding MeOH (0.5 ml) and NaBH4 (4 mg) to facilitate the 
purification.  
Purification: 10% EtOAc/hexane.  
Yield: Colorless oil, 55.47 mg, 83%. [α]25D = +7.62 (c 1.81, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.57 (d, J = 1.9 Hz, 2H), 7.40 (t, J = 1.9 Hz, 1H), 5.52 (s, 1H), 3.29-
3.24 (m, 2H), 1.01 (s, 3H), 0.97 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 143.7, 134.5, 128.7, 123.2, 101.4, 79.5, 76.0, 26.2, 24.9.  
HRMS (EI(FE)) m/z calculated for C11H12O2Br2 (M) 333.9204, found 333.9201.  
HPLC (OD-H), n-heptane/i-PrOH 99:1, 0.5 ml/min, λ = 220 nm, tmajor = 8.25 min, tminor = 7.81 
min, er = 99.5:0.5. 
 
(S)-2-(4-chloro-3-nitrophenyl)-4,4-dimethyl-1,3-dioxolane (4w) 
Reaction time: 7 days at 60 °C. The excess of aldehyde was reduced 
by adding MeOH (0.5 ml) and NaBH4 (4 mg) to facilitate the 
purification.  
Purification: 10% EtOAc/hexane.  
Yield: Colorless oil, 40.72 mg, 79%. [α]25D = +12.376 (c 1.66, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.75 (d, J = 1.9 Hz, 1H), 7.05 (dd, J = 1.9, 8.2 Hz, 1H), 6.75 (d, J = 
8.2 Hz, 1H), 5.48 (s, 1H), 3.30-3.26 (m, 2H), 1.03 (s, 3H), 0.99 (s, 3H).  
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13C NMR (125 MHz, C6D6) δ 139.9, 131.6, 130.7, 127.1, 123.7, 101.2, 79.7, 76.2, 26.3, 24.9.  
HRMS (ESI+) m/z calculated for C11H12NO4ClNa (M+Na) 280.0347, found 280.0350.  
HPLC (OJ-H), n-heptane/i-PrOH 95:5, 0.5 ml/min, λ = 220 nm, tmajor = 27.26 min, tminor = 31.97 
min, er = 97.5:2.5.  
 
(S)-2-(6-bromonaphthalen-2-yl)-4,4-dimethyl-1,3-dioxolane (4x) 
Reaction time: 52 hours. The excess of aldehyde was reduced 
by adding MeOH (0.5 ml) and NaBH4 (4 mg) to facilitate the 
purification.  
Purification: 10% EtOAc/hexane.  
Yield: Colorless solid, 47.57 mg, 77%. [α]25D = +8.452 (c 1.82, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.82 (s, 1H), 7.73 (s, 1H), 7.67 (d, J = 8.4 Hz, 1H), 7.35 (d, J = 8.5 
Hz, 1H), 7.30 (d, J = 8.8 Hz, 1H), 7.22 (d, J = 8.7 Hz, 1H), 6.00 (s, 1H), 3.56 (d, J = 7.7 Hz, 1H), 
3.46 (d, J = 7.7 Hz, 1H), 1.18 (s, 3H), 1.16 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 137.5, 135.2, 131.8, 130.3, 130.2, 129.7, 127.5, 126.3, 125.7, 
120.6, 103.5, 79.3, 76.5, 26.7, 25.2.  
HRMS (ESI+) m/z calculated for C15H15O2BrNa (M+Na) 329.0148, found 329.0150.  
HPLC (AD), n-heptane/i-PrOH 99.5:0.5, 1.0 ml/min, λ = 220 nm, tmajor = 9.63 min, tminor = 8.42 
min, er = 96.5:3.5. 
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7.2.3. X-Ray data for compounds 4j and 4x 
Absolute configuration determination of 4j by X-ray single-crystal structure analysis 
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Figure 7.1. Single crystal structure of 4j. 
The crystals were grown in an open flask from an acetonitrile solution at 4 °C. X-ray 
crystallographic data have been deposited in the Cambridge Crystallographic Data Centre 
database (http://www.ccdc.cam.ac.uk/) under accession code CCDC 915231. 
 
 
Crystal data and structure refinement for 4j. 
Empirical formula    C20 H17 Cl O2 
Color       colourless 
Formula weight     324.79  g · mol-1  
Temperature      100 K 
Wavelength      1.54178 Å 
Crystal system     MONOCLINIC 
Space group      c 2,  (no. 5)  
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Unit cell dimensions    a = 21.464  (2) Å α= 90°. 
      b =   6.2342(6) Å α= 126.357(4)°. 
      c = 14.4025(14) Å α= 90°. 
Volume     1552.1(3) Å3 
Z      4 
Density (calculated)    1.390  Mg · m-3 
Absorption coefficient   2.231 mm-1 
F(000)      680 e 
Crystal size     0.40 x 0.05 x 0.04 mm3 
θ range for data collection   3.81 to 66.39°. 
Index ranges     -25 ≤ h ≤ 21, -7≤ k ≤ 7, -16 ≤ 1 ≤ 17 
Reflections collected    31210 
Independent reflections   2658 [Rint = 0.0464] 
Reflections with I>2σ(I)   2590 
Completeness to θ = 66.39°   99.4 %  
Absorption correction   Gaussian 
Max. and min. Transmission   0.92879 and 0.59764 
Refinement method    Full-matrix least-squares on F2 
Data / restraints / parameters  2658 / 1 / 208 
Goodness-of-fit on F2    1.027 
Final R indices [I>2σ(I)]   R1 = 0.0274  w R
2 = 0.0714 
R indices (all data)    R1 = 0.0282  w R
2 = 0.0721 
Absolute structure parameter  -0.005(12) 
Largest diff. peak and hole   0.147 and -0.167 e · Å-3 
 
 
Selected bond lengths [Å] and angles [°] for 4j. 
___________________________________________________________________________ 
C(1)-O(3)    1.404(2)  C(1)-O(2)    1.441(2) 
C(1)-C(9)   1.505(2)   C(2)-O(3)    1.430(2) 
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C(2)-C(3)    1.509(2)   C(3)-C(4)    1.392(2) 
C(3)-C(8)    1.395(2)   C(4)-C(5)    1.381(3) 
C(5)-C(6)    1.394(3)   C(5)-Cl(1)    1.7491(17) 
C(6)-C(7)    1.387(2)   C(7)-C(8)    1.395(2) 
C(8)-O(2)    1.373(2)   C(9)-C(10)    1.524(3) 
C(10)-C(11)    1.516(2)   C(11)-C(12)    1.373(2) 
C(11)-C(20)   1.421(2)   C(12)-C(13)    1.417(2) 
C(13)-C(14)    1.415(3)   C(13)-C(18)    1.424(3) 
C(14)-C(15)    1.376(3)   C(15)-C(16)    1.411(3) 
C(16)-C(17)    1.369(3)   C(17)-C(18)    1.421(2) 
C(18)-C(19)    1.420(3)   C(19)-C(20)    1.366(3) 
 
O(3)-C(1)-O(2)   110.09(13)   O(3)-C(1)-C(9)   108.37(14) 
O(2)-C(1)-C(9)   109.49(13)   O(3)-C(2)-C(3)   110.29(14) 
C(4)-C(3)-C(8)    119.33(16)   C(4)-C(3)-C(2)    121.76(16) 
C(8)-C(3)-C(2)    118.86(15)   C(5)-C(4)-C(3)    119.71(16) 
C(4)-C(5)-C(6)    121.46(16)   C(4)-C(5)-Cl(1)   119.29(14) 
C(6)-C(5)-Cl(1)   119.20(14)   C(7)-C(6)-C(5)    118.92(16) 
C(6)-C(7)-C(8)    120.01(16)   O(2)-C(8)-C(3)   121.85(15) 
O(2)-C(8)-C(7)   117.59(15)   C(3)-C(8)-C(7)    120.54(15) 
C(1)-C(9)-C(10)   113.47(14)   C(11)-C(10)-C(9)   113.77(15) 
C(12)-C(11)-C(20)   118.33(16)   C(12)-C(11)-C(10)   122.78(17) 
C(20)-C(11)-C(10)   118.87(15)   C(11)-C(12)-C(13)   121.80(17) 
C(14)-C(13)-C(12)   121.82(18)   C(14)-C(13)-C(18)   118.85(15) 
C(12)-C(13)-C(18)   119.31(16)   C(15)-C(14)-C(13)   120.93(17) 
C(14)-C(15)-C(16)   120.05(18)   C(17)-C(16)-C(15)   120.49(17) 
C(16)-C(17)-C(18)   120.71(18)   C(19)-C(18)-C(17)   122.96(17) 
C(19)-C(18)-C(13)   118.03(16)   C(17)-C(18)-C(13)   118.95(16) 
C(20)-C(19)-C(18)   121.05(16)   C(19)-C(20)-C(11)  121.42(16) 
C(8)-O(2)-C(1)   112.99(12)   C(1)-O(3)-C(2)   110.17(13) 
___________________________________________________________________________ 
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Absolute configuration determination of 4x by X-ray single-crystal structure analysis 
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Figure 7.2. Single crystal structure of 4x. 
The crystals were grown in an open flask from a diethyl ether/hexane solution at 4 °C. X-ray 
crystallographic data have been deposited in the Cambridge Crystallographic Data Centre 
database (http://www.ccdc.cam.ac.uk/) under accession code CCDC 915232. 
 
 
 
Crystal data and structure refinement for 4x. 
Empirical formula     C15 H15 Br O2 
Color       colourless 
Formula weight     307.18  g · mol-1  
Temperature      100 K 
Wavelength      1.54178 Å 
Crystal system     ORTHORHOMBIC 
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Space group      p 21 21 21, (no. 19)  
Unit cell dimensions    a =   5.8173 (4) Å α= 90°. 
      b =   9.3911 (6) Å α= 90°. 
      c = 23.7120(16) Å α= 90°. 
Volume     1295.41(15) Å3 
Z      4 
Density (calculated)    1.575  Mg · m-3 
Absorption coefficient   4.251 mm-1 
F(000)      624 e 
Crystal size     0.48 x 0.14 x 0.03 mm3 
θ range for data collection   3.73 to 66.82°. 
Index ranges     -6 ≤ h ≤ 6, -11 ≤ k ≤ 11, -28 ≤ 1 ≤ 28 
Reflections collected    53866 
Independent reflections   2273 [Rint = 0.0398] 
Reflections with I>2σ(I)   2268 
Completeness to θ = 66.82°   99.6 %  
Absorption correction   Gaussian 
Max. and min. transmission   0.88120 and 0.31270 
Refinement method    Full-matrix least-squares on F2 
Data / restraints / parameters  2273 / 0 / 165 
Goodness-of-fit on F2    1.136 
Final R indices [I>2σ(I)]   R1 = 0.0184  w R
2 = 0.0480 
R indices (all data)    R1 = 0.0185  w R
2 = 0.0480 
Absolute structure parameter  -0.014(14) 
Largest diff. peak and hole   0.217 and -0.239 e · Å-3 
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Bond lengths [Å] and angles [°] for 4x. 
_____________________________________________________________________ 
Br(1)-C(11)  1.9063(19)  C(1)-O(1)  1.413(2) 
C(1)-O(2)   1.422(2)   C(1)-C(6)   1.503(3) 
C(2)-O(1)   1.432(2)   C(2)-C(3)   1.547(3) 
C(3)-O(2)   1.461(2)   C(3)-C(5)   1.513(3) 
C(3)-C(4)   1.517(3)   C(6)-C(15)   1.370(3) 
C(6)-C(7)   1.417(3)   C(7)-C(8)   1.363(3) 
C(8)-C(9)  1.424(3)  C(9)-C(10)   1.417(3) 
C(9)-C(14)   1.419(3)   C(10)-C(11)   1.365(3) 
C(11)-C(12)   1.406(3)   C(12)-C(13)   1.370(3) 
C(13)-C(14)   1.417(3)   C(14)-C(15)   1.417(3) 
 
O(1)-C(1)-O(2)  105.29(13)   O(1)-C(1)-C(6)  111.53(15) 
O(2)-C(1)-C(6)  109.82(14)   O(1)-C(2)-C(3)  104.86(14) 
O(2)-C(3)-C(5)  107.06(14)   O(2)-C(3)-C(4)  109.50(15) 
C(5)-C(3)-C(4)   111.97(16)   O(2)-C(3)-C(2)  102.63(13) 
C(5)-C(3)-C(2)   113.44(16)   C(4)-C(3)-C(2)   111.67(15) 
C(15)-C(6)-C(7)  119.89(17)   C(15)-C(6)-C(1)  119.77(15) 
C(7)-C(6)-C(1)   120.33(16)   C(8)-C(7)-C(6)  120.21(17) 
C(7)-C(8)-C(9)   121.13(17)   C(10)-C(9)-C(14)  119.35(17) 
C(10)-C(9)-C(8)  121.95(17)   C(14)-C(9)-C(8)  118.70(17) 
C(11)-C(10)-C(9)  119.24(17)   C(10)-C(11)-C(12)  122.55(18) 
C(10)-C(11)-Br(1)  118.94(15)   C(12)-C(11)-Br(1)  118.51(14) 
C(13)-C(12)-C(11)  118.69(18)   C(12)-C(13)-C(14)  121.24(18) 
C(13)-C(14)-C(15)  122.25(17)   C(13)-C(14)-C(9)  118.92(17) 
C(15)-C(14)-C(9)  118.83(17)   C(6)-C(15)-C(14) 121.20(17) 
C(1)-O(1)-C(2)  103.50(14)   C(1)-O(2)-C(3)  106.55(12) 
______________________________________________________________________ 
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7.2.4. Mechanistic studies 
(with I. Čorić)[67, 158] 
Procedure for compounds Me-A1 and Me-C1 
 
2-((1-methoxyethoxy)methyl)phenol (Me-A1) and (2-(1-methoxyethoxy)phenyl)methanol 
(Me-C1) 
Acetyl chloride (604 μl, 10 mmol) was added dropwise to a solution of zinc bromide 
(approximately 0.56 mg, 0.025 mol%) in 1,1-dimethoxyethane (1.06 ml, 10 mmol) under 
argon at room temperature. The temperature was maintained at room temperature with a 
water bath. After 2.5 h the mixture was added dropwise via syringe to the solution of diol 2a 
(621 mg, 5 mmol) and N,N- diisopropylethylamine (5.2 ml, 30 mmol) in dichloromethane (25 
ml) at 0 °C. After 13 h at room temperature, a concentrated aqueous solution of NH4Cl (20 
ml) was added and the resulting mixture stirred for 15 min. Water (20 ml) and MTBE (150 
ml) were added and the organic layer was separated, washed with brine, dried (MgSO4), 
filtered and concentrated. Chromatography on silica gel using EtOAc/hexane 10-30% as 
eluents yielded Me-A1 (149 mg) and Me-C1 (137 mg) as colorless oils. 
 
2-((1-methoxyethoxy)methyl)phenol (Me-A1) 
1H NMR (500 MHz, C6D6) δ 7.53 (s, 1H), 7.07 (td, J = 7.7, 1.5 Hz, 1H), 7.03 
(dd, J = 8.0, 0.9 Hz, 1H), 6.92 (dd, J = 7.6 , 0.9 Hz, 1H), 6.75 (td, J = 7.3, 1.1 
Hz, 1H), 4.56 (d, J = 12.2 Hz, 1H), 4.39 (d, J = 12.2 Hz, 1H), 4.33 (q, J = 5.3 
Hz, 1H), 2.94 (s, 3H), 1.02 (d, J = 5.3 Hz, 3H). 
13C NMR (125 MHz, C6D6) δ 156.9, 129.8, 128.9, 123.4, 120.1, 117.0, 100.6, 66.3, 52.4, 19.0. 
 
OH
O
OMe
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(2-(1-methoxyethoxy)phenyl)methanol (Me-C1) 
1H NMR (500 MHz, C6D6) δ 7.32 (dd, J = 7.3, 1.4 Hz, 1H), 7.06 (td, J = 7.8 Hz, 
1.5 Hz, 1H), 6.90-6.87 (m, 2H), 5.01 (q, J = 5.2 Hz, 1H), 4.75 (dd, J = 13.1, 2.0 
Hz, 1H), 4.67 (dd, J = 13.2, 3.4 Hz, 1H), 3.01 (s, 3H), 2.36 (s, 1H), 1.21 (d, J = 
5.2 Hz, 3H).  
13C NMR (125 MHz, C6D6) δ 155.2, 131.8, 128.9, 128.6, 122.2, 115.5, 100.8, 61.4, 52.8, 19.8. 
 
Procedure for compounds Me-A3 and Me-C3  
OMe
Cl
OMe
MeO
ZnOTf2 (0.025 mol%)
AcCl
Ph Ph
OH
OH
+
iPr2NEt, CH2Cl2
Me-C3
O
OH
MeO
Ph
OH
O
MeO Ph
2n Me-A3
 
1-(1-methoxy-3-phenylpropoxy)-2-methylpropan-2-ol (Me-A3) and 2-(1-methoxy-3-
phenylpropoxy)-2-methylpropan-1-ol (Me-C3) 
Acetyl chloride (302 μl, 5 mmol) was added dropwise to a solution of zinc triflate 
(approximately 0.43 mg, 0.025 mol%) in (3,3-dimethoxypropyl)benzene (901 mg, 5 mmol) 
under argon at room temperature. The temperature was maintained at room temperature 
with a water bath. After 30 min the mixture was added dropwise via syringe to the solution 
of diol 2n (451 mg, 5 mmol) and N,N- diisopropylethylamine (2.6 ml, 15 mmol) in 
dichloromethane (12 ml) at 0 °C. After 14 h at room temperature, a concentrated aqueous 
solution of NH4Cl (20 ml) was added and the resulting mixture stirred for 15 min. Water (10 
ml) and MTBE (150 ml) were added and the organic layer was separated, washed with brine, 
dried (MgSO4), filtered and concentrated. Chromatography on silica gel using EtOAc/hexane 
10-20% as eluents yielded colorless oil (600 mg) containing Me-A3 and Me-C3 in a ratio 5:1. 
Repeating the chromatography with 200 g of silicagel and EtOAc/hexane 10-20% as eluents 
allowed the isolation of small amounts of pure isomers. 
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1-(1-methoxy-3-phenylpropoxy)-2-methylpropan-2-ol (Me-A3) 
1H NMR (500 MHz, C6D6) δ 7.16 (overlapped with solvent, 2H), 7.09- 
7.06 (m, 3H), 4.30 (t, J = 5.7 Hz, 1H), 3.26 (d, J = 9.1 Hz, 1H), 3.11 (d, J = 
9.1 Hz, 1H), 3.08 (s, 3H), 2.60 (t, J = 7.8 Hz, 2H), 2.14 (s, 1H), 1.89-1.84 
(m, 2H), 1.17 (s, 6H).  
13C NMR (125 MHz, C6D6) δ 142.0, 128.8, 126.3, 103.4, 74.2, 69.8, 52.7, 34.8, 31.3, 26.6, 26.5. 
 
2-(1-methoxy-3-phenylpropoxy)-2-methylpropan-1-ol (Me-C3) 
1H NMR (500 MHz, C6D6) δ 7.15 (overlapped with solvent, 2H), 7.08- 7.05 
(m, 3H), 4.53 (t, J = 5.3 Hz, 1H), 3.34 (d, J = 6.9 Hz, 2H), 3.12 (t, J = 6.9 Hz, 
1H), 2.92 (s, 3H), 2.64-2.58 (m, 1H), 2.51-2.45 (m, 1H), 1.82-1.78 (m, 2H), 
1.12 (s, 3H), 1.01 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 142.0, 128.7, 128.7, 126.2, 97.3, 77.1, 69.8, 49.8, 35.3, 31.3, 24.9, 
21.9. 
 
Representative procedure for reactions in Scheme 4.6 
 
A solution of hydroxyacetal Me-A1 (0.2 mmol) in toluene (2 ml) was added to a vial charged 
with catalyst 5i (5 mol%) and 5 Å molecular sieves (40 mg) and the mixture was stirred at 
room temperature. After specific time, representative samples (ca. 300 μl) were removed 
from the mixture and quenched with a drop of Et3N. Samples of the products were isolated 
by TLC and analyzed by HPLC to determine enantiomeric ratios.  
The reactions with Me-A3 and Me-C3 were performed on a 0.05 mmol scale. 
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7.2.5. Synthesis of confined Brønsted acid 
(with I. Čorić)[67] 
 
5d (Derived from (R)-BINOL) 
NaH
THF
+
POCl3
py, r.t.
5da
5db 5dc 5d
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(R)-4-chloro-2,6-bis(perfluorophenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-
oxide (5db) 
To a solution of 5da (480 mg, 0.78 mmol) in pyridine (2 ml) under 
argon, was added POCl3 (217 μl, 357 mg, 2.33 mmol) at room 
temperature. The mixture was stirred for 18.5 h and then 
concentrated to dryness under vacuum. The residue was passed 
through a short silica gel column (5 g) using CH2Cl2 as the eluent 
yielding the title compound as a colorless solid (498 mg, 91%). 
1H NMR (500 MHz, CD2Cl2) δ 8.19 (s, 1H), 8.18 (s, 1H), 8.10 (dd, J = 
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8.3, 2.9 Hz, 2H, two overlapped doublets), 7.68-7.65 (m, 2H), 7.53-7.47 (m, 4H). 
13C NMR (125 MHz, CD2Cl2) δ 144.2, 144.1, 144.0, 143.9, 134.9, 134.7, 133.11, 133.09, 132.1, 
131.9, 129.4, 129.3, 128.9, 127.8, 127.5, 127.3, 122.92, 122.89, 122.88, 122.8, 118.8, 118.2 
(heteronuclear coupling was not assigned).  
31P NMR (202 MHz, CD2Cl2): δ 8.68 (s). 
HRMS (ESI+) m/z calculated for C32H10O3ClF10PNa (M+Na) 720.9789, found 720.9792. 
 
(R)-4-amino-2,6-bis(perfluorophenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4- 
oxide (5dc) 
To a solution of 5da (345 mg, 0.56 mmol) in pyridine (1.7 ml) under 
argon was added POCl3 (156 μl, 256 mg, 1.67 mmol) at room 
temperature. After 21.5 h, the mixture was cooled to –78 °C and 
anhydrous ammonia gas was condensed into the reaction flask (ca. 
5 ml). The cooling bath was removed and the mixture was allowed 
to warm to room temperature. The reaction mixture was then 
concentrated to dryness under vacuum. The residue was purified by 
chromatography on silica gel using CH2Cl2 as the eluent yielding the title compound as a 
colorless solid (153 mg, 40%). 
1H NMR (500 MHz, CD2Cl2) δ 8.13 (s, 1H), 8.09 (s, 1H), 8.07 (d, J = 8.3 Hz, 1H), 8.05 (d, J = 8.3 
Hz, 1H), 7.64-7.60 (m, 2H), 7.51 (dd, J = 8.2, 3.4 Hz, 2H, two overlapped doublets) 7.48-7.45 
(m, 2H), 3.16 (d, J = 7.44 Hz, 2H). 
13C NMR (125 MHz, CD2Cl2) δ 145.0, 144.9, 144.1, 144.0, 140.7 (m), 139.1 (m), 137.2 (m), 
134.1, 133.9, 133.3, 133.2, 131.6, 131.5, 129.2, 129.1, 128.45, 128.39, 127.25, 127.20, 127.1, 
127.0, 123.2, 123.1, 122.8, 122.7, 119.2, 119.0, 111.7 (m) (heteronuclear coupling was not 
assigned). 
31P NMR (202 MHz, CD2Cl2): δ 13.28 (s). 
HRMS (ESI+) m/z calculated for C32H12NO3F10PNa (M+Na) 702.0287, found 702.0283. 
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Imidodiphosphoric acid 5d 
Sodium hydride (60% dispersion of in 
mineral oil, 24 mg, 0.60 mmol) was added 
to a solution of 5db (169 mg, 0.24 mmol) 
and 5dc (137 mg, 0.20 mmol) in THF (1.2 ml) 
under argon at room temperature. After 16 
h at room temperature, water (10 ml) and 
10% aqueous HCl solution (20 ml) were 
added and the mixture was extracted with CH2Cl2, washed with brine, filtered and 
concentrated. The residue was purified by column chromatography on silica gel using 0-14% 
EtOAc/DCM as the eluents giving a colorless solid. The solid was dissolved in CH2Cl2 (6 ml) 
and washed with 10% aqueous HCl (2·6 ml). The organic layer was concentrated under 
reduced pressure to give the title compound as a colorless solid (139 mg, 52%). 
1H NMR (500 MHz, CD2Cl2) δ 8.07 (s, 2H), 8.03 (d, J = 7.7 Hz, 2H), 8.98 (d, J = 7.3 Hz, 2H), 7.78 
(s, 2H), 7.64-7.57 (m, 6H), 7.50-7.40 (m, 9H, 6 CH + acidic H + H2O). 
13C NMR (125 MHz, CD2Cl2) δ 145.9 (m), 145.5 (m), 145.0 (m), 144.0 (m), 143.6 (m), 142.4 
(m), 140.4 (m), 139.2 (m), 138.7 (m), 136.7 (m), 133.6, 133.5, 133.4, 133.2, 131.6, 131.5, 
129.1, 128.8, 128.2, 127.87, 127.86, 127.6, 127.4, 127.0, 126.6, 123.5, 122.5, 119.1, 111.9 
(m), 111.4 (m) (heteronuclear coupling was not assigned). 
31P NMR (202 MHz, CD2Cl2) δ 3.03 (s). 
HRMS (ESI–) m/z calculated for C64H20NO6F20P2 (M–H) 1340.0452, found 1340.0461. 
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5f 
NaH
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+
POCl3
py, r.t.
5fb 5fc 5f
1) POCl3, py, r.t.
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(S)-2,6-di([1,1'-biphenyl]-4-yl)-4-chlorodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-
oxide (5fb) 
To a solution of 5fa (270 mg, 0.457 mmol) in pyridine (2 ml) under 
argon was added POCl3 (128 μl, 210 mg, 1.37 mmol) at room 
temperature. The mixture was stirred for 18 h at room 
temperature and then concentrated to dryness under vacuum. The 
residue was passed through a short silica gel column (5 g) using 
DCM as the eluent yielding the title compound as a colorless solid 
(262 mg, 85%). 
1H NMR (500 MHz, CD2Cl2) δ 8.23 (s, 1H), 8.20 (s, 1H), 8.08 (dd, J = 8.2, 3.4 Hz, 2H, two 
overlapped doublets), 7.87-7.84 (m, 2H), 7.81-7.76 (m, 6H), 7.73-7.70 (m, 4H), 7.62-7.58 (m, 
2H), 7.50-7.45 (m, 5H), 7.42-7.36 (m, 5H). 
13C NMR (125 MHz, CD2Cl2) δ 141.12, 141.06, 140.8, 140.7, 135.8, 135.7, 133.59, 133.57, 
133.38, 133.35, 132.5, 132.4, 132.32, 132.27, 130.7, 130.6, 129.22, 129.21, 129.1, 129.0, 
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127.93, 127.88, 127.5, 127.41, 127.36, 127.3, 127.12, 127.07, 123.32, 123.29, 123.20, 123.18 
(including signals due to unassigned C-P-coupling).  
31P NMR (202 MHz, CD2Cl2) δ 8.34 (s). 
HRMS (ESI+) m/z calculated for C44H28O3ClPNa (M+Na) 693.1357, found 693.1356. 
 
(S)-2,6-di([1,1'-biphenyl]-4-yl)-4-aminodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-
oxide (5fc) 
To a solution of 5fb (120 mg, 0.18 mmol) in CH2Cl2 (2 ml) under 
argon at –78 °C, anhydrous ammonia gas was condensed (ca. 6 ml). 
The cooling bath was removed and the mixture was allowed to 
warm to room temperature. The reaction mixture was passed 
through a short silica gel column (5 g) using DCM as the eluent 
yielding the title compound as a colorless solid (85 mg, 73%). 
1H NMR (500 MHz, CD2Cl2) δ 8.19 (s, 1H), 8.14 (s, 1H), 8.05 (dd, J = 8.1, 3.9 Hz, 2H, two 
overlapped doublets), 7.92-7.89 (m, 2H), 7.84-7.81 (s, 2H), 7.78-7.74 (m, 4H), 7.72-7.69 (m, 
4H), 7.58-7.54 (m, 2H), 7.50-7.44 (m, 5H), 7.40-7.34 (m, 5H), 2.76 (d, J = 7.0 Hz, 2H). 
13C NMR (125 MHz, CD2Cl2) δ 145.1, 145.0, 144.4, 144.3, 141.0, 140.9, 140.8, 140.7, 136.6, 
136.4, 134.0, 133.9, 133.7, 133.6, 132.5, 132.3, 132.1, 132.0, 131.9, 131.7, 130.8, 130.6, 
129.23, 129.18, 128.94, 128.88, 127.9, 127.8, 127.6, 127.40, 127.38, 127.3, 127.2, 127.12, 
127.08, 126.53, 126.49, 123.65, 123.64, 123.11, 123.10 (including signals due to unassigned 
C-P-coupling). 
31P NMR (202 MHz, CD2Cl2) δ 12.1 (s). 
HRMS (ESI+) m/z calculated for C44H30NO3PNa (M+Na) 674.1856, found 674.1860. 
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Imidodiphosphoric acid 5f 
Sodium hydride (60% dispersion of in mineral 
oil, 15 mg, 0.37 mmol) was added to a 
solution of 5fb (99 mg, 0.15 mmol) and 5fc 
(80 mg, 0.123 mmol) in THF (2 ml) under 
argon at room temperature. After 3 days at 
room temperature, 10% aqueous HCl 
solution (5 ml) and DCM (5 ml) were added, and the mixture was stirred for 30 min. The 
organic layer was separated and the solvent was removed under reduced pressure. The 
residue was purified by column chromatography on aluminum oxide (activity IV) using 0-32% 
EtOAc/DCM as the eluents giving a colorless solid. The solid was dissolved in CH2Cl2 (5ml) 
and stirred with 3 N aqueous HCl (5 ml) for 2 h. The organic layer was separated and 
concentrated under reduced pressure to give the title compound as a colorless solid (77 mg, 
49%). 
1H NMR (500 MHz, CD2Cl2) δ 8.21 (d, J = 7.4 Hz, 2H), 8.05-8.00 (m, 6H), 7.72 (t, J = 6.7 Hz, 
2H), 7.61-7.49 (m, 16H), 7.41-7.38 (m, 10H), 7.31 (t, J = 7.3 Hz, 2H), 7.23-7.18 (m, 6H), 7.08 
(bs, 4H), 6.88 (bs, 4H), 6.68 (bs, 4H), 3.78 (bs, 2.8H, acidic H + H2O, overlapped). 
13C NMR (125 MHz, CD2Cl2) δ 140.8, 140.4, 133.6, 132.5, 132.3, 132.2, 132.0, 131.0, 130.5, 
129.9, 129.2, 129.0, 129.0, 128.8, 127.6, 127.4, 127.2, 127.2, 127.1, 126.8, 126.6, 123.7, 
122.6, (C-P-coupling was not assigned).  
31P NMR (202 MHz, CD2Cl2) δ -0.46 (s).  
HRMS (ESI–) m/z calculated for C88H56NO6P2 (M–H) 1284.3588, found 1284.3582. 
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5h 
 
(S)-3,3'-bis(2-isopropylphenyl)-2,2'-dimethoxy-1,1'-binaphthalene (5hb) 
To magnesium turnings (292 mg, 12 mmol) activated with 1,2-
dibromoethane in diethyl ether (2 ml), 1-bromo-2-isopropylbenzene 
(1.59 g, 8 mmol) and diethylether (10 ml) were added alternately 
during 30 min. After complete addition, the mixture was refluxed (oil 
bath heating) for 19 h. After cooling to ambient temperature, the 
solution was added to a mixture of (S)-3,3'-dibromo-2,2'-dimethoxy-
1,1'-binaphthalene (5ha, 944 mg, 2.0 mmol) and Ni(PPh3)2Cl2 (196 mg, 0.30 mmol) in 
anhydrous diethyl ether (20 mL). The reaction mixture was refluxed for 26 h, cooled to 
ambient temperature, carefully treated with saturated aqueous NH4Cl solution (20 ml) and 
water (20 ml), and extracted with CH2Cl2 (100 ml, 20 ml). The combined organic layers were 
dried (MgSO4), filtered, and the solvent removed under reduced pressure. The residue was 
purified by column chromatography on silica gel using 20% CH2Cl2/hexane as the eluent 
yielding the title compound as a colorless solid (920 mg, 84%). 
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1H NMR (500 MHz, CD2Cl2) δ 7.93-7.91 (m, 2H), 7.85 (s, 1.1H), 7.84 (s, 0.4H), 7.83 (s, 0.5H), 
7.47-7.37 (m, 8H), 7.32-7.25 (m, 5.4H), 7.20 (d, J = 8.45 Hz, 0.6H), 3.25 (s, 1.7H), 3.15 (s, 
1.1H), 3.14-3.05 (m, 0.8H), 3.03 (s, 3.2H), 3.02-2.94 (m, 1.2H), 1.24-1.15 (m, 7.1H), 1.08 (d, J 
= 6.9 Hz, 3.2H), 1.01 (d, J = 6.8 Hz, 1.7H) (spectra complicated due to presence of rotamers).  
13C NMR (125 MHz, CD2Cl2) δ 155.2, 154.8, 154.7, 154.5, 148.15, 148.09, 147.8, 138.05, 
137.99, 137.93, 137.89, 136.2, 136.1, 136.0, 135.6, 134.1, 134.0, 133.9, 131.32, 131.29, 
131.2, 131.11, 131.08, 131.01, 130.97, 130.9, 130.8, 130.7, 130.6, 130.5, 128.42, 128.39, 
128.32, 128.25, 126.6, 126.42, 126.39, 126.3, 126.04, 126.03, 125.8, 125.74, 125.72, 125.67, 
125.64, 125.61, 125.57, 125.50, 125.48, 125.4, 125.32, 125.28, 125.2, 125.1, 60.80, 60.76, 
60.7, 60.4, 30.9, 30.8, 30.7, 30.6, 25.20, 25.16, 25.0, 24.9, 23.3, 23.0 (including signals due to 
presence of rotamers). 
HRMS (ESI+) m/z calculated for C40H38O2Na (M+Na) 573.2764, found 573.2767. 
 
(S)-3,3'-bis(2-isopropylphenyl)-[1,1'-binaphthalene]-2,2'-diol (5hc) 
A 1 M solution of BBr3 in CH2Cl2 (6.64 ml, 6.64 mmol) was added 
dropwise to a solution of (S)-5hb (914 mg, 1.66 mmol) in CH2Cl2 (20 ml) 
at 0 °C under argon. After 40 h at room temperature, the solution was 
cooled to 0 °C, water (50 ml) was carefully added, and the mixture was 
extracted with CH2Cl2. The organic layer was washed with saturated 
aqueous Na2CO3 solution (50 ml), dried (MgSO4), filtered, and the 
solvent was removed under reduced pressure. The residue was purified by column 
chromatography on silica gel using 50% CH2Cl2/hexane as the eluent yielding the title 
compound as a colorless solid (824 mg, 95%). 
1H NMR (500 MHz, CD2Cl2) δ 7.93-7.91 (m, 2H), 7.87 (s, 0.5H), 7.87 (s, 1.5H), 7.48-7.22 (m, 
14H), 5.19 (s, 0.5H), 5.18 (s, 0.5H), 5.16 (s, 1H), 3.06-2.98 (m, 1.1H), 2.95-2.88 (m, 0.9H), 
1.23-1.21 (m, 3.4H), 1.19-1.15 (m, 6H), 1.11-1.08 (m, 2.6H) (spectra complicated due to the 
presence of rotamers).  
13C NMR (125 MHz, CD2Cl2) δ 150.9, 150.84, 150.78, 148.5, 148.4, 136.1, 136.02, 136.00, 
135.9, 133.7, 133.6, 133.5, 133.4, 131.6, 131.5, 131.44, 131.39, 131.19, 131.17, 131.13, 
131.12, 130.8, 130.7, 130.62, 130.59, 129.60, 129.56, 129.04, 129.01, 128.7, 128.6, 127.3, 
127.2, 126.2, 126.1, 125.97, 125.95, 125.93, 125.88, 124.8, 124.6, 124.44, 124.42, 124.38, 
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124.29, 124.25, 112.9, 112.8, 112.7, 30.9, 30.8, 24.8, 24.73, 24.66, 23.44, 23.41, 23.37, 23.3 
(including signals due to presence of rotamers). 
HRMS (ESI+) m/z calculated for C38H34O2Na (M+Na) 545.2451, found 545.2451. 
 
(S)-4-chloro-2,6-bis(2-isopropylphenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-
oxide (5hd) 
To a solution of (S)-5hc (408 mg, 0.78 mmol) in pyridine (3 ml) under 
argon was added POCl3 (218 μl, 359 mg, 2.43 mmol) at room 
temperature. The mixture was stirred at 60 °C for 1.5 h and then 
concentrated to dryness under vacuum. The residue was passed 
through a short silica gel column (5 g) using CH2Cl2 as the eluent 
yielding the title compound as a colorless solid (467 mg, 99%). 
1H NMR (500 MHz, CD2Cl2) δ 8.04-7.98 (m, 4H), 7.61-7.57 (m, 2H), 7.54-7.52 (m, 0.4H), 7.47-
7.20 (m, 11.6H), 3.23-3.15 (m, 0.2H), 3.12-3.02 (m, 0.2H), 2.90-2.79 (m, 1.6H), 1.50-1.48 (m, 
0.5H), 1.38-1.36 (m, 0.6H), 1.25-1.22 (m, 2.5H), 1.20-1.15 (m, 3.5H), 1.08-1.07 (m, 2.4H), 1.00 
(d, J = 6.8 Hz, 2.5H) (spectra complicated due to the presence of rotamers).  
13C NMR (125 MHz, CD2Cl2) δ 148.2, 147.7, 144.8, 144.7, 135.2, 135.1, 134.2, 133.93, 133.91, 
133.3, 133.2, 133.1, 133.01, 132.97, 132.5, 132.42, 132.39, 131.92, 131.87, 131.6, 131.1, 
129.3, 129.24, 129.17, 129.1, 128.92, 128.89, 128.85, 128.8, 127.55, 127.51, 127.4, 127.32, 
127.29, 127.3, 127.25, 127.1, 127.0, 126.92, 126.90, 126.8, 125.8, 125.7, 125.6, 125.52, 
125.46, 125.4, 125.2, 122.24, 122.22, 122.20, 122.09, 122.08, 31.2, 31.0, 30.5, 30.1, 26.8, 
25.8, 25.2, 24.9, 23.8, 23.5, 23.3, 22.8 (including signals due to the presence of rotamers and 
unassigned C-P-coupling). 
31P NMR (202 MHz, CD2Cl2) δ 7.71 (major), 7.56, 7.44, 7.37 (including signals due to presence 
of rotamers). 
HRMS (ESI+) m/z calculated for C38H32O3ClPNa (M+Na) 625.1670, found 625.1669. 
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(S)-4-amino-2,6-bis(2-isopropylphenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-
oxide (5he) 
To a solution of (S)-5hc (408 mg, 0.78 mmol) in pyridine (3 ml) 
under argon was added POCl3 (218 μl, 359 mg, 2.34 mmol) at room 
temperature. After 1.5 h at 60 °C, the mixture was cooled to –78 °C 
and anhydrous ammonia gas was condensed into the reaction flask 
(ca. 10 ml). The cooling bath was removed and the mixture was 
allowed to warm to room temperature. The reaction mixture was 
then concentrated to dryness under vacuum. The residue was passed through a short silica 
gel column (10 g) using 10% EtOAc/CH2Cl2 as the eluent yielding the title compound as a 
colorless solid (440 mg, 97%). 
1H NMR (500 MHz, CD2Cl2) δ 8.02-7.90 (m, 4H), 7.57-7.53 (m, 2.1H), 7.51-7.34 (m, 8.6H), 
7.32-7.22 (m, 3.1H), 7.15-7.05 (m, 0.2H), 3.19-3.05 (m, 0.3H), 2.95-2.79 (m, 1.7H), 2.70-2.57 
(m, 2H), 1.49-1.46 (m, 0.4H), 1.35-1.33 (m, 0.7H), 1.25-1.22 (m, 2.8H), 1.20-1.18 (m, 0.7H), 
1.14-1.07 (m, 5H), 1.01 (d, J = 6.9 Hz, 2.6H) (spectra complicated due to the presence of 
rotamers). 
13C NMR (125 MHz, CD2Cl2) δ 148.5, 147.6, 145.44, 145.36, 144.8, 144.7, 136.2, 136.0, 
134.53, 134.51, 134.48, 134.46, 132.6, 132.5, 132.44, 132.41, 132.38, 132.3, 132.0, 131.83, 
131.76, 131.20, 131.19, 131.0, 130.9, 129.15, 129.10, 128.8, 128.7, 127.4, 127.3, 126.94, 
126.89, 126.8, 126.6, 126.4, 126.34, 126.31, 125.9, 125.82, 125.77, 125.75, 125.6, 125.18, 
125.15, 124.9, 122.52, 122.51, 122.27, 122.25, 31.13, 31.11, 30.9, 30.5, 30.2, 25.7, 25.18, 
25.6, 24.8, 23.5, 23.4, 22.9 (including signals due to presence of rotamers and unassigned C-
P-coupling). 
31P NMR (202 MHz, CD2Cl2) δ 12.4, 12.1, 12.0 (major), 11.8 (including signals due to presence 
of rotamers). 
HRMS (ESI+) m/z calculated for C38H34NO3PNa (M+Na) 606.2168, found 606.2170. 
O
O
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Imidodiphosphoric acid 5h 
Sodium hydride (60% dispersion of in mineral oil, 
70.4 mg, 1.76 mmol) was added to a solution of 
(S)-5he (257 mg, 0.44 mmol) and (S)-5hd (319 
mg, 0.53 mmol) in THF (3 ml) under argon at 
room temperature. After 17 h at room 
temperature, 10% aqueous HCl solution (5 ml) 
and DCM (5 ml) were added, and the mixture was stirred for 5 min. The organic layer was 
separated and the solvent was removed under reduced pressure. The residue was purified 
by column chromatography on aluminum oxide (activity III, 20 g) using 0-100% EtOAc/DCM 
as the eluents giving a colorless solid. The solid was dissolved in CH2Cl2 (5 ml) and stirred 
with 3 N aqueous HCl (5 ml) for 20 min. The organic layer was separated and concentrated 
under reduced pressure to give the title compound as a colorless solid (233 mg, 46%). 
1H NMR (500 MHz, CD2Cl2) δ 8.02-6.53 (m, 32H), 6.84 (s, 2H, acidic H + H2O, overlapped), 
5.70-5.36 (m, 4H), 4.00 (bs, 0.2H), 3.80 (bs, 0.1H), 3.04 (bs, 0.3H), 2.68-2.58 (m, 1.7H), 2.53-
2.44 (m, 2H), 1.29-0.56 (m, 24H) (spectra complicated due to the presence of rotamers). 
13C NMR (125 MHz, CD2Cl2) δ 148.9, 147.8, 147.1, 145.8, 145.5, 136.5, 135.5, 135.1, 134.7, 
132.7, 132.6, 132.4, 132.0, 131.8, 130.4, 128.8, 128.7, 128.4, 128.1, 127.9, 127.73, 127.77, 
127.3, 127.2, 126.9, 126.7, 126.3, 126.0, 125.7, 125.6, 125.52, 125.45, 125.1, 124.6, 122.9, 
122.2, 30.9, 30.7, 30.5, 29.8, 25.8, 25.2, 25.0, 24.5, 23.8, 23.2, 23.1, 22.5 (spectra 
complicated due to the presence of rotamers and unassigned C-P-coupling). 
31P NMR (202 MHz, CD2Cl2) δ 3.50 (major), 2.31, -0.59, -2.02 (including signals due to 
presence of rotamers). 
HRMS (ESI–) m/z calculated for C76H64NO6P2 (M–H) 1148.4214, found 1148.4225. 
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7.3. Resolutions of diols via asymmetric acetalization 
7.3.1. Synthesis of starting materials 
4-phenylbutane-1,2-diol (rac-6a) 
 
The compound rac-6a was synthesized following a literature procedure.[166]  
Yield: Colorless oil, 72%.  
 
General procedure for rac-6g, 6k-m, 6o-p, 8a 
 
A solution of aryl or alkyl magnesium bromide (3.0 equiv) was added dropwise to a solution 
of the hydroxy ketone (1.0 equiv) in THF (0.8 M) at 0 °C under an argon atmosphere. The 
cooling bath was removed and the mixture was allowed to warm to room temperature for 1 
hour. The mixture was quenched with saturated aq. NH4Cl and extracted with EtOAc. The 
organic layer was dried (MgSO4), filtered, and concentrated. The product was purified by 
column chromatography on silica gel using EtOAc/hexane as the eluent. 
 
2-(4-chlorophenyl)propane-1,2-diol (rac-6g) 
Yield: White solid, 65%.  
1H NMR (500 MHz, C6D6) δ 7.14-7.11 (m, 2H), 7.06-7.03 (m, 2H), 3.29 (d, J 
= 10.9 Hz, 1H), 3.22 (d, J = 10.9 Hz, 1H), 2.38 (s, 1H), 1.58 (bs, 1H), 1.18 (s, 
3H).  
13C NMR (125 MHz, C6D6) δ 144.4, 133.1, 128.6, 127.1, 74.3, 70.9, 26.0.  
HRMS (EI (DE)) m/z calculated for C9H11O2Cl (M) 186.0448, found 186.0446. 
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2-o-tolylpropane-1,2-diol (rac-6k) 
Yield: White solid, 88%.  
1H NMR (300 MHz, C6D6) δ 7.36-7.30 (m, 1H), 7.07-6.99 (m, 3H), 3.64 (d, J = 
10.9 Hz, 1H), 3.39 (d, J = 10.9 Hz, 1H), 2.40 (s, 3H), 1.35 (s, 3H).  
13C NMR (75 MHz, C6D6) δ 142.9, 136.3, 133.0, 127.5, 126.7, 126.0, 75.7, 
69.6, 25.6, 22.4.  
HRMS (ESI+) m/z calculated for C10H14O2Na (M+Na) 189.0886, found 189.0887.  
 
2-(naphthalen-1-yl)propane-1,2-diol (rac-6l) 
Yield: White solid, 53%.  
1H NMR (500 MHz, C6D6) δ 8.71 (d, J = 8.6 Hz, 1H), 7.66 (d, J = 8.0 Hz, 1H),  
7.57 (d, J = 8.1 Hz, 1H), 7.45 (d, J = 7.3 Hz, 1H), 7.31 (t, J = 7.6 Hz, 1H), 7.26 
(t, J = 7.3 Hz, 1H), 7.20 (t, J = 7.7 Hz, 1H), 3.90 (d, J = 10.9 Hz, 1H), 3.56 (d, J 
= 11.0 Hz, 1H), 2.62 (bs, 1H), 1.63 (bs, 1H), 1.56 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 140.8, 135.5, 131.8, 129.5, 129.0, 127.3, 125.6, 125.4, 125.2, 
124.4, 76.0, 70.0, 26.3.  
HRMS (EI (DE)) m/z calculated for C13H14O2 (M) 202.0994, found 202.0995.  
 
2-phenylbutane-1,2-diol (rac-6m) 
Yield:Colorless oil, 40%.  
1H NMR (500 MHz, C6D6) δ 7.32-1.29 (m, 2H), 7.19-7.17 (overlapped with 
solvent, 2H), 7.08 (t, J = 7.3 Hz, 1H), 3.45-3.36 (m, 2H), 2.24 (s, 1H), 1.72-
1.65 (m, 1H), 1.59-1.52 (m, 1H), 0.97 (bs, 1H), 0.73 (t, J = 7.4 Hz, 3H).  
13C NMR (125 MHz, C6D6) δ 144.2, 128.4, 127.0, 126.0, 77.1, 70.6, 31.4, 7.7.  
HRMS (EI (DE)) m/z calculated for C10H14O2 (M) 166.0994, found 166.0992.  
HO
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2-cyclohexylpropane-1,2-diol (rac-6o) 
Yield:White solid, 10%.  
1H NMR (300 MHz, C6D6) δ 3.32 (d, J = 10.7 Hz, 1H), 3.18 (d, J = 10.7 Hz, 1H), 
1.87 (m, 7H), 1.42-1.32 (m, 1H), 1.25-0.96 (m, 4H), 0.93 (s, 3H), 0.90-0.72 
(m, 2H).  
13C NMR (75 MHz, C6D6) δ 74.3, 68.6, 45.3, 28.0, 27.1, 26.9, 20.4.  
HRMS (ESI+) m/z calculated for C9H18O2Na (M+Na) 181.1199, found 181.1200.  
 
2-methylheptane-1,2-diol (rac-6p) 
Yield:Colorless oil, 38%.  
1H NMR (300 MHz, C6D6) δ 3.21 (d, J = 10.6 Hz, 1H), 3.14 (d, J = 10.6 Hz, 
1H), 1.51 (bs, 2H), 1.30-1.20 (m, 8H), 0.98 (s, 3H), 0.89 (t, J = 6.9 Hz, 3H).  
13C NMR (75 MHz, C6D6) δ 72.5, 70.0, 39.1, 32.9, 23.7, 23.5, 23.0, 14.3.  
HRMS (ESI+) m/z calculated for C8H18O2Na (M+Na) 169.1199, found 169.1200.  
 
3-phenylbutane-1,3-diol (rac-8a) 
Yield: Colorless oil, 67%.  
1H NMR (500 MHz, C6D6) δ 7.38 (d, J = 7.9 Hz, 2H), 7.21 (t, J = 7.7 Hz, 2H),  
7.09 (t, J = 7.3 Hz, 1H), 3.89 (bs, 1H), 3.43-3.39 (m, 1H), 3.35-3.31 (m, 1H), 
2.29 (bs, 1H), 1.88-1.82 (m, 1H), 1.73-1.69 (m, 1H), 1.41 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 148.5, 128.4, 126.6, 125.3, 75.7, 60.3, 44.1, 31.2.  
HRMS (CI(FE) i-Butane) m/z calculated for C10H15O2 (M+H) 167.1072, found 167.1071.  
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General procedure for rac-6h-j, 8g  
ArBr
i) Mg, THF
ii)
OH
O
OH
OH
Ar
n=1,2
n=1,2
 
A solution of aryl bromide (3.0 equiv) in THF (1.2 M) was added dropwise to activated 
magnesium turnings (3.3 equiv, activated with 1,2-dibromoethane) and the resulting mixture 
was stirred for 0.5-3 h at 40 °C under argon until most of the magnesium was consumed. The 
mixture was cooled to 0 °C, the hydroxy ketone (1.0 equiv) in THF (0.8 M) was added and the 
mixture was stirred for 1 h at 0 °C to room temperature. The mixture was quenched with 
saturated aqueous NH4Cl and extracted with EtOAc. The organic layer was dried (MgSO4), 
filtered, and concentrated. The product was purified by column chromatography on silica gel 
using EtOAc/hexane as the eluent. 
 
2-(4-methoxyphenyl)propane-1,2-diol (rac-6h) 
Yield: White solid, 60%.  
1H NMR (500 MHz, C6D6) δ 7.26 (d, J = 8.7 Hz, 1H), 6.80 (J = 8.6 Hz, 1H), 
3.45 (d, J = 10.8 Hz, 1H), 3.35 (d, J = 10.9 Hz, 1H), 3.32 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 144.4, 133.1, 128.6, 127.1, 74.3, 70.9, 26.0.  
HRMS (EI (DE)) m/z calculated for C10H14O2 (M) 182.0943, found 182.0941.  
 
2-p-tolylpropane-1,2-diol (rac-6i) 
Yield: White solid, 50%.  
1H NMR (500 MHz, C6D6) δ 7.28 (d, J = 10.9 Hz, 2H), 7.01 (d, J = 8.0 Hz, 2H), 
3.50 (d, J = 10.9 Hz, 1H), 3.39 (d, J = 10.9 Hz, 1H), 2.51 (bs, 1H), 2.13 (s, 3H), 
1.79 (bs, 1H), 1.35 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 143.1, 136.4, 129.2, 125.5, 74.6, 71.3, 26.2, 21.0.  
HRMS (EI (DE)) m/z calculated for C10H14O2 (M) 166.0994, found 166.0992.  
 
HO
OH
O
HO
OH
7. EXPERIMENTAL SECTION 
 
142 
2-m-tolylpropane-1,2-diol (rac-6j) 
Yield: White solid, 70%.  
1H NMR (300 MHz, C6D6) δ 7.26-7.26 (m, 1H), 7.18-7.09 (overlapped with 
solvent, 2H), 6.94-6.91 (m, 1H), 3.49 (d, J = 10.9 Hz, 1H), 3.38 (d, J = 10.9 Hz, 
1H), 2.16 (s, 3H), 1.34 (s, 3H).  
13C NMR (75 MHz, C6D6) δ 146.1, 137.9, 126.3, 122.7, 74.7, 71.3, 26.3, 21.6.  
HRMS (ESI+) m/z calculated for C10H14O2Na (M+Na) 189.0886, found 189.0887.  
 
3-(naphthalen-1-yl)butane-1,3-diol (rac-8g) 
Yield: Colorless oil, 20%.  
1H NMR (300 MHz, C6D6) δ 8.47 (d, J = 8.3 Hz, 1H), 7.79-7.76 (m, 1H), 
7.71-7.68 (m, 1H), 7.60 (d, J = 8.1 Hz, 1H), 7.33-7.23 (m, 3H), 3.46-3.36 
(m, 2H), 3.27-3.18 (m, 1H), 2.36 (ddd, J = 14.8, 6.2, 3.8 Hz, 1H), 2.00 (ddd, 
J = 14.8, 8.3, 4.2 Hz, 1H), 1.67 (s, 3H).  
13C NMR (75 MHz, C6D6) δ 143.7, 135.5, 131.2, 129.7, 128.7, 126.8, 125.5, 125.4, 125.2, 
124.3, 76.7, 60.5, 43.4, 30.2.  
HRMS (ESI+) m/z calculated for C14H16O2Na (M+Na) 239.1042, found 239.1043.  
 
3-methyl-2-phenylbutane-1,2-diol (rac-6n)[167]  
 
A solution of (isopropoxydimethylsilyl)methyl chloride (4.55 ml, 4.21 g, 25.26 mmol) in THF 
(30 ml) was added dropwise to the activated magnesium turnings (0.85 g, 27.20 mmol, 
activated with 1,2-dibromoethane) and the resulting mixture was refluxed for 0.5 h under an 
argon atmosphere until most of the magnesium was consumed. The mixture was cooled to 0 
°C, isobutyrophenone (2.91 ml, 2.88 g, 19.43 mmol) in THF (8 ml) was added dropwise with 
HO
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stirring over 30 min. The resulting mixture was stirred for 30 min at 0 °C and aq. 10% 
solution of NH4Cl was added dropwise at 0 °C. The organic layer was extracted, dried 
(MgSO4), filtered, and concentrated with a rotary evaporator at room temperature. 
To the crude 1-(isopropoxydimethylsilyl)-3-methyl-2-phenylbutan-2-ol were added 
THF/MeOH 1:1 (38 ml), KHCO3 (1.95 g, 19.43 mmol), and KF (2.26 g, 38.86 mmol). To the 
resulting mixture 30% aq. H2O2 (7.25 ml, 64.12 mmol) was added. After 15 min an 
exothermic reaction starts, which was kept at 40-50 °C by cooling using a water bath. After 
the end of the exothermic reaction, the resulting mixture was stirred for 2 h at room 
temperature. The remaining H2O2 was decomposed by a slow addition of 50% aq. solution of 
Na2S2O3 ·5 H2O with stirring over 30 min, keeping the temperature around 30 °C with an ice 
bath. A white precipitate was formed, the mixture was filtered and the residue washed with 
diethyl ether. The filtrate was concentrated, and dissolved in diethyl ether, washed with sat. 
aq. NaCl, dried (MgSO4), filtered, and concentrated. The product was purified by column 
chromatography on silica gel using EtOAc/hexane as the eluent.  
Yield: White solid, 1.43 g, 41%. 
1H NMR (500 MHz, C6D6) δ 7.31-7.28 (m, 2H), 7.18-7.15 (overlapped with solvent, 2H), 7.09-
7.06 (m, 1H), 3.59 (s, 2H), 2.55 (bs, 1H), 1.90-1.81 (m, 1H), 1.13 (bs, 1H), 0.89 (d, J = 6.8 Hz, 
3H), 0.72 (d, J = 6.9 Hz, 3H).  
13C NMR (125 MHz, C6D6) δ 144.0, 126.9, 126.6, 79.0, 68.4, 35.5, 17.6, 17.0.  
HRMS (ESI+) m/z calculated for C11H16O2Na (M+Na) 203.1042, found 203.1043.  
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7.3.2. Kinetic resolution of diols 
General procedure 
 
The aldehyde (2.0 mmol) was added to a mixture of diol (0.50 mmol), catalyst 5 (1-3 mol%) 
and 5 Å molecular sieves (100 mg) in toluene (5 ml). The mixture was stirred vigorously at 
designated temperature for indicated time and then quenched by adding a few drops of 
triethylamine. Purification was performed by column chromatography on silica gel using 
EtOAc/hexanes solvent gradient between 0-100%.  
Absolute configurations of diols 6a, 6c, 6p and 8a were determined by comparison of 
specific optical rotation with literature values. Configurations of other diols were assigned by 
analogy. Major diastereomers of the corresponding acetal products were assigned opposite 
configurations at the alcohol sterocenter. Acetal sterocenter configurations were assigned in 
analogy to the results from our previous asymmetric acetalization studies[67] and NOESY 
experiment for 9b.  
 
Racemates 
The samples of racemic products for GC or HPLC analysis were prepared from diol (0.05 
mmol), aldehyde (0.2 mmol), 5 Å molecular sieves (10 mg), and (PhO)2PO2H (5 mol%) as the 
catalyst in toluene (0.5 ml) and isolated by thin layer chromatography using EtOAc/hexanes 
as the eluent. 
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Products 
 
(2S,4S)-2-isobutyl-4-phenethyl-1,3-dioxolane (7a) 
Yield: Colorless oil, 93.7 mg, 80%.  
1H NMR (500 MHz, C6D6) δ 7.17-7.03 (m, 5H), 5.08 (t, J = 5.2 Hz, 1H), 3.87-3.82 (m, 1H), 3.77 
(dd, J = 8.0, 6.2 Hz, 1H), 3.13 (dd, J = 7.9, 7.2 Hz, 1H), 2.67-2.62 (m, 1H), 2.50-2.44 (m, 1H), 
1.98-1.90 (m, 1H), 1.77-1.71 (m, 1H), 1.68 (dd, J = 6.9, 5.2 Hz, 2H), 1.43-1.36 (m, 1H), 0.95-
0.94 (m, 6H).  
13C NMR (125 MHz, C6D6) δ 142.0, 128.8, 128.7, 126.2, 103.4, 75.1, 70.4, 43.6, 35.5, 32.5, 
25.0, 23.2, 23.2.  
HRMS (ESI+) m/z calculated for C15H22O2 (M) 257.1512, found 257.1513.  
GC (Column: 25 m Hydrodex-β-TBDAC (tert-butyl-diacetyl-cyclodextrin), i.D. 0.25 mm; 
Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 80 °C to 133 °C with 0.3 
°C/min, then to 245 °C with 10 °C/min; gas: 0.5 bar H2), major diastereomer: tmajor = 166.8 
min, tminor = 167.5 min; er = 99.5:0.5, minor diastereomer: tmajor = 159.8 min, tminor = 158.8 
min; er = 95:5, dr = 1.1:1. 
 
(R)-4-phenylbutane-1,2-diol (6a) 
Yield: Colorless oil, 7.5 mg, 10%. Absolute configuration was determined by comparison of 
HPLC trace with those of (R)-6a and (S)-6a. 
1H NMR (500 MHz, CDCl3) δ 7.30-7.27 (m, 2H), 7.21-7.18 (m, 3H),  3.76-3.71 (m, 1H), 3.66 
(dd, J = 11.0, 3.1 Hz, 1H), 3.47 (dd, J = 11.0, 7.6 Hz, 1H), 2.84-2.79 (m, 1H), 2.73-2.67 (m, 1H), 
1.97 (bs, 2H), 1.82-1.71 (m, 2H).  
13C NMR (125 MHz, CDCl3) δ 141.8, 128.6, 128.5, 126.1, 71.6, 66.9, 34.8, 31.9.   
HRMS (ESI+) m/z calculated for C10H14O2Na (M+Na) 189.0886, found 189.0886.  
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HPLC (OD-3), n-heptane/i-PrOH 95:5, 1.0 ml/min, λ = 210 nm, tmajor = 19.00 min, tminor = 28.87 
min, er = 69:31.  
 
 
(2S,4R)-2-isobutyl-4-methyl-4-phenyl-1,3-dioxolane (7c) 
Yield: Colorless oil, 51.0 mg, 50%. [α]25D = -47 ° (c 1.59, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.38-7.37 (m, 2H), 7.20-7.18 (overlapped with solvent, 2H), 7.08 
(t, J = 7.4 Hz, 1H), 5.26 (t, J = 5.2 Hz, 1H), 3.90 (d, J = 7.9 Hz, 1H), 3.60 (d, J = 7.9 Hz, 1H), 1.96 
(dt, J = 13.4, 6.7 Hz, 1H), 1.80-1.71 (m, 2H), 1.39 (s, 3H), 0.94 (dd, J = 6.5, 4.3 Hz, 6H) (signals 
of the minor diastereomer are not included).  
13C NMR (125 MHz, C6D6) δ 146.7, 128.4, 127.1, 125.2, 104.0, 81.7, 77.5, 43.6, 26.3, 25.1, 
23.2, 23.2 (signals of the minor diastereomer are not included).  
HRMS (CI (DE) i-Butan) m/z calculated for C14H21O2 (M+H) 221.1542, found 221.1539.  
GC (Column: 25 m Lipodex G (Octakis-(2,3-di-O-pentyl-6-O-methyl)-γ-cyclodextrin), i.D. 0.25 
mm; Detector: FID; Temperature: injector 220 °C, detector 320 °C, oven 100 °C to 125 °C 
with 1 °C/min; gas: 0.5 bar H2), major diastereomer: tmajor = 21.2 min, tminor = 21.4 min; er = 
98.5:1.5, minor diastereomer: tmajor = 20.0 min, tminor = 19.6 min; er = 98.5:1.5, dr = 58:1. 
 
(S)-2-phenylpropane-1,2-diol (6c) 
Yield: White solid, 38.0 mg, 46%. [α]25D = +6 ° (c 1.39, CH2Cl2). 
1H NMR (500 MHz, C6D6) δ 7.32 (d, J = 8.0 Hz, 2H), 7.20-7.16 (overlapped with solvent, 2H), 
7.08 (t, J = 7.3 Hz, 1H), 3.40 (d, J = 10.9 Hz, 1H), 3.31 (d, J = 10.9 Hz, 1H), 2.12 (bs, 1H), 1.29 (s, 
3H), 1.09 (bs, 1H).  
13C NMR (125 MHz, C6D6) δ 146.0, 128.5, 127.1, 125.5, 74.6, 71.2, 26.1.  
HRMS (EI (FE)) m/z calculated for C9H12O2 (M) 152.0837, found 152.0836.  
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HPLC (OD-3), n-heptane/i-PrOH 95:5, 1.0 ml/min, λ = 210 nm, tmajor = 9.38 min, tminor = 8.78 
min; er = 97.5:2.5. 
 
5i (1 mol%)
MS 5 Å, toluene
20 °C, 23 h
conversion 55 %
s-factor 39
+ +
H
O
HO
OH
HO
OH
O
O
(2S,4R)-7b (S)-6crac-6c 3b
 
(2S,4R)-2,4-dimethyl-4-phenyl-1,3-dioxolane (7b) 
Yield: Colorless oil, 43.1 mg, 48%. [α]25D = -41 ° (c 1.45, CH2Cl2). 
1H NMR (300 MHz, C6D6) δ 7.37-7.33 (m, 2H), 7.19-7.13 (overlapped with solvent, 2H), 7.10-
7.04 (m, 1H), 5.23 (q, J = 4.8 Hz, 1H), 3.89 (d, J = 7.9 Hz, 1H), 3.59 (d, J = 7.9 Hz, 1H), 1.39 (d, J 
= 4.8 Hz, 3H), 1.37 (s, 3H) (signals of the minor diastereomer are not included).  
13C NMR (725 MHz, C6D6) δ 146.7, 127.1, 125.2, 101.7, 82.0, 77.8, 26.2, 20.5 (signals of the 
minor diastereomer are not included).  
HRMS (ESI+) m/z calculated for C11H14O2Na (M+Na) 201.0886, found 201.0886.  
GC (Column: 30 m G-TA (Trifluoroacetyl-γ-cyclodextrin), i.D. 0.25 mm; Detector: FID; 
Temperature: injector 220 °C, detector 350 °C, oven 80 °C to 120 °C with 1 °C/min; gas: 0.5 
bar H2), major diastereomer: tmajor = 20.9 min, tminor = 21.7 min; er = 94:6, minor 
diastereomer: tmajor = 19.3 min; er >99.5:0.5, dr = 20:1. 
 
(S)-2-phenylpropane-1,2-diol (6c) 
Yield: White solid, 30.8 mg, 40%. [α]25D = +4.7 ° (c 0.8, EtOH), lit.
[168] [α]25D = +4.29 ° (c 0.96, 
EtOH) for (S)-enantiomer of 80% ee.  er = 99:1.  
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(2S,4R)-2-butyl-4-methyl-4-phenyl-1,3-dioxolane (7c) 
Yield: Colorless oil, 51.6 mg, 47%. [α]25D = -45 ° (c 1.50, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 7.39-7.35 (m, 2H), 7.20-7.17 (overlapped with solvent, 2H), 7.10-
7.05 (m, 1H), 5.19 (t, J = 5.0 Hz, 1H), 3.90 (d, J = 7.8 Hz, 1H), 3.64 (d, J = 7.8 Hz, 1H), 1.85-1.77 
(m, 2H), 1.55-1.45 (m, 2H), 1.41 (s, 3H), 1.35-1.23 (m, 2H), 0.84 (t, J = 7.3 Hz, 3H) (signals of 
the minor diastereomer are not included).  
13C NMR (75 MHz, C6D6) δ 146.6, 127.1, 125.2, 104.9, 81.8, 77.5, 34.6, 26.9, 26.3, 23.0, 14.2 
(signals of the minor diastereomer are not included).  
HRMS (ESI+) m/z calculated for C14H20O2Na (M+Na) 243.1356, found 243.1357.  
GC (Column: 25 m Lipodex-G (Octakis-(2,3-di-O-pentyl-6-O-methyl)-γ-cyclodextrin), i.D. 0.25 
mm; Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 100 °C to 130 °C 
with 1 °C/min; gas: 0.5 bar H2), major diastereomer: tmajor = 22.7 min, tminor = 23.0 min; er = 
97:3, minor diastereomer: tmajor = 22.0 min, tminor = 21.6 min; er = 97.5:2.5, dr = 57:1. 
 
(S)-2-phenylpropane-1,2-diol (6c) 
Yield: White solid, 35.4 mg, 47%. er = 94.5:5.5. 
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(2S,4R)-2-isopropyl-4-methyl-4-phenyl-1,3-dioxolane (7d) 
Yield: Colorless oil, 50.4 mg, 49%. [α]25D = -38 ° (c 0.29, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 7.36-7.32 (m, 2H), 7.20-7.14 (overlapped with solvent, 2H), 7.10-
7.04 (m, 1H), 4.91 (d, J = 5.2 Hz, 1H), 3.84 (d, J = 7.7 Hz, 1H), 3.65 (d, J = 7.7 Hz, 1H), 1.99-1.89 
(m, 1H), 1.39 (s, 3H), 1.05 (dd, J = 6.8, 3.1 Hz, 6H) (signals of the minor diastereomer are not 
included).  
13C NMR (75 MHz, C6D6) δ 146.2, 127.1, 125.1, 108.4, 81.9, 77.4, 33.0, 26.2, 17.5, 17.3 
(signals of the minor diastereomer are not included).  
HRMS (CI (DE)) m/z calculated for C13H19O2 (M+H) 207.1385, found 207.1387.  
GC (Column: 25m Cyclodextrin-H/OV-1701 (2,3-dimethyl-3-pentyl-γ-cyclodextrin), i.D. 0.25 
mm; Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 100 °C to 135 °C 
with 0.5 °C/min; gas: 0.4 bar H2), major diastereomer: tmajor = 26.3 min, tminor = 25.6 min; er = 
98:2, minor diastereomer: tmajor = 23.8 min; er >99.5:0.5, dr = 26:1. 
 
(S)-2-phenylpropane-1,2-diol (6c) 
Yield: White solid, 31.9 mg, 42%. er = 99:1.  
 
 
GC odor threshold measurement of racemic mixture of 7d (performed by Dr. P. Kraft in 
Givaudan Schweiz AG, Fragrance Research) 
7. EXPERIMENTAL SECTION 
 
150 
GC threshold value  65.98 ng/L air   
Olfactive note  MAP: herbal fruity, clary sage claritone, labienone 
Panelists: floral, ionone, woody, camphor.    
GC  DB-1  15 m x 0.53 mm  (1.5 um) 
Instrument: HP 6890 
p = 38 kPa He, flow = 8 ml/min, T (iso) = 205°C      
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(2S,4R)-4-methyl-2-neopentyl-4-phenyl-1,3-dioxolane (7f) 
Yield: Colorless oil, 55.5 mg, 47%. [α]25D = -47 ° (c 1.72, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 7.40-7.36 (m, 2H), 7.21-7.18 (overlapped with solvent, 2H), 7.11-
7.05 (m, 1H), 5.33 (t, J = 5.0 Hz, 1H), 3.90 (d, J = 7.9 Hz, 1H), 3.59 (d, J = 7.9 Hz, 1H), 1.83 (dd, 
J = 5.0, 3.3 Hz, 1H), 1.39 (s, 1H), 1.02 (s, 9H) (signals of the minor diastereomer are not 
included).  
13C NMR (75 MHz, C6D6) δ 146.8, 127.1, 125.2, 103.3, 81.6, 77.5, 48.0, 30.3, 29.4, 26.3 
(signals of the minor diastereomer are not included).  
HRMS (ESI+) m/z calculated for C15H22O2Na (M+Na) 257.1512, found 257.1512.  
GC (Column: 24 m Lipodex G (Octakis-(2,3-di-O-pentyl-6-O-methyl)-γ-cyclodextrin), i.D. 0.25 
mm; Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 100 °C to 150 °C 
with 1 °C/min; gas: 0.5 bar H2), major diastereomer: tmajor = 24.1 min, tminor = 24.5 min; er = 
98:2, minor diastereomer: tmajor = 22.6 min; er >99.5:0.5, dr = 52:1. 
 
(S)-2-phenylpropane-1,2-diol (6c) 
Yield: White solid, 29.7 mg, 39%. er = 99.5:0.5. 
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(2S,4R)-4-(4-chlorophenyl)-2-isobutyl-4-methyl-1,3-dioxolane (7g) 
Yield: Colorless oil, 57.7 mg, 45%. [α]25D = -47 ° (c 1.50, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.13-7.12 (m, 2H), 7.08-7.06 (m, 2H), 5.18 (t, J = 5.2 Hz, 1H), 3.75 
(d, J = 8.0 Hz, 1H), 3.50 (d, J = 8.0 Hz, 1H), 1.92 (dt, J = 13.5, 6.7 Hz, 1H), 1.71-1.68 (m, 2H), 
1.27 (s, 3H), 0.94 (dd, J = 6.7, 1.6 Hz, 6H) (signals of the minor diastereomer are not 
included).  
13C NMR (125 MHz, C6D6) δ 145.2, 133.0, 128.5, 126.7, 104.1, 81.2, 77.4, 43.5, 26.1, 25.0, 
23.1, 23.1 (signals of the minor diastereomer are not included).  
HRMS (CI (DE) i-Butan) m/z calculated for C14H20O2Cl (M+H) 255.1152, found 255.1150.  
GC (Column: 30 m BGB-176/SE-52 (2,3-dimethyl-6-tert-butyldimethyl-silyl-β-cyclodextrin), 
i.D. 0.25 mm; Detector: FID; Temperature: injector 220 °C, detector 320 °C, oven 140 °C; gas: 
0.4 bar H2), major diastereomer: tmajor = 55.8 min, tminor = 54.6 min; er = 98.5:1.5, minor 
diastereomer: tmajor = 52.0 min; er >99.5:0.5, dr = 52:1. 
 
(S)-2-(4-chlorophenyl)propane-1,2-diol (6g) 
Yield: White solid, 44.3 mg, 47%. [α]25D = +10 ° (c 1.56, CH2Cl2).
  
1H NMR (500 MHz, C6D6) δ 7.14-7.11 (m, 2H), 7.06-7.03 (m, 2H), 3.29 (d, J = 10.9 Hz, 1H), 
3.22 (d, J = 10.9 Hz, 1H), 2.38 (s, 1H), 1.58 (bs, 1H), 1.18 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 144.4, 133.1, 128.6, 127.1, 74.3, 70.9, 26.0.  
HRMS (EI (DE)) m/z calculated for C9H11O2Cl (M) 186.0448, found 186.0446.  
HPLC (OD-3), n-heptane/i-PrOH 95:5, 1.0 ml/min, λ = 220 nm, tmajor = 8.84 min, tminor = 8.26 
min, er = 94.5:5.5. 
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(2S,4R)-2-isobutyl-4-(4-methoxyphenyl)-4-methyl-1,3-dioxolane (7h) 
Yield: Colorless oil, 60.1 mg, 48%. [α]25D = -42 ° (c 2.15, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.31 (d, J = 8.7 Hz, 2H), 6.81 (d, J = 8.7 Hz, 2H), 5.29 (t, J = 5.2 Hz, 
1H), 3.92 (d, J = 7.8 Hz, 1H), 3.62 (d, J = 7.8 Hz, 1H), 3.32 (s, 3H), 1.98 (dt, J = 13.4, 6.7 Hz, 1H), 
1.82-1.75 (m, 2H), 1.43 (s, 3H), 0.96 (dd, J = 6.5 Hz, 6H) (signals of the minor diastereomer 
are not included).  
13C NMR (125 MHz, C6D6) δ 159.2, 138.7, 126.4, 113.9, 104.0, 81.5, 77.7, 54.8, 43.7, 26.2, 
25.1, 23.2, 23.2 (signals of the minor diastereomer are not included).  
HRMS (ESI+) m/z calculated for C15H22O3Na (M+Na) 273.1461, found 273.1458.  
GC (Column: 25 m Hydrodex-β-TBDAC (Heptakis-(2,3-di-O-acetyl-6-O-tert-butyldimethyl-
silyl)-β-cyclodextrin), i.D. 0.25 mm; Detector: FID; Temperature: injector 220 °C, detector 320 
°C, oven 145 °C; gas: 0.4 bar H2), major diastereomer: tmajor = 45.8 min, tminor = 44.2 min; er = 
98.5:1.5, minor diastereomer: tmajor = 41.1 min, tminor = 42.2 min; er = 98:2, dr = 53:1. 
 
(S)-2-(4-methoxyphenyl)propane-1,2-diol (6h) 
Yield: White solid, 45.0 mg, 49%. [α]25D = +9 ° (c 1.70, CH2Cl2). 
1H NMR (500 MHz, C6D6) δ 7.26 (d, J = 8.7 Hz, 1H), 6.80 (J = 8.6 Hz, 1H), 3.45 (d, J = 10.8 Hz, 
1H), 3.35 (d, J = 10.9 Hz, 1H), 3.32 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 144.4, 133.1, 128.6, 127.1, 74.3, 70.9, 26.0.  
HRMS (EI (DE)) m/z calculated for C10H14O2 (M) 182.0943, found 182.0941.  
HPLC (OD-3), n-heptane/i-PrOH 95:5, 1.0 ml/min, λ = 220 nm, tmajor = 17.32 min, tminor = 13.28 
min, er = 96.5:3.5. 
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(2S,4R)-2-isobutyl-4-methyl-4-p-tolyl-1,3-dioxolane (7i) 
Yield: Colorless oil, 54.1 mg, 46%. [α]25D = -42 ° (c 1.98, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.32 (d, J = 8.2 Hz, 2H), 7.03 (d, J = 8.0 Hz, 2H), 5.28 (t, J = 5.2 Hz, 
1H), 3.94 (d, J = 7.8 Hz, 1H), 3.63 (d, J = 7.8 Hz, 1H), 2.13 (s, 3H), 1.97 (dt, J = 13.5, 6.7 Hz, 1H), 
1.81-1.73 (m, 2H), 1.43 (s, 3H), 0.95 (dd, J = 6.7, 3.8 Hz, 6H) (signals of the minor 
diastereomer are not included).  
13C NMR (125 MHz, C6D6) δ 143.8, 136.4, 129.1, 125.2, 104.0, 81.7, 77.6, 43.7, 26.3, 25.1, 
23.2, 23.2, 21.0 (signals of the minor diastereomer are not included).  
HRMS (ESI+) m/z calculated for C15H22O2Na (M+Na) 257.1512, found 257.1511.  
GC (Column: 25 m Hydrodex-β-TBDAC (Heptakis-(2,3-di-O-acetyl-6-O-tert-butyldimethyl-
silyl)-β-cyclodextrin), i.D. 0.25 mm; Detector: FID; Temperature: injector 220 °C, detector 320 
°C, oven 105 °C; gas: 0.4 bar H2), major diastereomer: tmajor = 112.9 min, tminor = 110.4 min; er 
= 96:4, minor diastereomer: tmajor = 99.3 min, tminor = 101.7 min; er = 92.5:7.5, dr = 52:1. 
 
(S)-2-p-tolylpropane-1,2-diol (6i) 
Yield: White solid, 36.4 mg, 44%. [α]25D = +11 ° (c 0.92, CH2Cl2). 
1H NMR (500 MHz, C6D6) δ 7.28 (d, J = 10.9 Hz, 2H), 7.01 (d, J = 8.0 Hz, 2H), 3.50 (d, J = 10.9 
Hz, 1H), 3.39 (d, J = 10.9 Hz, 1H), 2.51 (bs, 1H), 2.13 (s, 3H), 1.79 (bs, 1H), 1.35 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 143.1, 136.4, 129.2, 125.5, 74.6, 71.3, 26.2, 21.0.  
HRMS (EI (DE)) m/z calculated for C10H14O2 (M) 166.0994, found 166.0992.  
HPLC (OD-3), n-heptane/i-PrOH 98:2, 1.0 ml/min, λ = 220 nm, tmajor = 19.75 min, tminor = 17.38 
min, er = 97.5:2.5. 
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(2S,4R)-2-isobutyl-4-methyl-4-m-tolyl-1,3-dioxolane (7j) 
Yield: Colorless oil, 53.0 mg, 45%. [α]25D = -38 ° (c 1.70, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 7.27-7.22 (m, 2H), 7.14-7.11 (overlapped with solvent, 1H), 6.93 
(d, J = 7.4 Hz, 1H), 5.29 (t, J = 5.2 Hz, 1H), 3.95 (d, J = 7.8 Hz, 1H), 3.65 (d, J = 7.8 Hz, 1H), 2.16 
(s, 3H), 1.97 (dt, J = 13.5, 6.7 Hz, 1H), 1.79-1.74 (m, 2H), 1.43 (s, 3H), 0.95 (dd, J = 6.6, 2.5 Hz, 
6H) (signals of the minor diastereomer are not included).  
13C NMR (75 MHz, C6D6) δ 146.7, 137.8, 125.9, 122.4, 104.0, 81.8, 77.5, 43.7, 26.4, 25.1, 23.2, 
23.2, 21.6 (signals of the minor diastereomer are not included).  
HRMS (Cl (DE)) m/z calculated for C15H23O2 (M+H) 235.1698, found 235.1696.  
GC (Column: 25 m Lipodex G (Octakis-(2,3-di-O-pentyl-6-O-methyl)-γ-cyclodextrin), i.D. 0.25 
mm; Detector: FID; Temperature: injector 220 °C, detector 320 °C, oven 100 °C to 145 °C 
with 1 °C/min; gas: 0.4 bar H2), major diastereomer: tmajor = 30.11 min, tminor = 30.8 min; er = 
98.5:1.5, minor diastereomer: tmajor = 29.6 min; er >99.5:0.5, dr = 124:1. 
 
(S)-2-p-tolylpropane-1,2-diol (6j) 
Yield: White solid, 44.7 mg, 54%. [α]25D = +7.8 ° (c 1.56, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 7.26-7.26 (m, 1H), 7.18-7.09 (overlapped with solvent, 2H), 6.94-
6.91 (m, 1H), 3.49 (d, J = 10.9 Hz, 1H), 3.38 (d, J = 10.9 Hz, 1H), 2.16 (s, 3H), 1.34 (s, 3H).  
13C NMR (75 MHz, C6D6) δ 146.1, 137.9, 126.3, 122.7, 74.7, 71.3, 26.3, 21.6.  
HRMS (ESI+) m/z calculated for C10H14O2Na (M+Na) 189.0886, found 189.0887.  
HPLC (OD-3), n-heptane/i-PrOH 98:2, 1.0 ml/min, λ = 220 nm, tmajor = 18.30 min, tminor = 16.41 
min, er = 90.5:9.5. 
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(2S,4R)-2-isobutyl-4-methyl-4-o-tolyl-1,3-dioxolane (7k) 
Yield: Colorless oil, 55.0 mg, 47%. [α]25D = -45 ° (c 1.47, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 7.74 (dd, J = 7.7, 1.5 Hz, 1H), 7.12-6.96 (m, 3H), 5.30 (t, J = 5.2 Hz, 
1H), 3.99-3.97 (m, 1H), 3.86 (d, J = 7.5 Hz, 1H), 2.07 (s, 3H), 1.94 (dt, J = 13.5, 6.6 Hz, 1H), 
1.71-1.66 (m, 2H), 1.42 (s, 3H), 0.95 (dd, J = 6.7, 1.0 Hz, 6H) (signals of the minor 
diastereomer are not included).  
13C NMR (75 MHz, C6D6) δ 144.2, 133.5, 131.9, 127.3, 126.2, 126.0, 102.8, 82.8, 75.5, 43.7, 
25.8, 25.0, 23.2, 23.2, 21.1 (signals of the minor diastereomer are not included).  
HRMS (Cl (DE)) m/z calculated for C15H23O2 (M+H) 235.1698, found 235.1700.  
GC (Column: 30 m BGB-176/SE-52 (2,3-dimethyl-6-tert-butyldimethyl-silyl-β-cyclodextrin), 
i.D. 0.25 mm; Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 120 °C to 
150 °C with 0.4 °C/min; gas: 0.4 bar H2), major diastereomer: tmajor = 51.7 min, tminor = 52.4 
min; er = 98.5:1.5, minor diastereomer: tmajor = 50.0 min, tminor = 49.1 min; er = 72:28, dr = 
92:1. 
 
(S)-2-o-tolylpropane-1,2-diol (6k) 
Yield: White solid, 44.0 mg, 51% (corrected for residual EtOAc in the sample). [α]25D = -0.11 ° 
(c 1.75, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 7.36-7.30 (m, 1H), 7.07-6.99 (m, 3H), 3.64 (d, J = 10.9 Hz, 1H), 
3.39 (d, J = 10.9 Hz, 1H), 2.40 (s, 3H), 1.35 (s, 3H).  
13C NMR (75 MHz, C6D6) δ 142.9, 136.3, 133.0, 127.5, 126.7, 126.0, 75.7, 69.6, 25.6, 22.4.  
HRMS (ESI+) m/z calculated for C10H14O2Na (M+Na) 189.0886, found 189.0887.  
HPLC (OD-3), n-heptane/i-PrOH 95:5, 1.0 ml/min, λ = 220 nm, tmajor = 8.32 min, tminor = 7.51 
min, er = 96.5:3.5. 
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(2S,4R)-2-isobutyl-4-methyl-4-(naphthalen-1-yl)-1,3-dioxolane (7l) 
Yield: Colorless oil, 59.1 mg, 44%. [α]25D = -80 ° (c 1.90, CH2Cl2). 
1H NMR (500 MHz, C6D6) δ 8.01 (d, J = 7.2 Hz, 1H), 7.75-7.73 (m, 1H), 7.67-7.65 (m, 1H), 7.57 
(d, J = 8.1 Hz, 1H), 7.31 (t, J = 7.7 Hz, 1H), 7.27-7.22 (m, 2H), 5.36 (t, J = 5.2 Hz, 1H), 4.31 (d, J 
= 7.7 Hz, 1H), 4.05 (d, J = 7.7 Hz, 1H), 2.02-1.94 (m, 1H), 1.79-1.70 (m, 2H), 1.66 (s, 3H), 0.96 
(dd, J = 6.6, 4.0 Hz, 6H) (signals of the minor diastereomer are not included).  
13C NMR (125 MHz, C6D6) δ 142.5, 135.0, 130.2, 129.7, 128.5, 125.9, 125.6, 125.3, 125.3, 
123.5, 102.9, 82.6, 76.3, 43.6, 27.5, 25.0, 23.2, 23.2 (signals of the minor diastereomer are 
not included).  
HRMS (ESI+) m/z calculated for C18H22O2Na (M+Na) 293.1512, found 293.1509.  
GC (Column: 25 m Hydrodex-β-TBDAC (Heptakis-(2,3-di-O-acetyl-6-O-tert-butyldimethyl-
silyl)-β-cyclodextrin), i.D. 0.25 mm; Detector: FID; Temperature: injector 220 °C, detector 320 
°C, oven 145 °C; gas: 0.4 bar H2), major diastereomer: tmajor = 132.3 min; er >99.5:0.5, minor 
diastereomer: tminor = 120.1 min; er >99.5:0.5, dr = 93:1. 
 
(S)-2-(naphthalen-1-yl)propane-1,2-diol (6l) 
Yield: White solid, 45.5 mg, 45%. [α]25D = -2.7 ° (c 1.56, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 8.71 (d, J = 8.6 Hz, 1H), 7.66 (d, J = 8.0 Hz, 1H),  7.57 (d, J = 8.1 Hz, 
1H), 7.45 (d, J = 7.3 Hz, 1H), 7.31 (t, J = 7.6 Hz, 1H), 7.26 (t, J = 7.3 Hz, 1H), 7.20 (t, J = 7.7 Hz, 
1H), 3.90 (d, J = 10.9 Hz, 1H), 3.56 (d, J = 11.0 Hz, 1H), 2.62 (bs, 1H), 1.63 (bs, 1H), 1.56 (s, 
3H).  
13C NMR (125 MHz, C6D6) δ 140.8, 135.5, 131.8, 129.5, 129.0, 127.3, 125.6, 125.4, 125.2, 
124.4, 76.0, 70.0, 26.3.  
HRMS (EI (DE)) m/z calculated for C13H14O2 (M) 202.0994, found 202.0995.  
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HPLC (OD-3), n-heptane/i-PrOH 95:5, 1.0 ml/min, λ = 220 nm, tmajor = 14.72 min, tminor = 13.50 
min, er = 98.5:1.5.  
 
 
(2S,4R)-4-ethyl-2-isobutyl-4-phenyl-1,3-dioxolane (7m) 
Yield: Colorless oil, 52.0 mg, 44%. [α]25D = -51 ° (c 1.10, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.33-7.31 (m, 2H), 7.20-7.19 (overlapped with solvent, 2H), 7.08 
(t, J = 7.1 Hz, 1H), 5.25 (t, J = 5.2 Hz, 1H), 3.95 (d, J = 7.9 Hz, 1H), 3.70 (d, J = 7.9 Hz, 1H), 1.95 
(dt, J = 13.4, 6.7 Hz, 1H), 1.82-1.69 (m, 3H), 1.66-1.59 (m, 1H), 0.96-0.93 (m, 6H), 0.79 (t, J = 
7.3 Hz, 3H) (signals of the minor diastereomer are not included).  
13C NMR (125 MHz, C6D6) δ 145.0, 127.0, 125.7, 104.3, 84.9, 76.7, 43.7, 32.3, 25.1, 23.2, 23.1, 
8.6 (signals of the minor diastereomer are not included).  
HRMS (CI (DE) i-Butan) m/z calculated for C15H23O2 (M+H) 235.1698, found 235.1698.  
GC (Column: 25 m Lipodex G (Octakis-(2,3-di-O-pentyl-6-O-methyl)-γ-cyclodextrin), i.D. 0.25 
mm; Detector: FID; Temperature: injector 220 °C, detector 320 °C, oven 110 °C; gas: 0.5 bar 
H2), major diastereomer: tmajor = 30.8 min, tminor = 31.5 min; er = 98:2, minor diastereomer: 
tmajor = 29.2 min, tminor = 28.4 min; er = 99.5:0.5, dr = 36:1. 
 
(S)-2-phenylbutane-1,2-diol (6m) 
Yield: Colorless oil, 38.0 mg, 46%. [α]25D = -2 ° (c 2.20, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.32-1.29 (m, 2H), 7.19-7.17 (overlapped with solvent, 2H), 7.08 
(t, J = 7.3 Hz, 1H), 3.45-3.36 (m, 2H), 2.24 (s, 1H), 1.72-1.65 (m, 1H), 1.59-1.52 (m, 1H), 0.97 
(bs, 1H), 0.73 (t, J = 7.4 Hz, 3H).  
13C NMR (125 MHz, C6D6) δ 144.2, 128.4, 127.0, 126.0, 77.1, 70.6, 31.4, 7.7.  
HRMS (EI (DE)) m/z calculated for C10H14O2 (M) 166.0994, found 166.0992.  
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HPLC (OD-3), n-heptane/i-PrOH 95:5, 1.0 ml/min, λ = 210 nm, tmajor = 8.33 min, tminor = 7.66 
min, er = 99.5:0.5. 
 
 
(2S,4R)-2-isobutyl-4-isopropyl-4-phenyl-1,3-dioxolane (7n) 
Yield: Colorless oil, 60.3 mg, 49%. [α]25D = -31 ° (c 2.04, CH2Cl2). 
1H NMR (300 MHz, C6D6) δ 7.32-7.28 (m, 2H), 7.20-7.17 (overlapped with solvent, 2H), 7.11-
7.05 (m, 1H), 5.29 (t, J = 5.3 Hz, 1H), 4.10 (d, J = 8.3 Hz, 1H), 3.88 (d, J = 8.3 Hz, 1H), 1.99-1.83 
(m, 2H), 1.70-1.55 (m, 2H), 0.93-0.88 (m, 9H), 0.72 (d, J = 6.9 Hz, 3H) (signals of the minor 
diastereomer are not included).  
13C NMR (75 MHz, C6D6) δ 144.2, 126.9, 126.6, 105.3, 87.2, 74.6, 44.1, 36.5, 25.1, 23.1, 23.1, 
18.3, 17.6 (signals of the minor diastereomer are not included).  
HRMS (EI (DE)) m/z calculated for C16H24O2 (M) 248.1776, found 248.1778.  
GC (Column: 30 m BGB-176/SE-52 (2,3-dimethyl-6-tert-butyldimethyl-silyl-β-cyclodextrin), 
i.D. 0.25 mm; Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 120 °C to 
220 °C with 0.2 °C/min; gas: 0.4 bar H2), major diastereomer: tmajor = 41.9 min, tminor = 41.0 
min; er = 99.5:0.5, minor diastereomer: tmajor = 39.4 min; er >99.5:0.5, dr = 191:1. 
 
(S)-3-methyl-2-phenylbutane-1,2-diol (6n) 
Yield: White solid, 39.5 mg, 44%. [α]25D = -19 ° (c 1.90, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.31-7.28 (m, 2H), 7.18-7.15 (overlapped with solvent, 2H), 7.09-
7.06 (m, 1H), 3.59 (s, 2H), 2.55 (bs, 1H), 1.90-1.81 (m, 1H), 1.13 (bs, 1H), 0.89 (d, J = 6.8 Hz, 
3H), 0.72 (d, J = 6.9 Hz, 3H).  
13C NMR (125 MHz, C6D6) δ 144.0, 126.9, 126.6, 79.0, 68.4, 35.5, 17.6, 17.0.  
HRMS (ESI+) m/z calculated for C11H16O2Na (M+Na) 203.1042, found 203.1043.  
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HPLC (OD-3), n-heptane/i-PrOH 95:5, 1.0 ml/min, λ = 220 nm, tmajor = 7.84 min, tminor = 7.12 
min, er = 99:1. 
 
 
(2S,4S)-2,4-dimethyl-4-phenyl-1,3-dioxane (9b) 
Yield: Colorless oil, 52.3 mg, 54%. [α]25D = -49 ° (c 1.17, CH2Cl2). The absolute configuration of 
the quaternary carbon stereocenter was assigned opposite to the configuration in the 
recovered diol, and the relative configuration of the acetal stereocenter was determined 
from NOESY spectra.  
1H NMR (500 MHz, C6D6) δ 7.46 (dd, J = 8.4, 1.1 Hz, 2H), 7.23 (t, J = 7.8 Hz, 2H),  7.11 (t, J = 
7.4 Hz, 1H), 4.98 (q, J = 5.0 Hz, 1H), 3.70 (ddd, J = 11.6, 5.5, 1.5 Hz, 1H), 3.59 (dt, J = 12.4, 2.4 
Hz, 1H), 1.93 (dt, J = 13.0, 5.4 Hz, 1H), 1.45 (d, J = 5.0 Hz, 3H), 1.32 (s, 3H), 1.20 (td, J = 13.3, 
1.9 Hz, 1H) (signals of the minor diastereomer are not included).  
13C NMR (125 MHz, C6D6) δ 149.8, 128.4, 126.8, 124.3, 92.7, 74.3, 62.9, 36.1, 22.9, 22.0 
(signals of the minor diastereomer are not included).  
HRMS (ESI+) m/z calculated for C12H16O2Na (M+Na) 215.1042, found 215.1043.  
GC (Column: Supelco/Astec 30 m G-TA (γ-cyclodextrin-trifluoroacetyl), i.D. 0.25 mm; 
Detector: FID; Temperature: injector 220 °C, detector 320 °C, oven 80 °C to 180 °C with 1 
°C/min; gas: 0.6 bar H2), major diastereomer: tmajor = 31.3 min, tminor = 31.7 min; er = 91:9, 
minor diastereomer: tmajor = 25.1 min, tminor = 24.4 min; er = 97:3, dr = 17:1.  
 
(R)-3-phenylbutane-1,3-diol (8a) 
Yield: Colorless oil, 33.2 mg, 40%. [α]25D = +55 ° (c 0.9, C6H6), the absolute configuration was 
assigned by comparison with literature value.[169] 
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1H NMR (500 MHz, C6D6) δ 7.38 (d, J = 7.9 Hz, 2H), 7.21 (t, J = 7.7 Hz, 2H),  7.09 (t, J = 7.3 Hz, 
1H), 3.89 (bs, 1H), 3.43-3.39 (m, 1H), 3.35-3.31 (m, 1H), 2.29 (bs, 1H), 1.88-1.82 (m, 1H), 
1.73-1.69 (m, 1H), 1.41 (s, 3H).  
13C NMR (125 MHz, C6D6) δ 148.5, 128.4, 126.6, 125.3, 75.7, 60.3, 44.1, 31.2.  
HRMS (CI(FE) i-Butane) m/z calculated for C10H15O2 (M+H) 167.1072, found 167.1071.  
HPLC (OD-3), n-heptane/i-PrOH 98:2, 1.0 ml/min, λ = 210 nm, tmajor = 25.03 min, tminor = 22.61 
min, er = 99:1.  
 
NOESY experiments of compound 9b 
ppm
3.33.43.53.63.73.83.94.04.14.24.34.44.54.64.74.84.95.05.15.2 ppm
1.0
1.5
2.0
2.5
3.0
3.5
4.0
O
O
CH3
HH
B
A
C
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(2S,4S)-2,4-dimethyl-4-(naphthalen-1-yl)-1,3-dioxane (9g) 
Yield: Colorless oil, 66.4 mg, 55%. [α]25D = -13 ° (c 2.55, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 8.77 (d, J = 8.8 Hz, 1H), 7.71-7.69 (m, 1H), 7.61 (d, J = 8.2 Hz, 1H), 
7.56 (d, J = 7.3 Hz, 1H), 7.40-7.37 (m, 1H), 7.30-7.25 (m, 2H), 5.10 (q, J = 5.0 Hz, 1H), 3.81-
3.69 (m, 2H), 2.40 (td, J = 12.9, 5.6 Hz, 1H), 1.59 (s, 3H), 1.45 (d, J = 5.0 Hz, 3H), 1.43-1.39 (m, 
1H) (signals of the minor diastereomer are not included).  
13C NMR (75 MHz, C6D6) δ 144.0, 135.6, 131.2, 129.6, 128.9, 127.5, 125.3, 125.2, 125.1, 
122.7, 92.8, 76.1, 63.1, 35.7, 22.0, 21.9 (signals of the minor diastereomer are not included).  
HRMS (ESI+) m/z calculated for C16H18O2Na (M+Na) 265.1199, found 265.1199.  
GC (Column: 30 m Cyclodextrin-H/OV-1701 (2,3-dimethyl-3-pentyl-γ-cyclodextrin), i.D. 0.25 
mm; Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 120 °C; gas: 0.6 bar 
H2), major diastereomer: tmajor = 50.2 min, tminor = 50.6 min; er = 94.5:5.5, minor 
diastereomer: tmajor = 40.0 min, tminor = 38.3 min; er = 89:11, dr = 20:1. 
 
(R)-3-(naphthalen-1-yl)butane-1,3-diol (8g) 
Yield: Colorless oil, 40.9 mg, 38%. [α]25D = +12 ° (c 1.50, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 8.47 (d, J = 8.3 Hz, 1H), 7.79-7.76 (m, 1H), 7.71-7.68 (m, 1H), 7.60 
(d, J = 8.1 Hz, 1H), 7.33-7.23 (m, 3H), 3.46-3.36 (m, 2H), 3.27-3.18 (m, 1H), 2.36 (ddd, J = 
14.8, 6.2, 3.8 Hz, 1H), 2.00 (ddd, J = 14.8, 8.3, 4.2 Hz, 1H), 1.67 (s, 3H).  
13C NMR (75 MHz, C6D6) δ 143.7, 135.5, 131.2, 129.7, 128.7, 126.8, 125.5, 125.4, 125.2, 
124.3, 76.7, 60.5, 43.4, 30.2.  
HRMS (ESI+) m/z calculated for C14H16O2Na (M+Na) 239.1042, found 239.1043.  
HPLC (OD-3), n-heptane/i-PrOH 95:5, 1.0 ml/min, λ = 220 nm, tmajor = 18.00 min, tminor = 16.70 
min, er = 94.5:5.5. 
7. EXPERIMENTAL SECTION 
 
163 
 
(2S,4R)-4-cyclohexyl-2-isobutyl-4-methyl-1,3-dioxolane (7o) 
Yield: Colorless oil, 55.2 mg, 49%. [α]25D = -19 ° (c 2.00, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 5.11 (t, J = 5.1 Hz, 1H), 3.71 (d, J = 8.0 Hz, 1H),  3.29 (d, J = 7.9 Hz, 
1H), 2.00-1.86 (m, 2H), 1.73-1.55 (m, 7H), 1.46 (m, 1H), 1.23-1.08 (m, 3H), 1.05 (s, 3H), 0.96 
(d, J = 8.0 Hz, 3H), 0.93 (d, J = 1.0 Hz, 3H), 0.92-0.83 (m, 1H) (signals of the minor 
diastereomer are not included).  
13C NMR (75 MHz, C6D6) δ 102.9, 82.6, 74.0, 47.1, 43.7, 28.5, 27.9, 26.9, 26.9, 26.8, 25.0, 
23.3, 23.2, 20.6 (signals of the minor diastereomer are not included).  
HRMS (CI (FE) i-Butan) m/z calculated for C14H27O2 (M) 227.2011, found 227.2009.  
GC (Column: 25 m Lipodex G (Octakis-(2,3-di-O-pentyl-6-O-methyl)-γ-cyclodextrin), i.D. 0.25 
mm; Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 80 °C; gas: 0.4 bar 
H2), major diastereomer: tmajor = 44.3 min, tminor = 45.3 min; er = 95.5:4.5, minor 
diastereomer: tmajor = 46.0 min, tminor = 44.8 min; er = 96.5:3.5, dr = 11:1. 
 
(S)-2-cyclohexylpropane-1,2-diol (6o) 
Yield: White solid, 35.3 mg, 45%. [α]25D = -11 ° (c 1.07, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 3.32 (d, J = 10.7 Hz, 1H), 3.18 (d, J = 10.7 Hz, 1H), 1.87 (m, 7H), 
1.42-1.32 (m, 1H), 1.25-0.96 (m, 4H), 0.93 (s, 3H), 0.90-0.72 (m, 2H).  
13C NMR (75 MHz, C6D6) δ 74.3, 68.6, 45.3, 28.0, 27.1, 26.9, 20.4.  
HRMS (ESI+) m/z calculated for C9H18O2Na (M+Na) 181.1199, found 181.1200.  
GC (Column: 30 m BGB-178/BGB-15 (2,3-diethyl-6-tert-butyldimethyl-silyl-β-cyclodextrin), 
i.D. 0.25 mm; Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 80 °C to 
140 °C with 0.5 °C/min; gas: 0.4 bar H2), tmajor = 56.95 min, tminor = 57.58 min; er = 95.5:4.5. 
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(2S,4R)-2-isobutyl-4-methyl-4-pentyl-1,3-dioxolane (7p) 
Yield: Colorless oil, 58.4 mg, 54%. [α]25D = -10 ° (c 2.18, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 5.13 (t, J = 5.09 Hz, 1H), 3.61 (d, J = 7.9 Hz, 1H), 3.33 (d, J = 7.9 Hz, 
1H), 2.02-1.88 (m, 1H), 1.73-1.69 (m, 2H), 1.52-1.19 (m, 8H), 1.09 (s, 3H), 0.95 (dd, J = 6.7, 0.8 
Hz, 6H), 0.87 (t, J = 7.0 Hz, 3H) (signals of the minor diastereomer are not included or 
overlapped with major diastereomer. For NMR characterization of the minor diastereomer 
see epi-7p from the stereodivergent resolution).  
13C NMR (75 MHz, C6D6) δ 103.2, 80.3, 75.1, 43.9, 40.6, 32.7, 25.0, 24.3, 23.5, 23.3, 23.0, 14.2 
(signals of the minor diastereomer are not included. For NMR characterization of minor 
diastereomer see epi-7p from stereodivergent resolution).  
HRMS (CI (DE)) m/z calculated for C13H27O2 (M) 215.2011, found 215.2012.  
GC (Column: 30 m BGB-178/BGB-15 (2,3-diethyl-6-tert-butyldimethyl-silyl-β-cyclodextrin), 
i.D. 0.25 mm; Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 80 °C to 
105 °C with 0.2 °C/min; gas: 0.3 bar H2), major diastereomer: tmajor = 92.3 min, tminor = 90.5 
min; er = 98.5:1.5, minor diastereomer: tmajor = 93.5 min; er >99.5:0.5, dr = 4:1. 
 
(S)-2-methylheptane-1,2-diol (6p) 
Yield: Colorless oil, 24.4 mg, 33%. [α]25D = -2 ° (c 0.90, CH2Cl2).  
1H NMR (300 MHz, C6D6) δ 3.21 (d, J = 10.6 Hz, 1H), 3.14 (d, J = 10.6 Hz, 1H), 1.51 (bs, 2H), 
1.30-1.20 (m, 8H), 0.98 (s, 3H), 0.89 (t, J = 6.9 Hz, 3H).  
13C NMR (75 MHz, C6D6) δ 72.5, 70.0, 39.1, 32.9, 23.7, 23.5, 23.0, 14.3.  
HRMS (ESI+) m/z calculated for C8H18O2Na (M+Na) 169.1199, found 169.1200.  
GC (Column: 25 m Hydrodex-β-TBDAC (Heptakis-(2,3-di-O-acetyl-6-O-tert-butyldimethyl-
silyl)-β-cyclodextrin), i.D. 0.25 mm; Detector: FID; Temperature: injector 220 °C, detector 350 
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°C, oven 80 °C to 135 °C with 1 °C/min; gas: 0.4 bar H2), tmajor = 46.3 min, tminor = 47.3 min; er 
= 93:7.  
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7.3.3. Determination of conversion and selectivity factors 
 
The ee and dr values used for the calculations of conversions and s-factors were obtained 
from the relative area values given in HPLC and GC traces and were not significantly rounded 
before the calculations. Conversions were calculated from ee values of recovered starting 
materials and ee and dr (dr = n(B)/n(C)) values of products using formula (1). 
 
The formula was derived from two reasonable assumptions[56]: 
a) Since the reactions are very clean and no observable byproducts are formed, the 
conversion can be represented by (2). 
 
b) The alcohol stereocenter is not racemizing under the reaction conditions. The 
absolute configuration of this stereocenter in the major enantiomer of the major 
diastereomer is opposite to the configuration in the major enantiomer of the minor 
diastereomer and the starting material. As the starting material is racemic, the total 
number of molecules which have a tertiary alcohol derived stereocenter in S 
configuration has to be equal to the total number of molecules which have this 
stereocenter in R configuration: 
 
Reorganizing (3) gives : 
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and from the definition of ee value (X being A, or B, or C): 
 
we get: 
 
Using n(C) = n(B)/dr, gives, after rearrangement: 
 
Placing this expression for n(A) into (2), gives after cancelling n(B), an expression which can 
be simplified to (1). 
 
S-factors were determined using conversion from (1) and ee of the recovered starting 
material according to literature.[141] 
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7.3.4. Synthesis of catalyst 5k  
(performed by I. Čorić)[68] 
NaH
THF
+
OMe
OMe
B(OH)2
B(OH)2
BBr3 OTf
Cy
Pd(PPh3)4
Cy = cyclohexyl
5ka5kb5kc
5kd 5ke 5k
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O
NH2
OH
Tf2O, py, DCM
POCl3
py, r.t.
1) POCl3, py, r.t.
2) NH3
 
 
2-cyclohexyl-5-methylphenyl trifluoromethanesulfonate 
Trifluoromethanesulfonic anhydride (6.1 ml, 10.2 g, 36 mmol) was added 
dropwise to the solution of 2-cyclohexyl-5-methylphenol (5.71 g, 30 
mmol) and pyridine (7.3 ml) in dry CH2Cl2 (30 ml) at 0 °C under argon. The 
mixture was stirred at room temperature for 19.5 h. Then water (60 ml) was added and the 
mixture was extracted with CH2Cl2. The combined organic extracts were washed with aq. 1 N 
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HCl, water, and brine, dried (MgSO4), filtered, and the solvent was removed under reduced 
pressure yielding the title compound as a colorless liquid. Yield: 9.28 g, 96%. 
1H NMR (500 MHz, CDCl3) δ 7.24 (d, J = 7.9 Hz, 1H), 7.13 (d, J = 8.0 Hz, 1H), 7.03 (s, 1H), 2.85-
2.79 (m, 1H), 2.34 (s, 3H), 1.85-1.75 (m, 5H), 1.46-1.34 (m, 4H), 1.30-1.22 (m, 1H). 
13C NMR (125 MHz, CDCl3) δ 147.1, 137.8, 137.2, 129.4, 128.2, 121.7, 118.8 (q, J(C-F) = 320 
Hz), 37.2, 33.7, 26.8, 26.1, 21.0. 
HRMS (ESI+) m/z calculated for C14H17O3F3SNa (M+Na) 345.0743, found 345.0745. 
 
(S)-3,3'-bis(2-cyclohexyl-5-methylphenyl)-2,2'-dimethoxy-1,1'-binaphthalene (5kb) 
A suspension of 5ka (2.41 g, 6.0 mmol), 2-cyclohexyl-5-
methylphenyl trifluoromethanesulfonate (7.73 g, 24 mmol) and 
Ba(OH)2·8H2O (7.5 g, 24 mmol) in dioxane/water 3:1 (60 ml) was 
degassed by bubbling argon gas for 15 min. Pd(PPh3)4 (348 mg, 0.3 
mmol) was added and the mixture was stirred for 1.5 h at room 
temperature, and further 1 h at 100 °C. After being cooled at room 
temperature, water (500 ml) was added and the mixture extracted with CH2Cl2 (2 · 250 ml). 
Combined organic extracts were washed with water (500 ml), dried (MgSO4), filtered, and 
the solvent removed under reduced pressure. The residue was purified by column 
chromatography on silica gel using 10-40% CH2Cl2/hexane as the eluents yielding the title 
compound as a colorless solid (2.35 g, 59%). 
1H NMR (500 MHz, CD2Cl2) δ 7.94-7.90 (m, 2H), 7.85-7.79 (4 singlets, 2H), 7.46-7.40 (m, 2H), 
7.35-7.20 (m, 10H), 3.20 (s, 1.6H), 3.19 (s, 1.6H), 3.06 (s, 1.25H), 3.05 (s, 1.55H), 2.72-2.54 
(m, 2H), 2.40 (s, 3.2H), 2.39 (s, 1.25H), 2.37 (s, 1.55H), 1.95-1.48 (m, 11.8H), 1.35-1.11 (m, 
7H), 1.01-0.89 (m, 1.4H) (spectra complicated due to presence of rotamers). 
13C NMR (125 MHz, CD2Cl2) δ 155.4, 154.7, 154.6, 154.6, 144.4, 144.2, 144.1, 143.9, 138.4, 
138.2, 138.1, 138.0, 136.7, 136.4, 136.2, 135.8, 135.2, 135.1, 134.9, 134.2, 134.1, 133.9, 
133.9, 131.9, 131.7, 131.6, 131.3, 131.2, 131.2, 131.1, 131.1, 131.0, 130.9, 130.8, 129.0, 
129.0, 128.9, 128.8, 128.4, 128.3, 126.5, 126.5, 126.3, 126.3, 126.1, 126.1, 126.0, 126.0, 
125.6, 125.3, 125.3, 125.2, 125.0, 125.0, 124.9, 61.2, 61.0, 60.8, 60.6, 41.4, 41.3, 41.0, 40.7, 
36.1, 36.0, 35.8, 33.5, 33.4, 33.4, 33.3, 27.7, 27.6, 27.5, 27.4, 27.3, 27.2, 27.0, 26.7, 26.6, 
26.6, 26.4, 21.1 (spectra complicated due to presence of rotamers).  
OMe
OMe
Cy
Cy
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HRMS (ESI+) m/z calculated for C48H50O2Na (M+Na) 681.3703, found 681.3704. 
 
(S)-3,3'-bis(2-cyclohexyl-5-methylphenyl)-[1,1'-binaphthalene]-2,2'-diol (5kc) 
A 1 M solution of BBr3 in CH2Cl2 (14.3 ml, 14.3 mmol) was added 
dropwise to the solution of (S)-5kb (2.35 g, 3.57 mmol) in CH2Cl2 (37 
ml) at 0 °C under argon. After 23 h at room temperature, the 
solution was cooled to 0 °C, water (110 ml) was carefully added, and 
the mixture was extracted with CH2Cl2. The organic layer was 
washed with saturated aqueous Na2CO3 solution (100 ml), dried 
(MgSO4), filtered, and the solvent was removed under reduced pressure. The residue was 
purified by column chromatography on silica gel using 30% CH2Cl2/hexane as the eluent 
yielding the title compound as a colorless solid. Yield: 1.95 g, 87%. 
1H NMR (500 MHz, CD2Cl2) δ 7.94-7.83 (m, 4H), 7.44-7.17 (m, 12H), 5.20 (s, 0.4H), 5.15 (s, 
1H), 5.13 (s, 0.6H), 3.62-2.56 (m, 1.4H), 2.52-2.43 (m, 0.7H), 2.40 (s, 1.1H), 2.39 (s, 1.9H), 
2.37 (s, 3.0H), 1.86-1.60 (m, 9.7H), 1.58-1.44 (m, 2H), 1.44-1.13 (m, 7.3H), 1.09-0.94 (m, 
1.3H) (spectra complicated due to presence of rotamers). 
13C NMR (125 MHz, CD2Cl2) δ 151.1, 150.9, 150.9, 150.8, 144.5, 144.5, 144.4, 136.2, 136.0, 
135.9, 135.9, 135.8, 135.8, 133.9, 133.7, 133.6, 133.5, 131.6, 131.6, 131.5, 131.5, 131.4, 
131.4, 131.3, 129.7, 129.7, 129.7, 129.6, 128.8, 128.8, 128.7, 128.7, 127.3, 127.1, 126.8, 
126.6, 126.6, 126.5, 124.9, 124.5, 124.4, 124.4, 124.3, 113.0, 112.9, 112.8, 112.7, 41.4, 41.4, 
41.3, 35.5, 35.4, 35.3, 35.3, 34.2, 34.1, 34.0, 33.8, 27.6, 27.5, 27.3, 27.3, 26.6, 26.5, 21.0, 21.0 
(spectra complicated due to presence of rotamers). 
HRMS (ESI+) m/z calculated for C46H46O2Na (M+Na) 653.3390, found 653.3394. 
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(S)-4-chloro-2,6-bis(2-cyclohexyl-5-methylphenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphos-
phepine 4-oxide (5kd) 
To a solution of (S)-5kc (500 mg, 0.793 mmol) in pyridine (2.6 ml) 
under argon was added POCl3 (222 μl, 365 mg, 2.38 mmol) at room 
temperature. The mixture was stirred at room temperature for 17 h 
and then concentrated to dryness under vacuum. The residue was 
passed through a short silica gel column (13 g) using 50-100% 
CH2Cl2/hexane as eluents yielding the title compound as a colorless 
solid. Yield: 512 mg, 91%. 
1H NMR (500 MHz, CD2Cl2) δ 8.05-7.93 (m, 4H), 7.61-7.56 (m, 2H), 7.44-7.35 (m, 4.5H), 7.30-
7.19 (m, 5.3H), 7.12-7.11 (m, 0.2H), 2.80-2.63 (m, 0.4H), 2.43-2.31 (m including large singlets 
at 2.39, 2.37 and 2.31 ppm, 7.6H), 2.26-2.23 (m, 0.3H), 2.10-2.06 (m, 0.2H), 1.89-1.40 (m, 
11.6H), 1.36-1.08 (m, 4.7H), 1.01-0.84 (m, 3.2H) (spectra complicated due to presence of 
rotamers). 
13C NMR (125 MHz, CD2Cl2) δ 144.9, 144.9, 144.8, 144.8, 144.2, 144.0, 143.9, 143.6, 143.3, 
135.2, 135.2, 135.1, 135.0, 134.7, 134.6, 134.4, 134.1, 134.1, 134.0, 133.9, 133.1, 132.9, 
132.9, 132.8, 132.5, 132.5, 132.4, 132.3, 132.2, 132.1, 132.0, 131.7, 131.6, 129.8, 129.7, 
129.6, 129.5, 128.9, 128.8, 127.6, 127.4, 127.4, 127.3, 127.2, 127.1, 127.1, 127.0, 126.9, 
126.9, 126.8, 126.1, 126.0, 126.0, 122.1, 122.1, 122.1, 122.1, 41.6, 41.6, 41.5, 41.5, 40.8, 
40.8, 40.7, 37.9, 36.8, 35.8, 35.7, 35.3, 34.2, 33.8, 33.6, 33.0, 32.9, 27.5, 27.4, 27.3, 27.3, 
27.2, 27.1, 26.9, 26.6, 26.4, 21.0, 21.0, 20.9 (including signals due to the presence of 
rotamers and unassigned C-P-coupling). 
31P NMR (202 MHz, CD2Cl2) δ 7.57 (major), 7.34, 7.21 (spectra complicated due to the 
presence of rotamers). 
HRMS (ESI+) m/z calculated for C46H44O3ClPNa (M+Na) 733.2609, found 733.2611. 
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(S)-4-amino-2,6-bis(2-cyclohexyl-5-methylphenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphos-
phepine 4-oxide (5ke) 
To a solution of (S)-5kc (416 mg, 0.66 mmol) in pyridine (2.1 ml) 
under argon was added POCl3 (185 μl, 304 mg, 1.98 mmol) at room 
temperature. After 18.5 h at room temperature, the mixture was 
cooled to –78 °C and anhydrous ammonia gas was condensed into 
the reaction flask (ca. 10 ml). The cooling bath was removed and the 
mixture was allowed to warm to room temperature. The reaction 
mixture was then concentrated to dryness under vacuum. Residue was passed through short 
silica gel column (20 g) using 0-64% EtOAc/CH2Cl2 as eluents yielding the title compound as a 
colorless solid. Yield: 402 mg, 88%. 
1H NMR (500 MHz, CD2Cl2) δ 8.09 (d, J = 8.2 Hz, 0.24H), 8.02-7.88 (m, 3.5H), 7.80 (s, 0.24H), 
7.61-7.51 (m, 2H), 7.46-7.30 (m, 5.7H), 7.27-7.09 (m, 3.8H), 7.01 (d, J = 1.1 Hz, 0.23H), 2.76-
2.63 (m, 2.4H), 2.44-2.21 (m including large singlet at 2.38 ppm, 7H), 2.09-1.77 (m, 2.6), 1.71-
1.08 (m, 14.7H), 1.03-0.82 (m, 3.2H) (spectra complicated due to the presence of rotamers). 
13C NMR (125 MHz, CD2Cl2) δ 145.5, 145.4, 144.9, 144.8, 144.4, 144.3, 144.0, 143.6, 142.8, 
136.3, 136.2, 136.1, 136.1, 135.3, 135.1, 135.0, 134.6, 134.6, 134.6, 134.4, 134.4, 133.7, 
132.7, 132.6, 132.5, 132.4, 132.2, 132.2, 132.1, 132.0, 131.9, 131.9, 131.8, 131.3, 131.2, 
129.7, 129.6, 129.5, 129.3, 128.8, 128.7, 128.7, 128.4, 127.5, 127.3, 127.1, 127.1, 127.0, 
126.9, 126.8, 126.8, 126.4, 126.3, 126.3, 126.2, 126.1, 125.7, 123.1, 122.6, 122.5, 122.5, 
122.2, 122.2, 41.5, 41.3, 41.3, 40.9, 40.3, 37.5, 36.6, 35.7, 35.6, 35.2, 34.5, 33.9, 33.8, 33.7, 
33.0, 27.6, 27.5, 27.4, 27.3, 27.2, 27.1, 27.0, 26.7, 26.6, 26.5, 26.4, 21.1, 21.0, 21.0, 21.0, 20.7 
(including signals due to the presence of rotamers and unassigned C-P-coupling). 
31P NMR (202 MHz, CD2Cl2) δ 13.8, 12.0 (major), 11.7 (spectra complicated due to the 
presence of rotamers). 
HRMS (ESI+) m/z calculated for C46H46NO3PNa (M+Na) 714.3107, found 714.3105. 
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Imidodiphosphoric acid 5k 
Sodium hydride (60% dispersion of in mineral 
oil, 83 mg, 2.08 mmol) was added to a 
solution of (S)-5ke (359 mg, 0.519 mmol) and 
(S)-5kd (442 mg, 0.622 mmol) in THF (3.9 ml) 
under argon at room temperature. After 18 h 
at room temperature, 10% aqueous HCl 
solution (5 ml) and DCM (5 ml) were added, and the mixture was stirred for 10 min. The 
organic layer was separated, and aqueous layer was extracted with DCM (2 · 10 ml). Organic 
layers were combined, and the solvent removed under reduced pressure. The residue was 
purified by column chromatography on aluminum oxide (activity III, 20 g) using 50% 
DCM/hexane and 0-32% EtOAc/DCM as the eluents giving a colorless solid. The solid was 
dissolved in CH2Cl2 (10 ml) and stirred with 10% aqueous HCl (10 ml) for 10 min. The organic 
layer was separated, washed with 10% aqueous HCl (10 ml), and concentrated under 
reduced pressure to give the title compound as a colorless solid. Yield: 386 mg, 54%. 
1H NMR (500 MHz, DMSO-d6) δ 8.33 (s, 0.7H), 8.19 (d, J = 8.0 Hz, 0.7H), 8.05-7.97 (m, 3.4H), 
7.88-7.81 (m, 2.0H), 7.56-7.54 (m, 2.0H), 7.43-7.38 (m, 3.7H), 7.33-7.19 (m, 7.9H), 7.13-6.94 
(m, 6.8H), 6.84-6.72 (m, 2.7H), 6.61-6.60 (m, 0.9H), 6.49 (s, 0.1H), 6.21 (s, 0.1H), 6.14-6.11 
(m, 0.8H), 5.93 (s, 0.1H), 5.51 (bs, 3H, acidic H+ water), 2.62-2.60 (m, 1.0H), 2.31 (s, 2.3H), 
2.27 (s, 2.3H), 2.20-2.14 (m, 3.9H), 2.08 (s, 0.5H), 1.98-0.96 (m, 40.0H), 0.67-0.63 (m, 3.2H), 
0.53-0.45 (m, 4.1H), 0.26-0.24 (m, 0.9H), -0.42 to -0.45 (m, 0.6H). 
13C NMR (125 MHz, DMSO-d6) δ 147.2, 146.0, 145.9, 142.2, 142.0, 141.9, 141.8, 135.8, 135.7, 
135.6,,134.8, 134.2, 133.7, 133.5, 133.2, 133.0, 132.6, 131.9, 131.5, 131.3, 131.2, 131.0, 
130.6, 130.5, 130.1, 129.9, 129.6, 129.5, 128.6, 128.3, 128.2, 128.2, 128.1, 127.5, 126.4, 
125.8, 125.5, 125.1, 125.0, 124.8, 124.0, 123.7, 122.7, 121.9, 121.1, 120.5, 35.5, 35.1, 34.8, 
34.3, 33.9, 33.4, 32.9, 32.6, 30.1, 26.7, 26.6, 26.6, 26.4, 25.8, 25.5, 25.4, 25.4, 25.3, 20.8, 
20.3, 20.1, 20.0 (spectra complicated due to the presence of rotamers, C-P-coupling was not 
assigned). 
31P NMR (202 MHz, DMSO-d6) δ 3.6, -15.7 (major), 14.9, 0.4, 0.1, -1.3 (minor) (spectra 
complicated due to the presence of rotamers). 
HRMS (ESI–) m/z calculated for C92H88NO6P2 (M–H) 1364.6092, found 1364.6091. 
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7.3.5. Stereodivergent resolution of diols 
Resolution of rac-6p 
 
Aldehyde 3a (2.0 mmol) was added to the mixture of diol rac-6p (0.50 mmol), catalyst 5i (5 
mol%) and 5 Å molecular sieves (100 mg) in toluene (5 ml). The mixture was stirred 
vigorously at 20 °C for 5 days and then quenched by adding a few drops of triethylamine. 
The purification was performed by column chromatography on silica gel, using 
CH2Cl2/pentane solvent gradient between 0-100%. 
 
(2S,4R)-2-isobutyl-4-methyl-4-pentyl-1,3-dioxolane (7p) 
Yield: Colorless oil, 47.4 mg, 44%.  
1H NMR (300 MHz, C6D6) δ 5.13 (t, J = 5.09 Hz, 1H), 3.61 (d, J = 7.9 Hz, 1H), 3.33 (d, J = 7.9 Hz, 
1H), 2.02-1.88 (m, 1H), 1.73-1.69 (m, 2H), 1.52-1.19 (m, 8H), 1.09 (s, 3H), 0.95 (dd, J = 6.7, 0.8 
Hz, 6H), 0.87 (t, J = 7.0 Hz, 3H)  
13C NMR (75 MHz, C6D6) δ 103.2, 80.3, 75.1, 43.9, 40.6, 32.7, 25.0, 24.3, 23.5, 23.3, 23.0, 
14.2.  
HRMS (CI (DE)) m/z calculated for C13H27O2 (M) 215.2011, found 215.2012.  
GC (Column: 25 m Cyclodextrin-H (2,3-dimethyl-3-pentyl-γ-cyclodextrin), i.D. 0.25 mm; 
Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 100 °C to 115 °C with 0.5 
°C/min; gas: 0.3 bar H2), tmajor = 20.2 min, tminor = 17.3 min; er = 95.5:4.5, dr >100:1. 
 
(2S,4S)-2-isobutyl-4-methyl-4-pentyl-1,3-dioxolane (epi-7p) 
Yield: Colorless oil, 42.8 mg, 40%.  
1H NMR (500 MHz, C6D6) δ 5.12 (t, J = 5.1 Hz, 1H), 3.52 (d, J = 7.9 Hz, 1H), 3.43 (d, J = 7.9 Hz, 
1H), 2.02-1.90 (m, 1H), 1.75-1.70 (m, 2H), 1.57-1.44 (m, 1H), 1.41-1.18 (m, 7H), 1.17 (s, 3H), 
0.95 (dd, J = 6.7, 4.0 Hz, 6H), 0.88 (t, J = 7.1 Hz, 3H).  
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13C NMR (125 MHz, C6D6) δ 103.8, 80.4, 75.6, 44.3, 38.9, 32.7, 25.1, 25.0, 24.3, 23.3, 23.2, 
23.0, 14.3.  
GC (Column: 25 m Cyclodextrin-H (2,3-dimethyl-3-pentyl-γ-cyclodextrin), i.D. 0.25 mm; 
Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 100 °C to 115 °C with 0.5 
°C/min; gas: 0.3 bar H2), tmajor = 17.9 min, tminor = 19.8 min; er = 99:1, dr = 88:1. 
 
Methanolysis[170] for (R)-6p, (S)-6p 
(±)-Camphorsulfonic acid (30 mol%) was added to the acetal in MeOH (0.1 M). The mixture 
was stirred at r.t. for 22 h and then quenched by adding a few drops of triethylamine. The 
purification was performed by column chromatography on silica gel, using EtOAc/hexanes 
solvent gradient between 0-100%. 
 
(R)-2-methylheptane-1,2-diol ((R)-6p) 
Yield: Colorless oil, 94%.  
[α]23D = +1.2 ° (c 0.8, CHCl3), lit.
[171] [α]23D = +1.9 ° (c 1.0, CHCl3) for (R)-
enantiomer of 78% ee.  
GC (Column: 30 m Hydrodex-β-TBDAC (Heptakis-(2,3-di-O-acetyl-6-O-
tert-butyldimethyl-silyl)-β-cyclodextrin), i.D. 0.25 mm; Detector: FID; Temperature: injector 
220 °C, detector 350 °C, oven 80 °C to 130 °C with 1 °C/min; gas: 0.4 bar H2), tmajor = 47.5 
min, tminor = 48.1 min; er = 95.5:4.5. 
 
(S)-2-methylheptane-1,2-diol ((S)-6p) 
Yield: Colorless oil, 93%.  
[α]23D = -3.4 ° (c 1.1, CHCl3).  
GC (Column: 30 m Hydrodex-β-TBDAC (Heptakis-(2,3-di-O-acetyl-6-O-
tert-butyldimethyl-silyl)-β-cyclodextrin), i.D. 0.25 mm; Detector: FID; 
Temperature: injector 220 °C, detector 350 °C, oven 80 °C to 130 °C with 1 °C/min; gas: 0.4 
bar H2), tmajor = 47.4 min, tminor = 48.2 min; er = 98:2. 
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Resolution of rac-6a 
 
Aldehyde 3a (2.0 mmol) was added to the mixture of diol rac-6a (0.50 mmol), catalyst 5k (5 
mol%) and 5 Å molecular sieves (100 mg) in toluene (5 ml). The mixture was stirred 
vigorously at 15 °C for 4 days and then quenched by adding a few drops of triethylamine. 
The purification was performed by column chromatography on silica gel, using 
CH2Cl2/hexanes solvent gradient between 0-100%.  
 
(2S,4S)-2-isobutyl-4-phenethyl-1,3-dioxolane (epi-7a) 
Yield: Colorless oil, 53.8 mg, 46%. [α]25D = -6.8 ° (c 0.5, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.17-7.03 (m, 5H), 5.08 (t, J = 5.2 Hz, 1H), 3.87-3.82 (m, 1H), 3.77 
(dd, J = 8.0, 6.2 Hz, 1H), 3.13 (dd, J = 7.9, 7.2 Hz, 1H), 2.67-2.62 (m, 1H), 2.50-2.44 (m, 1H), 
1.98-1.90 (m, 1H), 1.77-1.71 (m, 1H), 1.68 (dd, J = 6.9, 5.2 Hz, 2H), 1.43-1.36 (m, 1H), 0.95-
0.94 (m, 6H).  
13C NMR (125 MHz, C6D6) δ 142.0, 128.8, 128.7, 126.2, 103.4, 75.1, 70.4, 43.6, 35.5, 32.5, 
25.0, 23.2, 23.2.  
GC (Column: 25 m Hydrodex-β-TBDAC (Heptakis-(2,3-di-O-acetyl-6-O-tert-butyldimethyl-
silyl)-β-cyclodextrin), i.D. 0.25 mm; Detector: FID; Temperature: injector 220 °C, detector 350 
°C, oven 80 °C to 133 °C with 0.3 °C/min, then to 245 °C with 10 °C/min; gas: 0.5 bar H2), 
tmajor = 166.3 min, tminor = 166.9 min; er = 99.5:0.5, dr = 85:1. 
 
(2S,4R)-2-isobutyl-4-phenethyl-1,3-dioxolane (7a) 
Yield: Colorless oil, 55.2 mg, 47%. [α]25D = -1.2 ° (c 0.5, CH2Cl2).  
1H NMR (500 MHz, C6D6) δ 7.15-7.03 (m, 5H), 4.93 (t, J = 5.1 Hz, 1H), 3.74-3.69 (m, 1H), 3.54 
(dd, J = 7.5, 7.0 Hz, 1H), 3.29 (dd, J = 7.65, 6.5 Hz, 1H), 2.68-2.62 (m, 1H), 2.56-2.50 (m, 1H), 
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1.99-1.91 (m, 1H), 1.83-1.76 (m, 1H), 1.73 (dd, J = 6.9, 5.1 Hz, 2H), 1.58-1.51 (m, 1H), 0. 94 (d, 
J = 6.7 Hz, 6H).  
13C NMR (125 MHz, C6D6) δ 142.0, 128.8, 128.7, 126.2, 104.2, 75.8, 69.6, 43.6, 35.9, 32.4, 
25.0, 23.3, 23.2.  
GC (Column: 25 m Hydrodex-β-TBDAC (tert-butyl-diacetyl-cyclodextrin), i.D. 0.25 mm; 
Detector: FID; Temperature: injector 220 °C, detector 350 °C, oven 80 °C to 133 °C with 0.3 
°C/min, then to 245 °C with 10 °C/min; gas: 0.5 bar H2), tmajor = 158.2 min, tminor = 159.3 min; 
er = 96.5:3.5, dr >100:1. 
 
Methanolysis for (S)-6a, (R)-6a 
(±)-Camphorsulfonic acid (60 mol%) was added to the acetal in MeOH (0.025 M). The 
mixture was stirred at reflux for 2 days and then quenched by adding a few drops of 
triethylamine. The purification was performed by column chromatography on silica gel after 
evaporation of MeOH, using 80% EtOAc/hexanes. 
 
(S)-4-phenylbutane-1,2-diol ((S)-6a) 
Yield: Colorless oil, 92% 
[α]20D = -12.5 ° (c 1.2, CHCl3), lit.
[135] [α]20D = -16.2 ° (c 1.1, CHCl3) for (S)-
enantiomer of 94% ee.  
HPLC (OD-3), n-heptane/i-PrOH 95:5, 1.0 ml/min, λ = 210 nm, tmajor = 28.34 min, tminor = 18.89 
min, er = 98.5:1.5. 
 
(R)-4-phenylbutane-1,2-diol ((R)-6a) 
Yield: Colorless oil, 93%. 
[α]20D = +12.4 ° (c 0.9, CHCl3).  
HPLC (OD-3), n-heptane/i-PrOH 95:5, 1.0 ml/min, λ = 210 nm, tmajor = 18.5 
min, tminor = 28.7 min, er = 96.5:3.5. 
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